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In chapter 2, a novel and atom-economical synthesis of fully substituted 
4-aminoimidazoles via gold-catalyzed selective [3+2] annulation of 1,2,4-oxadiazoles 
with ynamides is achieved. This protocol represents a new strategy to access α-imino 
gold carbenes, which corresponds to an unprecedented intermolecular transfer of 
N-acylimino nitrenes to ynamides. Moreover, the reaction proceeds with 100% atom 




Chapter 3 describes a novel, short, and flexible approach to diverse N-doped 
polycyclic aromatic hydrocarbons (PAHs) through gold-catalyzed π-extension of 
anthranils with o-ethynylbiaryls as reagents. This strategy uses easily accessible 
starting materials, is simple due to high step and atom economy, and shows good 
functionalgroup compatibility as well as scale-up potential. Mechanistically, the 
tandem reaction is proposed to involve a nucleophilic addition/ring 
opening/regiospecific C–H annulation/protodeauration sequence terminated by a 
Friedel-Crafts-type cyclization. Photophysical studies of the products indicated 
violetblue fluorescence emission with quantum yields up to 0.45. 
 
X 
In chapter 4, a facile, site-selective and divergent approach to construct 
2-aminopyrroles and quinoline-fused polyazaheterocycles is enabled by a simple 
gold(III) catalyst from ynamides and anthranils under mild reaction condition. This 
one-pot strategy uses readily available starting materials, proceeds in a highly step- 
and atom-economical manner, with broad substrate scope and scale-up potential. 
Notably, the key element of success in the present tandem reaction is a 
catalyst-directed preferable quenching of the in-situ generated gold carbene 
intermediates by a nucleophilic benzyl/2-furanylmethyl moiety on the ynamides as an 
alternative to the known C–H annulation leading to indoles. 
 
 
In chapter 5, a gold-catalyzed regioselective cyclocarboamination of ynamides with 
1,3,5-triazinanes provides facile and modular access to valuable 
5-aminotetrahydropyrimidines in good to excellent yields. It constitutes an 
unprecedented yet challenging annulation of ynamides with unstrained saturated 
heterocycles. This new protocol is distinguished by easy operation, readily available 
starting materials, stable four-atom building units, good functional-group 
compatibility and scaling-up potential. The preliminary mechanistic studies indicate 
that the present intermolecular cyclocarboamination arises from a pseudo-three- 




In Kapitel 2 wurde eine neue und atomökonomische Synthese von voll substituierten 
4-Aminoimidazolen über eine goldkatalysierte selektive [3+2] Annulierung von 
1,2,4-Oxadiazolen mit Inamiden erzielt. Dieses Protokoll repräsentiert eine neue 
Strategie, α-imino Goldcarbene durch einen noch nicht da gewesenen Transfer von 
N-Acylimino Nitrenen auf Inamide herzustellen. Die Reaktion verläuft außerdem mit 
100% Atomökonomie, weist eine hohe Toleranz bezüglich funktioneller Gruppen auf 
und kann im Gramm Maßstab durchgeführt werden. 
 
 
Kapitel 3 beschreibt einen neuen, kurzen und flexiblen Weg zu verschiedenen 
N-haltigen polycyclischen aromatischen Kohlenwasserstoffen (PAK) über eine 
goldkatalysierte π-Erweiterungsreaktion von Anthranilen mit o-Ethinylbiarylen als 
Reagenzien. Diese Strategie nutzt leicht zugängliche Edukte, ist aufgrund einer hohen 
Stufen- und Atomökonomie einfach und zeigt eine gute Toleranz gegenüber 
funktionellen Gruppen, ein Hochskalieren ist ebenfalls mölich. Der mechanistische 
Vorschlag für die Tandemreaktion beinhaltet eine nukleophile 
Addition/Ringöffnung/regiospezifische C-H-Anellierung/Protodesaurierung und 
abschließend eine Friedel-Crafts-artige Cyclisierung. Photophysikalische Studien der 




In Kapitel 4 wird ein einfacher, ortsselektiver und divergenter Zugang zum Aufbau 
von 2-Aminopyrrolen und Chinolin-verknüpften Polyazaheterocyclen durch einen 
einfachen Gold(III)-Katalysator aus Inamiden und Anthranilen unter milden 
Reaktionsbedingungen ermöglicht. Diese Eintopf-Strategie benutzt leicht verfügbare 
Startmaterialien, verläuft hoch stufen- und atomökonomisch, mit breitem 
Substratspektrum und hat scale-up Potenzial. Auffallend ist, dass das 
Schlüsselelement der erfolgreichen Tandemreaktion ein Katalysator-gerichtetes 
bevorzugtes Quenching des in-situ gebildeten Gold Carben Intermediats durch eine 
nukleophile Benzyl/2-Furanylmethyl Einheit am Inamid ist, als Alternative zur 
bekannten C-H Annulierung, welche zu Indolen führt. 
 
 
In Kapitel 5 liefert eine goldkatalysierte regioselektive Cyclocarboaminierung von 
Inamiden mit 1,3,5-Triaziranen einen leichten und modularen Zugang zu nützlichen 
5-Aminotetrahydropyrimidinen in guten bis exzellenten Ausbeuten. Er stellt eine 
beispiellose aber anspruchsvolle Annulierung von Inamiden mit ungespannten 
gesättigten Heterocyclen dar. Diese neue Strategie unterscheidet sich durch einfache 
Durchführung, leicht zugänglichen Startmaterialien, stabile vier-Atom Baueinheiten, 
gute Verträglichkeit gegenüber funktionellen Gruppen und scale-up Potenzial. Die 
vorläufigen Mechanistischen Studien deuten darauf hin, dass die vorgestellte 




Chapter 1: General Introduction 
1.1 Homogeneous Gold Catalysis 
In the last decades, there has been a revolution in gold chemistry. Until Thomas[1] 
disclosed the first examples of homogeneous gold-catalyzed organic synthesis, gold 
had long been regarded inert and unreactive in catalytic transformations. Thereafter, 
homogeneous gold catalysis has gradually emerged to an efficient and frequently used 
tool in organic synthesis.[2] Owing to the preferable carbophilicity of gold catalysts, 
most reactions typically commence with the attack of a nucleophile onto the 
gold-coordinated alkynes, thus leading to a vinyl gold species. This intermediate often 
undergoes deauration by an electrophile (either discrete or bonded directly to the Nu) 
to complete a hydro/difunctionalization process. If the electrophile is tethered to the 
nucleophilic site in some distance, a cyclic product B is afforded. Alternatively, 
another cyclic compound C can be obtained through the generation of gold carbene 
species. This intermediate is then quenched by another nucleophilic moiety Nu’ 
(which could be either preinstalled or derived from the substrate) tied to the original 
nucleophilic site Nu by a suitable tether. The last two processes are known as formal 
cycloadditions, which are the research focus of this thesis. 
 
Scheme 1. Profile of gold-catalyzed intermolecular transformations with alkynes. 
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The first reaction involving gold carbene intermediates was the cycloisomerization of 
furan-ynes in the Hashmi phenol synthesis.[3a] This reaction is mechanistically related 
to the gold-catalyzed cycloisomerization of enynes, but in that case the furan ring 
serves as an electron-rich alkene.[3,4] In subsequent investigations, such an 
intermediate is often involved in homogeneous gold catalysis, although the nature of a 
given gold carbene species remains somewhat uncertain.[5] However, the isolation and 
full characterization of some electronically stabilized gold carbene complexes have 
provided new insight into their bonding situation.[6] Furthermore, the character of gold 
carbenes, carbocations or carbenoids were fully elaborated by Hashmi,[7a,b] 
Echavarren,[7c,d] and Fürstner[7e,f]. In 2009, Toste and Goddard proposed that the 
carbon-gold bond in a given gold-stabilized intermediate generally consists of varying 
degrees of both σ- and π-bonding based on theoretical and experimental analyses.[8] 
The proportions of each bonding are largely dependent upon the ancillary ligand and 
the carbene substituent. It is because: a) the 6s vacant valence orbital on gold can 
accept a pair of electrons from the ligand and carbene substrate, respectively, thus 
forming a three-center four-electron σ-hyperbond according to Pauli exclusion 
principle; b) two π-coordination bonds also exist at the gold center due to its 
backdonation from two filled 5d-orbitals into empty π-acceptors on the ligand and 
carbene substrate. In this thesis, the term gold carbene is used to describe the 
gold-coordinated carbene species, regardless of the dominant carbene or carbocation 
form. Typical strategies to access gold carbene intermediates are outlined in Scheme 2: 
a) 1,2-acyloxy migration of propargylic carboxylates;[9] b) cycloisomerization of 
1,6-enynes;[4] c) ring opening of cyclopropenes;[10] d) decomposition of diazo 
compounds;[11] e) the retro-Buchner reaction of cycloheptatrienes;[12] f) carbon-, 
oxygen-, or nitrogen-transfer onto alkynes.[13] In this chapter, gold-catalyzed formal 
cycloadditions of alkynes to access azaheterocycles will be summarized, with the 
α-imino gold carbene pathway underlined. 
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Scheme 2. Most common approaches to access gold carbenes. 
 
1.2 Recent Advances in α-Imino Gold Carbene Chemistry for 
Azaheterocycle Syntheses 
1.2.1 Intramolecular Generation 
The first introduction of an α-imino gold carbene came from the Toste group in 2005 
via an intramolecular acetylenic Schmidt reaction of homopropargyl azides for the 
synthesis of pyrroles.[14] This success benefits from the π-acidity and the 
electron-donating nature of gold complexes. A plausible mechanism was proposed 
initialized by the addition of the proximal nitrogen of azides to the gold-activated 
alkyne (Scheme 3). The electron donating property of the gold center promoted the 
release of dinitrogen. The ensuing α-imino gold carbene species underwent a 
1,2-hydride/alkyl/siloxy migration terminated by tautomerization, furnishing the 
pyrrole product under liberation of the cationic gold catalyst. Inspired by this 
pioneering work, the intra-/intermolecular nucleophilic capture of gold carbene 
intermediates was achieved by several groups.[15] For instance, the treatment of 
2-alkynylaryl azides under gold catalysis was reported by Zhang’s and Gagosz’s 
groups, respectively (Scheme 4).[15b,c,h] Both groups exploited the Umpolung strategy 
to access valuable and versatile indole derivatives by means of the nucleophilic 
quenching to the C3 position of indoles. Recently, a sequential annulation of 
4 
conjugated azido-diynes with pyrroles involving α-imino gold carbene intermediates 
was reported.[15l] It allowed for the rapid assembly of the pyrrolo[2,3-c]carbazole 
skeleton, a key intermediate in a diversity-oriented and total synthesis of 
dictyodendrin derivatives (Scheme 5). 
 
Scheme 3. Pyrrole synthesis from homopropargyl azides. 
 
 




Scheme 5. Gold-carbene route towards pyrrolo[2,3-c]carbazole framework and 
application in the total synthesis of dictyodendrins. 
 
In 2014, a new method towards α-imino gold carbene intermediates was introduced 
by Gagosz and co-workers through a gold-promoted intramolecular transfer of alkenyl 
nitrenes to alkynes.[16] In this work, azirines, a strained three-membered ring could be 
opened via the initial nucleophilic adduct. The resulting gold carbene enabled 
1,2-hydride migration, affording a set of polysubstituted pyridines after 
protodeauration. 
 
Scheme 6. Azirine as alkenyl nitrene precursor via intramolecular transfer to alkynes. 
 
In 2016, Park et al. disclosed a divergent synthesis of pyrroles and oxazoles from 
6 
α-diazo oxime ethers, a precursor to the α-imino gold carbenes.[17] The latter was then 
trapped by an external nucleophile, such as enol ethers or nitriles, terminated by a ring 
expansion or cyclization to yield pyrroles or oxazoles, respectively (Scheme 7). 
 
Scheme 7. α-Diazo compounds as a precursor of gold carbenes. 
 
1.2.2 Intermolecular Generation 
Despite the aforementioned intramolecular entry to α-imino gold carbene for 
azaheterocycle syntheses, intermolecular protocols would provide an alternative and 
particularly appealing approach towards such kind of intermediates, thus allowing for 
more facile and flexible synthesis from readily accessible starting materials. Davies et 
al. envisioned that an intermolecular nitrene-transfer reaction from a nucleophilic 
nitrenoid to gold-activated alkynes could also lead to α-imino gold carbenes.[18] It 
would be quenched by a preinstalled nucleophilic functionality adjacent to the 
electrophilic organogold center, thus completing the formal cycloaddition. (Scheme 8) 
In 2011, this concept was first realized via nitrene transfer of pyridine-N-aminides 
onto ynamides assisted by gold(III) complexes, producing a wide array of oxazoles 
(Scheme 9a).[18a] Noteworthy is the absence of competing 1,2-hydride shift with 
aliphatic ynamides, which is indicative of the faster formation of C–O than N–N bond 
fission. Besides ynamides, internal alkynes with conjugation from a remote nitrogen 
atom turned out to be competent although higher reaction temperatures were required 
alongside the switch from a gold(III) complex to a cationic phosphite gold(I) 
catalyst.[19] Importantly, the utilization of alkynyl thioethers led to an inverse 
regioselectivity, likely due to σ-activation mode complementary to the general 
7 
π-activation pattern in ynamides (Scheme 9b versus 9a).[18,20] Furthermore, 
pyridinium N-(heteroaryl)aminides were able to act as a robust nucleophilic 
1,3-N,N-dipole equivalent in a formal [3+2] cycloaddition onto electron-rich internal 
alkynes enabled by gold catalysis (Scheme 9c).[21] 
 




Scheme 9. Pyridinium ylides as nucleophilic nitrenoid equivalents. 
 
In 2015, Huang and Liu groups independently revealed intermolecular [3+2] 
8 
annulations of 2H-azirines with ynamides, en route to polysubstituted 
2-aminopyrroles (Scheme 10a).[22a,b] Interestingly, the nature of Cβ-substituent (X) on 
2H-aziridines directs the regioselectivity via distinct pathways. For 2H-aziridines with 
aromatic or aliphatic Cβ-substituents, the intermediacy of gold carbene was proposed 
by Huang et al. (path a). In the case of 2H-aziridines with an ester moiety, the 
common intermediate A preferred to undergo a 1,2-hydrogen shift followed by a 
Michael-type reaction, further giving the pyrrole product (path b, Liu’s work). In 
addition, both groups found vinyl azides as a precursor of 2H-aziridines, also reacting 
with ynamides to furnish [3+2] formal cycloadducts under gold catalysis (Scheme 
10b).[22b,c] The choice of ynamides with electron-rich (hetero)aromatic groups on 
C-terminus provided access to 1H-benzo[d]azepine products via [4+3] annulation. 
 
Scheme 10. 2H-Azirines and their equivalents vinyl azides as nucleophilic nitrenoids. 
 
Meanwhile, Ye et al. reported an alternative method for pyrrole synthesis via 
gold-assisted [3+2] annulation of ynamides and isoxazoles (Scheme 11a).[23] Herein 
9 
the latter was employed as a nitrene-transfer precursor via sequential nucleophilic 
addition onto ynamides and ring opening by N–O cleavage to generate the α-imino 
gold carbene. Due to its high electrophilicity, ensuing 1,5-cyclization readily took 
place to afford 3H-pyrroles after deauration. As a result of varied substrate 
substitution, different product outcomes could be explained through a hydride shift 
pathway (path a), water-assisted deacylation (path b), or intermolecular C-to-N acyl 
shift facilitated by the more electron-rich oxazolidinone moiety than the related 
sulfonyl groups (path c). Inspired by those work, Liu and co-workers recently 
developed two novel annulations of isoxazoles with propiolates under gold catalysis 
(Scheme 11b).[24] Notably, most isoxazoles follow a weaker nucleophilic O-attack 
pathway to enable the cleavage of carbon-carbon triple bonds, leading to pyrroles via 
[4+1] annulations, whereas the unsubstituted isoxazole underwent an initial N attack 
step to furnish imidazo[1,2-a]pyridines by a sequential [2+2+1]/[4+2] cycloaddition. 
Both initial O and N additions gave two key seven-membered ring intermediates, 
between which a reversible equilibrium existed. A ring contraction and subsequent 
rearrangement provided the pyrrole product (upper part of Scheme 11b). Alternatively, 
another discrete unsubstituted isoxazole acted as a potent heterodiene for the [4+2] 
cycloaddition with its corresponding seven-membered ring intermediate, finally 
providing imidazo[1,2-a]pyridines instead (lower part of Scheme 11b). Very recently, 
the same group further realized a gold-catalyzed [4+3] annulation of 3-en-1-ynamides 
with isoxazoles, furnishing 4H-azepines enabled by a 6π-electrocyclization of the 
gold-stabilized 3-azaheptatrienyl cation (Scheme 11c).[25] With the aid of catalytic 
Zn(OTf)2, the obtained 4H-azepine could undergo a ring-contraction rearrangement to 
yield a pyridine skeleton. In addition, an one-pot synthesis of pyridines was also 
feasible by a relay Au(I)/Zn(II) catalysis. 
10 
 
Scheme 11. Amination or oxidation of activated alkynes enabled by isoxazoles. 
 
In 2015, our group described a gold-catalyzed C–H annulation of anthranils with 
alkynes for 7-acylindolyl synthesis taking advantage of the potential binucleophilicity 
of anthranil (Scheme 12a, upper).[26a] Remarkably, some non-polarized alkynes also 
worked well for this reaction. If a propargylic ether was introduced, the in situ 
generated α-imino gold carbene species was then quenched by a 1,2-hydride 
shift/deauration sequence to give an enolether, which allowed for a Mukaiyama aldol 
11 
cyclization with the electrophilic carbonyl moiety derived from the anthranil substrate. 
This Umpolung concept was later realized by the gold-catalyzed reactions of 
propargyl silyl ethers and anthranils, providing access to various quinolines (Scheme 
12a, lower).[26b] Very recently, Liu group contributed a gold-catalyzed reaction of 
anthranils with propiolates, affording various dihydroquinolines, where anthranils 
underwent an initial O-attack complementary to our proposed N attack step.[26c] In 
addition, a gold(I) and Zn(II) relay catalysis led to highly oxygenated 
tetrahydroquinolines. 
 
Scheme 12. Amination or oxidation of alkynes enabled by anthranils. 
 
In 2016, Liu and co-workers revealed that 1,4,2-dioxazoles could be also utilized as a 
robust N-acyl nitrenoid precursor in the gold-aided nitrene transfer reaction onto 
activated alkynes (Scheme 13a).[27a] This reaction engaged the key α-imino gold 
carbene intermediate in a 4π-cyclization/deauration sequence. The regioselectivity of 
12 
oxazole products was directed by the substituent pattern of alkynes. Electron-rich 
ynamides favored the nitrene transfer to α-C-terminus position while 
electron-deficient alkynes (alkynyl esters or alkynyl ketones) reversed the selective 
attack. It is noteworthy that such a gold-carbene mechanism could be supported by the 
intramolecular cyclization of dioxazole-ynamide, where the C(sp2)–H insertion 
instead of C–O bond formation occurred to give the tetracyclic compound (Scheme 
13b). Later, this group found 1,2,4-oxadiazoles as an efficient N-imino nitrene 
equivalent, applied for imidazole synthesis via gold-assisted [3+2] annulations with 
ynamides (Scheme 13c).[27b] 
 
Scheme 13. 1,4,2-Dioxazoles and its analogue 1,2,4-oxadiazoles as nitrene 
equivalents. 
 
Despite the intramolecular nitrene transfer of azide moieties onto alkynes to access 
α-imino gold carbene intermediates, such an intermolecular protocol has not been 
realized until 2015 by Ye group.[28] Likewise, the interaction of ynamides and azides 
also led to the gold carbene species.[28a] It could be quenched either by an aryl group 
on ynamides or by a more nucleophilic indolyl part fixed on the azides. The former 
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constituted a gold-catalyzed formal [4+2] cycloaddition, en route to indoles; the latter 
gave carbolines after dehydrogenative oxidation (Scheme 14a, upper verse lower). 
Later, this group further developed other tandem reactions enabled by such gold 
carbene intermediates, including an aza-Nazarov cyclization for pyrrole synthesis and 
a 1,4-hydride shift to access 2-aza-1,3-butadienes (Scheme 14b).[28b,c] 
 
Scheme 14. Intermolecular nitrene transfer of azides to ynamides. 
 
Noteworthy is the initial α-site-regioselective addition onto ynamides in the above 
cases. In 2016, Huang and co-workers discovered a complementary β-site 
regioselective [3+2] annulation of pyrido[1,2-b]indazoles with ynamides under gold 
catalysis, leading to a variety of 3-aminoindoles (Scheme 15).[29] Mechanistic studies 
indicated the reaction pathway initially involves a transient five-membered ring, 
directing the β-addition of the nucleophilic nitrenoid. After a ring opening, the 
α-imino gold carbene was formed, which in turn enabled the ensuing C(sp2)−H 
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insertion of the phenyl ring to give the final product. 
 
Scheme 15. Pyrido[1,2-b]indazoles as nucleophilic nitrenoids. 
 
In 2016, Ballesteros group contributed a gold-catalyzed tandem reaction containing 
three components: triazapentalenes (or its precursor propargylic benzotriazoles), 
alkynes and nitriles (Scheme 16).[30] Notably, this protocol, in addition to our previous 
report, are the only two routes involving an intermolecular nitrene transfer to 
non-polarized alkynes to access the α-imino gold carbene species. This highly 
electrophilic intermediate was captured by an external nitrile, terminated by a 
cyclization to construct a new imidazole ring. 
 
Scheme 16. Triazapentalenes as a nucleophilic nitrenoid. 
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1.3 Recent Advances in Gold-Catalyzed Intermolecular 
Annulations of Alkynes with Saturated Heterocycles 
Gold-catalyzed intermolecular annulations of alkynes with saturated heterocycles 
provided an efficient and powerful strategy to build a wide range of heterocyclic 
scaffolds.[31] For instance, in 2011, He and co-workers showcased that diaziridines 
were valuable three-atom synthons for the synthesis of pyrazolines under gold 
catalysis (Scheme 17).[32a] Mechanistic investigations supported an initial gold-aided 
ring opening of the diazridine and subsequent alkyne insertion, terminated by an 
intramolecular hydroamination to yield the product. 
 
Scheme 17. [3+2] Annulation of diazridines with alkynes 
 
In 2012, Liu et al. employed epoxides as the three-atom building blocks for a 
gold-catalyzed intermolecular formal [4+3] cycloaddition with ynamides (Scheme 
18a).[32b] This group later used relatively less ring-strained oxetanes as four-atom units 
for efficient [4+2] annulations of ynamides (Scheme 18b).[32c] 
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Scheme 18. Epoxides and oxetanes applied for annulation with ynamides. 
 
Recently, this group further applied the epoxides and oxetanes for gold-catalyzed [4+n] 
annulations (n = 3, 4) with tert-butyl propiolates, yielding various seven- and 
eight-membered oxaheterocyclic products (Scheme 19a, 19b).[32d] Even a 
nine-membered ring was also accessible via a formal [4+5] cycloaddition between 
tert-butyl propiolate and γ-lactol (Scheme 19c). 
 
Scheme 19. Epoxides and oxetanes used for annulation with tert-butyl propiolates.
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1.4 Research Objectives and Thesis Outline 
The research interests in this thesis center on the novel and facile synthesis of 
azaheterocycles via gold-catalyzed formal cycloadditions of alkynes. Herein most 
synthetic approaches are enabled by α-imino gold carbene intermediates. 
 
In chapter 2, a novel, concise, and atom-economical synthesis of fully substituted 
4-aminoimidazoles through a gold-catalyzed selective [3+2] annulation of 
1,2,4-oxadiazoles with ynamides is realized. Chapter 3 describes a novel, short, and 
flexible approach to diverse N-doped polycyclic aromatic hydrocarbons via 
gold-catalyzed ring-expansion/π-extension of anthranils with o-ethynylbiaryls. In 
chapter 4, a facile, site-selective and divergent route is provided to access 
2-aminopyrroles and quinoline-fused polyazaheterocycles directed by a simple gold 
catalyst from ynamides and anthranils. In chapter 5, a gold-catalyzed regioselective 
cyclocarboamination of ynamides with 1,3,5-triazinanes leads to the valuable 
5-aminotetrahydropyrimidines in good and excellent yields. 
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Chapter 2: α-Imino Gold Carbenes from 1,2,4-Oxadiazoles: 
Concise and Atom-Economical Access to Fully Substituted 
4-Aminoimidazoles 
2.1 Introduction 
As one fundamental framework, imidazole motifs frequently exist in a large number 
of natural products,[1] pharmaceuticals,[2] ionic liquids,[3] and precursors of 
N-heterocyclic carbenes.[4] In this family, fully substituted 4-aminoimidazole 
derivatives are core structures of some bioactive compounds and also serve as 
versatile building blocks (Figure 1).[5] However, in contrast with the wealth of 
imidazole synthesis, few routes can allow direct access to fully substituted 
4-aminoimidazoles.[6] Hence, the development of general and practical methods for 
the construction of highly functionalized 4-aminoimidazole scaffolds is meaningful to 
synthetic and medicinal chemistry. Recently, we and other groups verified that highly 
reactive α-imino gold carbenes generated in situ from various nucleophilic nitrenoid 
equivalents, such as azides,[7] N-iminopyridiumylides,[8] 2H-azirines,[9] and very 
recently developed isoxazoles,[10] anthranils,[11] triazapentalenes[12] and dioxazoles,[13] 
pyrido[1,2-b]indazoles,[14] provided a powerful platform to construct an array of 
structurally diverse aza-heterocycles.[15] Notwithstanding the recent advance attained, 
the exploration of α-imino gold carbene chemistry with less sensitive nitrene-transfer 
reagents, especially in an atom-economical and selective manner, is highly desirable. 
 
1,2,4-Oxadiazole is an appealing candidate due to its stability, structural diversity and 
easy operation. To date, the further transformations of 1,2,4-oxadiazoles were still 
surprisingly scarce.[16,17] One representative work is the photo-induced rearrangement 
of 1,2,4-oxadiazoles to form N-acylimino nitrene intermediates which subsequently 
trapped by different nucleophiles (Scheme 1a).[17] Inspired by our previous work on 
gold carbenes,[11,18] we considered the possibility of using 1,2,4-oxadiazoles as 
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nucleophilic nitrene equivalents to form α-imino gold carbene intermediates via 
regioselective addition to gold-activated ynamides. Based on their high 
electrophilicity, subsequent intramolecular chemoselective trapping completed a [3+2] 
annulation, affording fully substituted 4-aminoimidazoles (Scheme 1b). If successful, 
this process would open a new window for the reaction pattern of 1,2,4-oxadiazoles, 
and also complement the existing strategies for the synthesis of polysubstituted 
4-aminoimidazole derivatives. Herein, we disclose a new route to α-imino gold 
carbenes from 1,2,4-oxadiazoles and ynamides, enabling the convergent, concise, and 
atom-economical synthesis of fully substituted 4-aminoimidazoles. 
 





Scheme 1. Previous works and our design 
 
2.2 Results and Discussion 
2.2.1 Optimization of Reaction Condition 
To evaluate the feasibility, ynamide 1a and 1,2,4-oxadiazole 2a were initially chosen 
as the model reaction (Table 1). Gratifyingly, employing 5 mol% of IPrAuCl/AgNTf2 
as a catalyst at 80 oC can afford the desired product 3a in 95% NMR yield (entry 1). 
Control experiments without any catalyst or silver salt alone showed no conversion 
(entries 2 and 3). Other gold catalysts, PPh3AuNTf2, (2,4-
tBu2PhO)3PAuCl/AgNTf2, 
SPhosAuNTf2, KAuBr4, were much less efficient, leading to 3a in lower yields 
(entries 4–7). Switching counter anion from NTf2 to OTf lead to a significantly 
decreased yield (95% versus 67%, entries 1 and 8). In addition, other solvents such as 
1,2-DCE and toluene could not improve the reaction efficiency (entries 9 and 10). 
Decreasing reaction temperature from 90 oC to 60 oC delivered 3a in moderate yield 
(entry 11). 
26 
Table 1: Screening for optimal reaction conditions[a] 
 
entry deviation from “standard” conditions yieldb 
1 none 95% (90%) 
2 no catalyst n.d. 
3 AgNTf2 trace 
4 PPh3AuNTf2 52% 
5 (2,4-tBu2PhO)3PAuCl/AgNTf2 30% 
6 SPhosAuNTf2 48% 
7 KAuBr4 39% 
8 IPrAuCl/AgOTf 67% 
9 1,2-DCE, instead of PhCF3 72% 
10 toluene, instead of PhCF3 57% 
11 60 oC 54% 
[a] “Standard” conditions: 1a (0.1 mmol), 2a (0.15 mmol), 
IPrAuCl/AgNTf2 (5 mol%) reacted in PhCF3 (0.5 mL) for 18 h at 80 oC. 
[b] Measured by 1H NMR with 1,3,5-trimethoxybenzene as the internal 
standard. Yield of isolated product given in parentheses. n.d. = not 
detected. 
 
2.2.2 Scope with regard to the Substrate 
Under the optimized reaction conditions, the scope of this novel transformation was 
investigated (Table 2). First, with 1,2,4-oxadiazole 2a as the reaction partner, diverse 
ynamides bearing different protecting groups (Ms, Ts, and Bs) and substituents on 
nitrogen tolerated the reaction conditions well, furnishing 3a–f in satisfying yields. 
We then examined the influence of R1 group on the alkyne terminus. Aryl substituted 
ynamides with various substituents on the phenyl ring uniformly afford the desired 
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products 3g–m in 71–91% yields, regardless of their electronic and positional 
properties. An array of functional groups, including chloride, bromide, fluoride, ether, 
and ester remain intact, offering opportunities for further modification at these 
positions (3h–m, 3p, 3w). When thiophenyl substituted ynamide was subjected to 
standard conditions, imidazole 3n was obtained in high yield. Concerning the scope 
with regard to the 3,5-diaryl-1,2,4-oxadiazoles, it was found that electron-donating, 
electron-withdrawing and neutral substituents on the aromatic ring were all 
compatible (3e, 3o–r). 
 
Encouraged by these results, we further broaden the scope of this reaction by using a 
series of 1,2,4-oxadiazoles bearing one alkyl group on the parent ring (Table 3). 
However, the use of 5 equiv. of 1,2,4-oxadiazoles 2 was necessary to obtain the 
desired products in acceptable yields, probably due to their reduced nucleophilicity. In 
this case, the 4-aminoimidazole products were afforded in moderate yields. Of note, 
the ester group was tolerated in this transformation, providing 3w in 41% yield. To 
further confirm the 4-aminoimidazole framework, X-ray crystallography of 3v was 
conducted (Table 3).[19] 
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Table 2: Reaction scope for ynamides and 3,5-diaryl-1,2,4-oxadiazoles.[a,b] 
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Table 3: Reaction scope for 3,5-disubstituted 1,2,4-oxadiazoles.[a,b] 
 
 
To further probe the practicality of this methodology, a 1.07 gram-scale synthesis with 
a slightly lower catalyst loading (4 mol%) was conducted. It delivered 
4-aminoimidazole 3a in a good yield of 80% (Scheme 2). Finally, we prepared 
alkyl-substituted ynamide 1o and then reacted with 1,2,4-oxadiazole 2d under the 
standard condition. As expected, α,β-unsaturated imine 4 was isolated in 49% total 
yield without detection of the desired imidazole (Scheme 3). The successful 
1,2-hydride shift leading to alkenes indicates α-imino gold carbenoid intermediate is 
very likely.[8a,20] 
 
Scheme 2. Gram-scale synthesis 
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Scheme 3. Reaction of alkyl-substituted ynamide with 1,2,4-oxadiazole 
 
2.3 Conclusion 
In conclusion, we have demonstrated 1,2,4-oxadiazoles could serve as novel 
nucleophilic nitrenoid equivalents for the generation of α-imino gold carbenes, 
corresponding to an intermolecular transfer of N-acyliminonitrenes to ynamides. This 
protocol offers a new reaction pattern of 1,2,4-oxadiazoles and opens up a novel, 
concise, and atom-economical strategy for the synthesis of valuable fully substituted 
4-aminoimidazoles. The present reaction proceeds with 100% atom economy, 
displayed good functional-group compatibility, and can be conducted in gram-scale 
synthesis. Further applications of 1,2,4-oxadiazoles in other organic synthesis are still 
ongoing in our group. 
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2.5 Experimental Section 
General Remarks: Chemicals were purchased from commercial suppliers and used 
without further purification. Reagents 1 and 2 were easily prepared according to the 
previous literatures.[1,2] Dry solvents were dispensed from the solvent purification 
system MB SPS-800. Deuterated solvents were bought from Euriso-Top. NMR 
spectra were recorded at room temperature on the following spectrometers: Bruker 
Avance-III-300, Bruker Avance DRX-300 or Bruker Avance 500. Chemical shifts 
were referenced to residual solvent protons and reported in ppm and coupling 
constants in Hz. The following abbreviations were used for 1H NMR spectra to 
indicate the signal multiplicity: s (singlet), d (doublet), t (triplet), q (quartet), and m 
(multiplet). All 13C NMR spectra were measured with 1H-decoupling. The 
multiplicities mentioned in these spectra [s (singlet, quaternary carbon), d (doublet, 
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CH-group), t (triplet, CH2-group), q (quartet, CH3-group)] were determined by 
DEPT135. HRMS were determined at the chemistry department of the University of 
Heidelberg. EI+-spectra were measured on a JOEL JMS-700 spectrometer. For 
DART-spectra a Bruker ICR Apex-Qe spectrometer was applied. IR spectra were 
recorded on a Bruker Vector 22, and the absorption maxima were given in wavelength 
in cm-1 units. X-ray crystal structure analyses were measured at the chemistry 
department of the University of Heidelberg under the direction of Dr. F. Rominger on 
a Bruker Smart CCD or Bruker APEX-II CCD instrument using Mo-Kα-radiation. 
The structures were solved and refined by Dr. F. Rominger using the SHELXTL 
software package. Thin-layer chromatography (TLC) was performed on precoated 
polyester sheets (POLYGRAM SIL G/UV254), and components were visualized by 
observation under UV light. Melting points were uncorrected. 
 
Experiment Procedures 
General Procedure 1: Synthesis of ynamides 1[2] 
 
To a solution of terminal alkynes (3.0 mmol) in acetone (10 mL) were added NBS 
(3.6 mmol) and AgNO3 (0.15 mmol), the resulting mixture was stirred under N2 at 
room temperature for 3 hours. After removing excess acetone, the reaction was 
quenched with saturated NH4Cl solution, and the organic layer was extracted with 
petroleum ether (10 mL × 2), dried over anhydrous NaSO4, filtered and concentrated 
under reduced pressure to give bromoalkynes. 
 
To a dried flask were added sulfonamides (2.4 mmol), CuSO4
●5H2O (0.2 mmol), 
1,10-phenanthroline (0.4 mmol) and K2CO3 (5.0 mmol). The resulting mixture was 
subsequently treated with anhydrous toluene (10 mL) and bromoalkynes (2.0 mmol), 
and stirred at 80 oC overnight under N2. When the reaction is complete, the crude 
mixture was cooled to room temperature, filtered through Celite, and concentrated in 
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vacuo. The resulting residue was purified by chromatography on silica gel (eluent: 
PE/EA) to afford ynamides 1. 
 
General Procedure 2: Gold-catalyzed formal [3+2] cycloaddition of ynamides 
with 1,2,4-oxadiazoles 
A round bottom flask equipped with a magnetic stirrer bar was charged with IPrAuCl 
(5 mol%, 6.2 mg), AgNTf2 (5 mol%, 3.9 mg), and PhCF3 (0.5 mL). The mixture was 
stirred for 5 minutes at room temperature. Ynamides (0.2 mmol) and 
1,2,4-oxadiazoles (0.3 mmol or 1.0 mmol) were added followed by 0.5 mL PhCF3. 
The reaction mixture was then stirred at 80 oC and the progress of the reaction was 
monitored by TLC. Upon completion, the mixture was concentrated and the residue 
was purified by chromatography on silica gel (eluent: PE/EA) to afford the desired 
product 3. 
 
Gram-scale reaction: A round bottom flask equipped with a magnetic stirrer bar was 
charged with IPrAuCl (4 mol%, 74.4 mg), AgNTf2 (4 mol%, 46.6 mg), and PhCF3 (10 
mL). The mixture was stirred for 5 minutes at room temperature. The ynamide 1a (3.0 
mmol) and the 1,2,4-oxadiazole 2a (4.5 mmol) were added followed by 5 mL PhCF3. 
The reaction mixture was then stirred at 80 oC and the progress of the reaction was 
monitored by TLC. Upon completion, the mixture was concentrated and the residue 
was purified by chromatography on silica gel (eluent: PE/EA) to afford the desired 
product 3a in 80% yield (1.07 g). 
 
[1] K. K. D. Amarasinghe, M. B. Maier, A. Srivastavab, J. L. Graya, Tetrahedron Lett. 
2006, 47, 3629–3631. 




382.1 mg (50% yield), yellow oil; Rf = 0.42 (PE/EA = 5:1); 1H 
NMR (300 MHz, CDCl3) δ 7.56–7.53 (m, 2H), 7.29–7.15 (m, 11H), 
2.37 (s, 3H) ppm; 13C NMR (75 MHz, CDCl3) δ 145.2 (s), 138.7 (s), 134.1 (s), 133.0 
(s), 131.1 (d), 129.6 (d), 129.5 (d), 129.4 (d), 129.2 (d), 128.4 (d), 128.3 (d), 128.1 (d), 
126.3 (d), 124.5 (s), 84.2 (s), 69.4 (s), 21.7 (q) ppm; IR (reflection): ṽ 3067, 3039, 
2923, 2239, 1707, 1593, 1560, 1490, 1477, 1455, 1409, 1373, 1334, 1295, 1258, 1201, 
1173, 1089, 1027, 1004, 923, 890, 832, 813, 784, 757, 706, 690, 671, 653 cm-1; 
HRMS (DART) calcd for [C21H17NO2SCl]
+ (M)+: 382.0663; found: 382.0664. 
 
1l:  N-((2-chlorophenyl)ethynyl)-4-methyl-N-phenylbenzenesulfonamide 
573.1 mg (75% yield), light yellow solid, m.p.: 79–80 oC; Rf = 0.55 
(PE/EA = 5:1); 1H NMR (300 MHz, CDCl3) δ 7.58 (d, J = 8.3 Hz, 
2H), 7.37–7.10 (m, 11H), 2.35 (s, 3H) ppm; 13C NMR (75 MHz, CDCl3) δ 145.1 (s), 
138.8 (s), 135.7 (s), 133.0 (d), 134.0 (s), 129.6 (d), 129.2 (d), 129.1 (d), 128.9 (d), 
128.4 (d), 128.3 (d), 126.5 (d), 126.3 (d), 122.8 (s), 87.8 (s), 67.8 (s), 21.7 (q) ppm; 
IR (reflection): ṽ 3066, 2241, 1919, 1595, 1492, 1479, 1455, 1438, 1377, 1343, 1307, 
1294, 1254, 1202, 1187, 1174, 1089, 1043, 1029, 922, 892, 813, 793, 755, 705, 692, 
670, 654 cm-1; HRMS (DART) calcd for [C21H17NO2SCl]




317.7 mg (75% yield), yellow solid, m.p.: 115–116 oC; Rf = 0.40 
(PE/EA = 5:1); 1H NMR (500 MHz, CDCl3) δ 7.53 (d, J = 8.0 Hz, 2H), 7.31–7.15 (m, 
9H), 6.98 (d, J = 4.8 Hz, 1H), 2.35 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 145.1 
(s), 138.9 (s), 133.0 (s), 130.2 (d), 129.6 (d), 129.2 (d), 129.0 (d), 128.3 (d), 126.3 (d), 
125.3 (d), 121.3 (s), 82.3 (s), 65.6 (s), 21.8 (q) ppm; IR (ATR): ṽ 3113, 3052, 2232, 
1737, 1714, 1590, 1489, 1421, 1367, 1299, 1218, 1186, 1164, 1088, 1027, 938, 903, 
870, 802, 783, 766, 710, 702, 691, 655, 626 cm-1; HRMS (EI) calcd for 
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[C19H15NO2S2]




80.1 mg (90% yield), white solid, m.p.: 179–180 oC; Rf = 0.28 
(PE/EA = 2:1); 1H NMR (300 MHz, CDCl3) δ 7.59–7.52 (m, 6H), 7.44 (d, J = 7.4 Hz, 
1H), 7.31–7.21 (m, 5H), 7.15 (d, J = 8.0 Hz, 2H), 3.30 (s, 3H), 3.25 (s, 3H), 2.33 (s, 
3H) ppm; 13C NMR (75 MHz, CDCl3) δ 169.7 (s), 145.9 (s), 139.6 (s), 136.8 (s), 
135.0 (d), 132.4 (s), 130.8 (d), 130.3 (s), 129.4 (d), 129.3 (d), 128.9 (d), 128.6 (d), 
128.4 (d), 127.4 (s), 126.8 (s), 38.8 (d), 37.4 (d), 21.3 (d) ppm; IR (ATR): ṽ 3067, 
3024, 2934, 1714, 1597, 1587, 1493, 1454, 1415, 1338, 1293, 1278, 1218, 1188, 1149, 
1103, 1078, 1031, 998, 971, 908, 869, 835, 812, 772, 732, 697, 665, 629 cm-1; HRMS 
(DART) calcd for [C25H24N3O3S]




79.1 mg (78% yield), yellow solid, m.p.: 188–189 oC; Rf = 0.26 
(PE/EA = 5:1); 1H NMR (300 MHz, CDCl3) δ 7.59–7.53 (m, 6H), 7.48–7.41 (m, 3H), 
7.34–7.15 (m, 10H), 3.42 (s, 3H), 2.35 (s, 3H) ppm; 13C NMR (75 MHz, CDCl3) δ 
169.7 (s), 145.7 (s), 140.8 (s), 139.6 (s), 136.3 (s), 135.0 (d), 132.4 (s), 131.0 (s), 
130.8 (d), 129.4 (d), 129.3 (d), 129.1 (d), 128.9 (d), 128.6 (d), 128.5 (d), 128.3 (d), 
127.53 (d), 127.48 (d), 127.3 (s), 126.9 (s), 39.0 (q), 21.4 (q) ppm; IR (ATR): ṽ 3062, 
3033, 2967, 2928, 2868, 1721, 1595, 1583, 1561, 1489, 1447, 1410, 1347, 1299, 1277, 
1260, 1226, 1155, 1116, 1077, 1020, 1001, 965, 914, 889, 837, 764, 737, 720, 697, 
627, 609 cm-1; HRMS (DART) calcd for [C30H26N3O3S]






120.4 mg (93% yield), yellow solid, m.p.: 173–174 oC; Rf = 0.23 (PE/EA = 5:1); 1H 
NMR (500 MHz, CDCl3) δ 7.82–7.80 (m, 2H), 7.60 (dd, J = 12.9, 8.3 Hz, 4H), 7.50 
(d, J = 8.0 Hz, 2H), 7.45–7.42 (m, 3H), 7.31–7.19 (m, 10H), 7.14 (d, J = 7.9 Hz, 2H), 
2.33 (s, 3H) ppm; 13C NMR (75 MHz, CDCl3) δ 169.7 (s), 145.5 (s), 140.2 (s), 139.5 
(s), 138.1 (s), 136.2 (s), 135.0 (d), 132.5 (s), 131.6 (d), 130.8 (d), 130.7 (d), 129.5 (d), 
129.3 (d), 128.94 (d), 128.89 (d), 128.6 (d), 128.5 (d), 128.4 (d), 128.0 (d), 127.9 (s), 
127.6 (d), 127.4 (s), 127.0 (s), 21.4 (q) ppm; IR (ATR): ṽ 3070, 1721, 1597, 1574, 
1488, 1450, 1389, 1358, 1298, 1274, 1219, 1169, 1089, 1069, 1012, 910, 821, 769, 
738, 696, 662 cm-1; HRMS (DART) calcd for [C35H27N3O3SBr]





91.0 mg (78% yield), yellow solid, m.p.: 186–187 oC; Rf = 0.34 
(PE/EA = 5:1); 1H NMR (500 MHz, CDCl3) δ 7.84 (d, J = 7.7 Hz, 2H), 7.60 (d, J = 
8.1 Hz, 2H), 7.54 (d, J = 7.5 Hz, 2H), 7.50 (d, J = 8.0 Hz, 2H), 7.45 (t, J = 7.5 Hz, 
1H), 7.34–7.27 (m, 8H), 7.25–7.19 (m, 4H), 7.15 (d, J = 8.0 Hz, 2H), 2.45 (s, 3H), 
2.34 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 169.9 (s), 145.5 (s), 143.6 (s), 
140.5 (s), 139.4 (s), 136.4 (s), 136.2 (s), 134.9 (d), 132.5 (s), 131.7 (s), 130.8 (d), 
129.5 (d), 129.2 (d), 129.1 (d), 129.0 (d), 128.9 (d), 128.8 (d), 128.6 (d), 128.5 (d), 
128.3 (d), 128.0 (d), 127.6 (s), 127.3 (d), 127.1 (s), 21.7 (q), 21.4 (q) ppm; IR (ATR): 
ṽ 3072, 3029, 2954, 2923, 2853, 1917, 1720, 1597, 1585, 1565, 1488, 1452, 1412, 
1351, 1300, 1276, 1223, 1184, 1159, 1089, 1019, 947, 922, 887, 816, 769, 739, 728, 
708, 696, 668, 647, 611 cm-1; HRMS (DART) calcd for [C36H30N3O3S]
+ (M+H)+: 




68.8 mg (66% yield), yellow solid, m.p.: 211–212 oC; Rf = 0.26 
(PE/EA = 5:1); 1H NMR (300 MHz, CDCl3) δ 7.92 (d, J = 8.3 Hz, 2H), 7.59–7.51 (m, 
40 
4H), 7.48–7.43 (m, 3H), 7.36 (d, J = 8.1 Hz, 2H), 7.32–7.22 (m, 5H), 7.12 (d, J = 8.0 
Hz, 2H), 3.12 (s, 3H), 2.48 (s, 3H), 2.32 (s, 3H) ppm; 13C NMR (75 MHz, CDCl3) δ 
169.8 (s), 145.7 (s), 143.6 (s), 139.5 (s), 136.9 (s), 135.3 (s), 134.9 (d), 132.6 (s), 
130.8 (s), 130.7 (d), 129.5 (d), 129.3 (d), 129.2 (d), 128.9 (d), 128.6 (d), 128.44 (d), 
128.41 (d), 127.8 (s), 126.9 (s), 38.1 (q), 21.6 (q), 21.3 (q) ppm; IR (ATR): ṽ 2967, 
2925, 2855, 1713, 1597, 1582, 1491, 1452, 1343, 1304, 1277, 1190, 1176, 1159, 1110, 
1088, 1032, 995, 921, 862, 809, 770, 725, 691, 665, 644, 626 cm-1; HRMS (DART) 
calcd for [C31H28N3O3S]




76.4 mg (64% yield), yellow solid, m.p.: 172–173 oC; Rf = 0.26 
(PE/EA = 5:1); 1H NMR (300 MHz, CDCl3) δ 7.99 (d, J = 8.3 Hz, 2H), 7.49–7.37 (m, 
7H), 7.28–7.22 (m, 2H), 7.20–7.02 (m, 12H), 4.59 (s, 2H), 2.50 (s, 3H), 2.33 (s, 3H) 
ppm; 13C NMR (75 MHz, CDCl3) δ 169.7 (s), 145.5 (s), 143.6 (s), 139.4 (s), 136.2 (s), 
135.2 (s), 134.7 (d), 134.3 (s), 133.0 (s), 132.6 (s), 130.6 (d), 129.7 (d), 129.5 (d), 
129.4 (d), 129.2 (d), 128.9 (d), 128.7 (d), 128.5 (d), 128.2 (d), 128.0 (d), 127.9 (d), 
127.6 (d), 127.5 (s), 127.0 (s), 54.2 (t), 21.7 (q), 21.3 (q) ppm; IR (ATR): ṽ 3067, 
3031, 2962, 2926, 1719, 1596, 1493, 1449, 1350, 1335, 1273, 1264, 1217, 1184, 1162, 
1088, 1028, 912, 885, 851, 818, 807, 764, 731, 695, 666, 651 cm-1; HRMS (DART) 
calcd for [C37H32N3O3S]




99.1 mg (83% yield), yellow solid, m.p.: 180–181 oC; Rf = 
0.33 (PE/EA = 5:1); 1H NMR (500 MHz, CDCl3) δ 7.73 (d, J = 8.1 Hz, 2H), 7.47 (d, 
J = 7.7 Hz, 2H), 7.41 (d, J = 7.9 Hz, 2H), 7.32 (t, J = 7.5 Hz, 1H), 7.27–7.15 (m, 8H), 
7.09–7.06 (m, 3H), 7.01 (d, J = 8.0 Hz, 2H), 6.96 (d, J = 7.9 Hz, 2H), 2.32 (s, 3H), 
2.20 (s, 3H), 2.16 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 170.0 (s), 145.2 (s), 
143.5 (s), 140.6 (s), 139.3 (s), 138.4 (s), 136.3 (s), 136.2 (s), 134.9 (d), 132.6 (s), 
41 
131.9 (s), 130.8 (d), 129.4 (d), 129.2 (d), 129.11 (d), 129.10 (s), 129.0 (d), 128.9 (d), 
128.8 (d), 128.5 (d), 127.9 (d), 127.24 (d), 127.21 (s), 124.6 (s), 21.7 (q), 21.36 (q), 
21.35 (q) ppm; IR (ATR): ṽ 3064, 3032, 1718, 1597, 1508, 1489, 1451, 1412, 1350, 
1297, 1271, 1165, 1092, 1032, 910, 817, 758, 730, 693, 655 cm-1; HRMS (DART) 
calcd for [C37H32N3O3S]




87.1 mg (71% yield), light yellow solid, m.p.: 150–151 oC; 
Rf = 0.18 (PE/EA = 5:1); 1H NMR (300 MHz, CDCl3) δ 7.74 (d, J = 8.1 Hz, 2H), 
7.44 (dd, J = 15.8, 7.7 Hz, 4H), 7.35–7.31 (m, 3H), 7.22–7.14 (m, 6H), 7.11–7.00 (m, 
5H), 6.69 (d, J = 8.8 Hz, 2H), 3.64 (s, 3H), 2.32 (s, 3H), 2.20 (s, 3H) ppm; 13C NMR 
(75 MHz, CDCl3) δ 170.1 (s), 159.7 (s), 145.0 (s), 143.5 (s), 140.6 (s), 139.3 (s), 
136.3 (s), 136.1 (s), 134.9 (d), 132.6 (s), 131.7 (s), 131.0 (d), 130.8 (d), 129.2 (d), 
129.1 (d), 129.0 (d), 128.9 (d), 128.8 (d), 128.5 (d), 127.9 (d), 127.24 (s), 127.23 (d), 
119.9 (s), 113.8 (d), 55.2 (q), 21.7 (q), 21.3 (q) ppm; IR (ATR): ṽ 2933, 1718, 1615, 
1597, 1508, 1489, 1452, 1417, 1352, 1301, 1278, 1253, 1167, 1093, 1039, 1026, 946, 
911, 837, 824, 735, 696, 656 cm-1; HRMS (DART) calcd for [C37H32N3O4S]
+ (M+H)+: 




109.4 mg (91% yield), light yellow solid, m.p.: 91–92 oC; Rf 
= 0.44 (PE/EA = 5:1); 1H NMR (500 MHz, CDCl3) δ 7.83 (d, J = 7.9 Hz, 2H), 7.57 (d, 
J = 8.2 Hz, 2H), 7.53–7.48 (m, 5H), 7.31–7.26 (m, 6H), 7.20–7.18 (m, 3H), 7.14 (d, J 
= 8.0 Hz, 2H), 6.97 (t, J = 8.7 Hz, 2H), 2.43 (s, 3H), 2.32 (s, 3H) ppm; 13C NMR (125 
MHz, CDCl3) δ 169.8 (s), 162.7 (s, d: JC-F = 249.0 Hz), 145.6 (s), 143.7 (s), 140.4 (s), 
139.5 (s), 136.7 (s), 136.0 (s), 135.1 (d), 132.4 (s), 131.6 (d, d: JC-F = 8.4 Hz), 130.8 
(d), 130.7 (s), 129.3 (d), 129.1 (d, d: JC-F = 3.1 Hz), 129.0 (d), 128.9 (d), 128.5 (d), 
128.0 (d), 127.4 (d), 127.0 (s), 123.7 (s, d: JC-F = 3.2 Hz), 115.5 (d, d: JC-F = 21.7 Hz), 
42 
21.7 (q), 21.4 (q) ppm; 19F NMR (470 MHz, CDCl3) δ -112.06– -112.07 (m) ppm; IR 
(ATR): ṽ 3024, 2933, 1718, 1596, 1505, 1488, 1451, 1411, 1351, 1296, 1270, 1227, 
1164, 1092, 1028, 908, 842, 817, 759, 731, 693, 653 cm-1; HRMS (DART) calcd for 
[C36H29FN3O3S]




104.9 mg (85% yield), yellow solid, m.p.: 176–177 oC; Rf = 
0.39 (PE/EA = 5:1); 1H NMR (500 MHz, CDCl3) δ 7.82 (d, J = 8.2 Hz, 2H), 7.57 (d, 
J = 8.2 Hz, 2H), 7.52 (d, J = 8.0 Hz, 2H), 7.46–7.44 (m, 3H), 7.33–7.24 (m, 8H), 
7.21–7.17 (m, 3H), 7.13 (d, J = 8.2 Hz, 2H), 2.42 (s, 3H), 2.31 (s, 3H) ppm; 13C 
NMR (125 MHz, CDCl3) δ 169.8 (s), 145.8 (s), 143.7 (s), 140.3 (s), 139.6 (s), 136.8 
(s), 136.0 (s), 135.2 (d), 134.7 (s), 132.3 (s), 130.9 (d), 130.8 (d), 130.5 (s), 129.3 (d), 
129.12 (d), 129.09 (d), 129.05 (d), 128.9 (d), 128.7 (d), 128.6 (d), 128.0 (d), 127.5 (d), 
126.9 (s), 126.1 (s), 21.7 (q), 21.4 (q) ppm; IR (ATR): ṽ 2960, 2924, 2853, 1719, 
1596, 1559, 1489, 1451, 1403, 1352, 1294, 1264, 1165, 1091, 1012, 909, 815, 759, 
731, 693, 655, 619 cm-1; HRMS (DART) calcd for [C36H28N3O3SCl]





95.0 mg (77% yield), light yellow solid, m.p.: 178–179 oC; 
Rf = 0.40 (PE/EA = 5:1); 1H NMR (300 MHz, CDCl3) δ 7.83 (d, J = 8.2 Hz, 2H), 
7.60 (d, J = 7.3 Hz, 2H), 7.55–7.21 (m, 16H), 7.16 (d, J = 8.0 Hz, 2H), 2.45 (s, 3H), 
2.34 (s, 3H) ppm; 13C NMR (75 MHz, CDCl3) δ 169.6 (s), 146.0 (s), 143.7 (s), 140.4 
(s), 139.6 (s), 137.1 (s), 136.0 (s), 135.1 (d), 134.1 (s), 132.4 (s), 130.7 (d), 130.1 (s), 
129.7 (d), 129.5 (d), 129.4 (s), 129.2 (d), 129.10 (d), 129.05 (d), 129.0 (d), 128.9 (d), 
128.63 (d), 128.58 (d), 128.0 (d), 127.7 (d), 127.5 (d), 126.9 (s), 21.7 (q), 21.4 (q) 
ppm; IR (ATR): ṽ 3068, 2964, 2923, 1719, 1597, 1576, 1487, 1477, 1451, 1410, 1352, 
1296, 1262, 1206, 1165, 1091, 1037, 910, 814, 792, 756, 727, 691, 663, 612 cm-1; 
43 
HRMS (DART) calcd for [C36H29N3O3SCl]




108.8 mg (88% yield), light yellow solid, m.p.: 56–57 oC; Rf = 
0.20 (PE/EA = 5:1); 1H NMR (500 MHz, CDCl3) δ 7.78 (d, J = 8.1 Hz, 2H), 7.64 (d, 
J = 7.7 Hz, 2H), 7.52–7.50 (m, 2H), 7.41–7.38 (m, 3H), 7.27–7.18 (m, 11H), 7.07 (d, 
J = 7.8 Hz, 2H), 2.43 (s, 3H), 2.30 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 168.5 
(s), 146.5 (s), 143.5 (s), 140.2 (s), 139.3 (s), 138.0 (s), 136.1 (s), 134.8 (s), 134.2 (d), 
133.7 (d), 132.2 (s), 131.0 (d), 130.5 (d), 130.1 (d), 130.0 (d), 129.1 (d), 129.04 (d), 
129.02 (d), 128.7 (d), 128.6 (d), 128.34 (d), 128.29 (d), 127.5 (s), 127.4 (s), 127.3 (d), 
126.6 (d), 21.7 (q), 21.4 (q) ppm; IR (ATR): ṽ 3068, 2922, 1716, 1598, 1488, 1451, 
1410, 1352, 1296, 1277, 1223, 1165, 1119, 1092, 1073, 1035, 948, 927, 907, 890, 814, 
760, 731, 693, 658, 613 cm-1; HRMS (DART) calcd for [C36H29N3O3SCl]
+ (M)+: 




103.1 mg (78% yield), yellow solid, m.p.: 194–195 oC; Rf = 
0.43 (PE/EA = 5:1); 1H NMR (500 MHz, CDCl3) δ 7.85–7.83 (m, 2H), 7.59 (d, J = 
7.8 Hz, 2H), 7.55–7.53 (m, 2H), 7.50–7.40 (m, 5H), 7.36–7.28 (m, 6H), 7.24–7.21 (m, 
3H), 7.15 (d, J = 8.0 Hz, 2H), 2.45 (s, 3H), 2.34 (s, 3H) ppm; 13C NMR (125 MHz, 
CDCl3) δ 169.8 (s), 145.8 (s), 143.7 (s), 140.3 (s), 139.6 (s), 136.8 (s), 135.9 (s), 135.2 
(d), 132.3 (s), 131.7 (d), 131.1 (d), 130.8 (d), 130.6 (s), 129.3 (d), 129.11 (d), 129.09 
(d), 129.06 (d), 128.9 (d), 128.5 (d), 128.0 (d), 127.5 (d), 126.9 (s), 126.6 (s), 123.0 
(s), 21.7 (q), 21.4 (q) ppm; IR (ATR): ṽ 2920, 1718, 1596, 1556, 1486, 1451, 1352, 
1293, 1264, 1165, 1091, 1073, 1028, 1008, 909, 821, 759, 731, 693, 673, 614 cm-1; 
HRMS (DART) calcd for [C36H29N3O3SBr]





96.6 mg (82% yield), light yellow solid, m.p.: 72–73 oC; Rf = 
0.38 (PE/EA = 5:1); 1H NMR (500 MHz, CDCl3) δ 7.89 (d, J = 
8.2 Hz, 2H), 7.63 (d, J = 7.7 Hz, 3H), 7.55 (d, J = 8.0 Hz, 2H), 7.49 (t, J = 7.5 Hz, 
1H), 7.40–7.38 (m, 2H), 7.35–7.28 (m, 5H), 7.23–7.20 (m, 4H), 7.15 (d, J = 7.9 Hz, 
2H), 2.45 (s, 3H), 2.33 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 170.2 (s), 145.2 
(s), 143.7 (s), 140.4 (s), 139.5 (s), 136.23 (s), 136.15 (s), 135.1 (d), 132.4 (s), 130.8 
(d), 129.3 (d), 129.12 (d), 129.06 (d), 129.0 (d), 128.9 (d), 128.4 (d), 128.1 (d), 127.8 
(d), 127.5 (s), 127.34 (d), 127.27 (s), 127.1 (s), 125.82 (d), 125.75 (d), 21.7 (q), 21.4 
(q) ppm; IR (ATR): ṽ 3066, 2920, 2851, 1718, 1596, 1555, 1486, 1451, 1352, 1293, 
1265, 1165, 1091, 1074, 1008, 909, 820, 759, 731, 693, 673, 617 cm-1; HRMS 
(DART) calcd for [C34H28N3O3S2]




97.9 mg (86% yield), yellow solid, m.p.: 64–65 oC; Rf = 0.20 (PE/EA 
= 5:1); 1H NMR (300 MHz, CDCl3) δ 7.89 (d, J = 8.1 Hz, 2H), 7.71–7.63 (m, 4H), 
7.56–7.22 (m, 18H), 2.47 (s, 3H) ppm; 13C NMR (75 MHz, CDCl3) δ 169.8 (s), 145.3 
(s), 143.6 (s), 140.5 (s), 136.6 (s), 136.2 (s), 135.0 (d), 132.5 (s), 132.0 (s), 130.8 (d), 
130.0 (s), 129.6 (d), 129.3 (d), 129.10 (d), 129.09 (d), 128.9 (d), 128.8 (d), 128.7 (d), 
128.6 (d), 128.5 (d), 128.4 (d), 128.0 (d), 127.6 (s), 127.4 (d), 21.7 (q) ppm; IR (ATR): 
ṽ 3065, 1717, 1597, 1491, 1475, 1447, 1348, 1295, 1274, 1207, 1165, 1091, 1028, 
1001, 908, 813, 767, 738, 721, 693, 669, 616 cm-1; HRMS (DART) calcd for 
[C35H28N3O3S]




93.9 mg (80% yield), yellow solid, m.p.: 154–155 oC; Rf = 0.25 
(PE/EA = 5:1); 1H NMR (500 MHz, CDCl3) δ 7.82 (d, J = 8.2 Hz, 
45 
2H), 7.64–7.60 (m, 4H), 7.49 (d, J = 6.9 Hz, 2H), 7.36–7.34 (m, 3H), 7.31–7.26 (m, 
7H), 7.19–7.18 (m, 3H), 6.96 (t, J = 8.5 Hz, 2H), 2.44 (s, 3H) ppm; 13C NMR (125 
MHz, CDCl3) δ 168.5 (s), 166.6 (s, d: JC-F = 259.3 Hz), 145.3 (s), 143.7 (s), 140.3 (s), 
136.6 (s), 136.1 (s), 133.7 (d, d: JC-F = 9.9 Hz), 131.9 (s), 129.8 (s), 129.5 (d), 129.4 
(d), 129.1 (d, d: JC-F = 3.1 Hz), 128.9 (s), 128.8 (d), 128.74 (d), 128.65 (d), 128.6 (d), 
128.5 (d), 128.0 (d), 127.40 (d), 127.39 (s), 116.4 (d, d: JC-F = 22.4 Hz), 21.7 (q) ppm; 
19F NMR (470 MHz, CDCl3) δ -100.45 ppm; IR (ATR): ṽ 3067, 2924, 1719, 1598, 
1506, 1491, 1475, 1446, 1413, 1348, 1296, 1274, 1243, 1206, 1185, 1166, 1156, 1092, 
1028, 1016, 947, 910, 855, 814, 791, 762, 695, 669, 619 cm-1; HRMS (DART) calcd 
for [C35H27FN3O3S2]




98.0 mg (84% yield), light yellow solid, m.p.: 140–141 oC; Rf = 
0.37 (PE/EA = 5:1); 1H NMR (500 MHz, CDCl3) δ 7.82 (d, J = 7.3 Hz, 2H), 7.56 (d, 
J = 8.2 Hz, 2H), 7.48–7.47 (m, 3H), 7.41–7.32 (m, 4H), 7.26–7.16 (m, 11H), 7.10 (d, 
J = 7.6 Hz, 1H), 2.40 (s, 3H), 2.31 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 169.8 
(s), 145.5 (s), 143.6 (s), 140.6 (s), 138.2 (s), 136.5 (s), 136.2 (s), 135.0 (d), 132.6 (s), 
131.9 (s), 130.8 (d), 130.2 (d), 129.8 (s), 129.6 (d), 129.5 (d), 129.12 (d), 129.09 (d), 
128.9 (d), 128.8 (d), 128.6 (d), 128.38 (d), 128.36 (d), 128.0 (d), 127.6 (s), 127.4 (d), 
125.7 (d), 21.7 (q), 21.5 (q) ppm; IR (ATR): ṽ 3066, 2968, 2925, 2855, 1720, 1595, 
1583, 1562, 1486, 1451, 1347, 1295, 1274, 1227, 1167, 1154, 1088, 1024, 1000, 934, 
889, 817, 797, 769, 742, 726, 715, 696, 671, 646, 634, 613 cm-1; HRMS (DART) 
calcd for [C36H30N3O3S]




85.1 mg (73% yield), yellow solid, m.p.: 171–172 oC; Rf = 0.37 
(PE/EA = 5:1); 1H NMR (500 MHz, CDCl3) δ 7.81 (d, J = 8.0 Hz, 2H), 7.56 (dd, J = 
13.9, 7.8 Hz, 4H), 7.44–7.40 (m, 3H), 7.33–7.21 (m, 13H), 7.14–7.11 (m, 1H), 2.52 (s, 
46 
3H), 2.42 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 168.9 (s), 145.0 (s), 143.6 (d), 
140.5 (s), 138.1 (s), 136.1 (s), 136.0 (s), 134.6 (s), 132.7 (s), 131.2 (s), 130.8 (d), 
130.53 (d), 130.47 (d), 129.6 (d), 129.5 (s), 129.4 (d), 129.1 (d), 128.9 (d), 128.6 (d), 
128.5 (d), 128.4 (d), 128.1 (d), 127.8 (s), 127.4 (d), 125.4 (d), 21.7 (q), 20.6 (q) ppm; 
IR (ATR): ṽ 3470, 3063, 2959, 2926, 2872, 2855, 1720, 1598, 1491, 1451, 1352, 
1299, 1275, 1209, 1167, 1093, 1029, 1015, 948, 927, 911, 814, 766, 726, 696, 670 
cm-1; HRMS (DART) calcd for [C36H30N3O3S]




62.9 mg (62% yield), light yellow solid, m.p.: 176–177 oC; Rf = 0.60 
(PE/EA = 2:1); 1H NMR (500 MHz, CDCl3) δ 7.70 (d, J = 8.2 Hz, 2H), 7.61–7.58(m, 
2H), 7.51–7.45 (m, 8H), 7.23–7.14 (m, 7H), 2.40 (s, 3H), 2.12 (s, 3H) ppm; 13C NMR 
(125 MHz, CDCl3) δ 171.6 (s), 145.0 (s), 143.6 (s), 140.3 (s), 137.3 (s), 136.0 (s), 
130.5 (s), 130.1 (s), 129.9 (d), 129.6 (d), 129.3 (d), 129.1 (d), 129.0 (d), 128.9 (d), 
128.8 (d), 128.7 (d), 128.4 (d), 128.3 (d), 128.1 (s), 127.5 (d), 28.3 (q), 21.6 (q) ppm; 
IR (ATR): ṽ 3067, 2962, 2925, 2848, 2258, 1750, 1596, 1491, 1475, 1446, 1353, 
1291, 1270, 1219, 1167, 1092, 1029, 948, 912, 814, 769, 731, 698, 675, 650, 618 cm-1; 
HRMS (DART) calcd for [C30H26N3O3S]
+ (M+H)+: 508.1689; found: 508.1690. 
 
3t: N-(1-acetyl-2,5-diphenyl-1H-imidazol-4-yl)-N,4-dimethylbenzenesulfonamide 
52.5 mg (59% yield), yellow solid, m.p.: 154–155 oC; Rf = 0.33 
(PE/EA = 5:1); 1H NMR (500 MHz, CDCl3) δ 7.80 (d, J = 8.2 Hz, 
2H), 7.58 (d, J = 6.9 Hz, 2H), 7.55 (dd, J = 6.5, 3.0 Hz, 2H), 
7.50–7.42 (m, 6H), 7.31 (d, J = 8.1 Hz, 2H), 3.02 (s, 3H), 2.43 (s, 3H), 2.13 (s, 3H) 
ppm; 13C NMR (125 MHz, CDCl3) δ 171.7 (s), 145.3 (s), 143.7 (s), 137.7 (s), 135.1 
(s), 130.3 (s), 129.71 (d), 129.68 (d), 129.4 (d), 129.33 (d), 129.26 (s), 129.1 (d), 
128.8 (d), 128.7 (d), 128.5 (d), 128.3 (s), 38.0 (q), 28.4 (q), 21.6 (q) ppm; IR (ATR): ṽ 
3057, 2924, 2853, 1748, 1597, 1583, 1569, 1493, 1480, 1463, 1445, 1368, 1340, 1285, 
1263, 1196, 1176, 1154, 1087, 1032, 1002, 970, 925, 865, 806, 782, 769, 757, 721, 
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700, 682, 666, 638, 607 cm-1; HRMS (DART) calcd for [C25H24N3O3S]
+ (M+H)+: 
446.1533; found: 446.1534. 
 
3u: N-(1-acetyl-2,5-diphenyl-1H-imidazol-4-yl)-N-phenylmethanesulfonamide 
33.6 mg (39% yield), white solid, m.p.: 110–111 oC; Rf = 0.40 (PE/EA 
= 2:1); 1H NMR (500 MHz, CDCl3) δ 7.65–7.62 (m, 2H), 749–7.43 
(m, 3H), 7.42–7.41 (m, 7H), 7.27–7.25 (m, 3H), 3.30 (s, 3H), 2.11 (s, 
3H) ppm; 13C NMR (125 MHz, CDCl3) δ 171.5 (s), 145.2 (s), 140.6 (s), 137.1 (s), 
130.3 (s), 129.8 (d), 129.7 (d), 129.4 (s), 129.3 (d), 129.14 (d), 129.10 (d), 128.7 (d), 
128.5 (d), 127.8 (s), 127.71 (d), 127.69 (d), 39.0 (q), 28.3 (q); IR (ATR): ṽ 3067, 3029, 
2923, 2851, 1752, 1592, 1583, 1567, 1490, 1473, 1446, 1417, 1366, 1339, 1296, 1275, 
1253, 1216, 1151, 1077, 1054, 1028, 973, 922, 857, 767, 730, 698, 652, 631 cm-1; 
HRMS (DART) calcd for [C24H22N3O3S]




45.9 mg (50% yield), yellow solid, m.p.: 174–175 oC; Rf = 
0.32 (PE/EA = 5:1); 1H NMR (500 MHz, CDCl3) δ 7.80 (d, J = 8.3 Hz, 2H), 
7.59–7.57 (m, 2H), 7.48–7.42 (m, 5H), 7.30 (d, J = 7.9 Hz, 2H), 7.24 (d, J = 7.9 Hz, 
2H), 3.01 (s, 3H), 2.43 (s, 3H), 2.40 (s, 3H), 2.12 (s, 3H) ppm; 13C NMR (125 MHz, 
CDCl3) δ 171.8 (s), 145.4 (s), 143.6 (s), 139.8 (s), 137.6 (s), 135.2 (s), 129.7 (d), 
129.3 (d), 129.22 (d), 129.15 (d), 129.1 (s), 129.0 (d), 128.8 (d), 128.7 (d), 128.4 (s), 
127.5 (s), 38.0 (q), 28.4 (q), 21.6 (q), 21.4 (q) ppm; IR (ATR): ṽ 3058, 2932, 2851, 
1751, 1615, 1598, 1492, 1461, 1447, 1365, 1340, 1297, 1268, 1256, 1194, 1158, 1114, 
1091, 1034, 997, 930, 879, 818, 782, 732, 716, 699, 672, 650, 635, 610 cm-1; HRMS 
(DART) calcd for [C26H26N3O3S]
+ (M+H)+: 460.1689; found: 460.1693. 
 
3w:  methyl  4-(2-ethyl-4-(4-methyl-N-phenylphenylsulfonamido)-5-phenyl-1H-imida
zole-1-carbonyl)benzoate 
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47.5 mg (41% yield), white solid, m.p.: 150–151 oC; Rf = 0.19 
(PE/EA = 5:1); 1H NMR (300 MHz, CDCl3) δ 7.87 (d, J = 8.3 Hz, 
2H), 7.75 (d, J = 8.3 Hz, 2H), 7.59 (d, J = 8.3 Hz, 2H), 7.33–7.04 (m, 
12H), 3.88 (s, 3H), 2.89 (q, J = 7.5 Hz, 2H), 2.43 (s, 3H), 1.34 (t, J = 
7.5 Hz, 3H) ppm; 13C NMR (75 MHz, CDCl3) δ 168.7 (s), 165.6 (s), 149.2 (s), 143.5 
(s), 140.2 (s), 136.2 (s), 135.9 (s), 135.4 (s), 134.5 (s), 130.3 (d), 129.8 (s), 129.5 (d), 
129.0 (d), 128.9 (d), 128.8 (d), 128.7 (d), 128.3 (d), 128.1 (d), 128.0 (s), 127.7 (d), 
127.2 (d), 52.5 (q), 21.9 (t), 21.6 (q), 12.2 (q) ppm; IR (ATR): ṽ 2925, 2852, 1721, 
1597, 1573, 1528, 1491, 1446, 1408, 1355, 1279, 1209, 1166, 1108, 1092, 1019, 940, 
916, 813, 772, 730, 698, 669, 611 cm-1; HRMS (DART) calcd for [C33H30N3O5S]
+ 




50.5 mg (49% yield), yellow solid, m.p.: 48–49 oC; isomers of 
compound 4 cannot be separated by column chromatography. 1H 
NMR (500 MHz, CDCl3) δ 7.76 (d, J = 8.2 Hz, 2H), 7.68 (d, J = 8.2 Hz, 1.6H), 7.23 
(d, J = 8.0 Hz, 2H), 7.19–7.15 (m, 4H), 7.12–7.05 (m, 4.4H), 7.02–6.96 (m, 6H), 
6.94–6.83 (m, 4.6H), 5.66 (d, J = 6.2 Hz, 1H), 5.11 (q, J = 6.0 Hz, 0.8H), 4.97 (q, J = 
6.9 Hz, 1H), 3.17 (s, 3H), 3.11 (d, J = 4.9 Hz, 2.4H), 2.34 (s, 3H), 2.20 (s, 2.4H), 2.12 
(s, 2.4H), 2.08 (s, 3H), 1.64–1.05 (m, 15.4H), 0.84 (t, J = 7.2 Hz, 3.4H), 0.79 (t, J = 
7.3 Hz, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 171.7 (s), 171.4 (s), 159.7 (s), 154.1 
(s), 152.5 (s), 143.4 (s), 142.9 (s), 142.0 (s), 141.8 (s), 138.1 (s), 137.7 (s), 136.5 (s), 
136.2 (s), 136.1 (s), 135.8 (s), 135.7 (s), 132.8 (d), 131.4 (d), 131.2 (d), 129.8 (d), 
129.5 (d), 129.4 (d), 129.0 (d), 128.4 (d), 128.3 (d), 128.01 (d), 128.00 (d), 127.95 (d), 
127.9 (d), 126.6 (d), 125.6 (d), 111.1 (d), 86.7 (s), 53.2 (q), 52.7 (q), 36.3 (q), 34.3 (t), 
32.5 (t), 28.9 (q), 27.6 (t), 26.8 (t), 22.6 (t), 22.55 (t), 21.58 (q), 21.4 (q), 21.14 (q), 
21.06 (q), 14.0 (q) ppm; IR (reflection): ṽ 3381, 3062, 3029, 2956, 2929, 2870, 2859, 
1674, 1603, 1557, 1449, 1381, 1348, 1271, 1208, 1178, 1161, 1133, 1087, 1061, 1001, 
972, 930, 898, 813, 791, 754, 720, 695, 677, 659 cm-1; HRMS (DART) calcd for 
[C30H34N3O3S]
+ (M+H)+: 516.2315; found: 516.2317. 
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Chapter 3: Gold-Catalyzed Regiospecific C–H Annulation of 
o-Ethynylbiaryls with Anthranils: π-Extension by 
Ring-Expansion en route to N-Doped PAHs 
3.1 Introduction 
π-Conjugated polycyclic aromatic hydrocarbons (PAHs) attract increasing attention 
from the synthetic community due to their use in pharmaceuticals and materials[1] as 
well as their potential for the bottom-up construction of structurally uniform 
graphenes.[2] Recently, direct C–H functionalization to access π-extended PAHs 
constitutes a rapid, facile and efficient synthetic strategy.[3,4] Among these, Itami and 
co-workers developed a palladium-catalyzed dual C–H annulative π-extension (APEX) 
of readily accessible electron-rich (hetero)arenes towards PAH derivatives, and even 
nanographenes.[4] A variety of π-extending building blocks, such as dibenzosiloles, 
dibenzogermoles and diiodobiaryls, have been employed to unite larger π-conjugated 
systems via the formation of a phenanthrene framework (Scheme 1a). 
o-Ethynylbiaryls were also considered as an important synthetic precursor to 
phenanthrene-fused PAHs.[5] For instance, a two-dimensional monolayer graphene 
was facilely prepared by the poly(o-ethynylbiphenyl) benzannulation.[5i] Despite these 
spectacular achievements, the direct π-extending synthesis of PAHs from 
o-ethynylbiaryls is still a challenge (Scheme 1b). Hence, exploring a convergent 
assembly protocol of o-ethynylbiaryls for π-expanding PAHs synthesis remains highly 
desirable and significant. 
 
The recent rapid advances in gold-catalyzed intermolecular formal cycloaddition of 
alkynes with nucleophilic nitrenoids have afforded efficient methodologies for the 
construction of aza-heterocyclic skeletons.[6] However, these transformations mostly 
rely on polarized alkynes,[7,8] especially ynamides,[7] which limits the generality of 
these reactions. Very recently, a gold-catalyzed [3+2] annulation of anthranils with 
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ynamides, delivering a set of 7-acylindole products, was disclosed by our group.[7n] 
Remarkably, some non-polarized alkynes were also suitable for this reaction. In 
continuation of this work, we herein report an unprecedented gold-catalyzed 
ring-expansion/π-extension of anthranils by taking advantage of o-ethynylbiaryls as 
modular building blocks (Scheme 1c). We envisioned that the in situ-generated 
α-imino gold carbene species B could be trapped by the C–Ha bond of 
o-ethynylbiphenyl as alternative to the C–Hb insertion known from the indole 
synthesis.[7n] Finally, the desired pyridine-embedded PAHs could be furnished by a 
Friedel-Crafts-type cyclization of intermediate C. 
 




3.2 Results and Discussion 
3.2.1 Optimization of Reaction Condition 
Initially, we performed the reaction between o-ethynylbiphenyl (1a) and anthranil 2a 
with the precatalyst IPrAuCl (10 mol%) and AgNTf2 (20 mol%) as chloride scavenger 
in PhCF3 at 80 
oC for 12 h, which delivered 50% of an 1:1 mixture of N-doped PAH 
3aa and the undesired indole product 4aa (Table 1, entry 1). The selectivity could be 
controlled by a phosphite ligand (ArO)3P (Ar = 2,4-di-tert-butylphenyl) and the yield 
of 3aa increased to 40% while no 4aa was formed (entry 2). The choice of anthranil 
2b instead of 2a afforded the corresponding N-doped PAH 3ab in an increased yield 
of 70%. On the basis of these results, the reaction of terminal alkyne 1a with anthranil 
2b was chosen as the model one for a further optimization (see SI for details). 
Precatalysts with a phosphite ligand showed higher catalytic activity than those with 
NHC and phosphane ligands (entries 3–7). (ArO)3PAuCl/AgNTf2 turned out to be the 
preferred catalytic system. The use of 1,2-DCE as reaction medium could not improve 
the efficiency (entry 8). The addition of water was not beneficial (entry 9). In contrast 
to our recent work,[7n] catalytic MsOH as an additive gave poor result, which is 
probably attributed to the faster intramolecular cyclization of o-ethynylbiphenyl 
(entry 10). The addition of 4 Å MS also failed to improve the conversion (entry 11). 
The 10 mol% (ArO)3PAuCl/10 mol% AgNTf2 afforded N-doped PAH 3ab in 
moderate yield (entry 12). Control experiments in the presence of only silver or other 
transition metal catalysts showed no conversion (entry 13). The structural assignment 
of compound 3ab was further verified by X-ray diffraction (Figure 1).[9] 
 
Figure 1. Solid-state molecular structure of 3ab (hydrogen atoms omitted). 
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Table 1: Representative examples from the optimization of the reaction conditions.[a] 
 
entry 2 catalyst (mol%) solvent yield [%][b] 
1 2a IPrAuCl/AgNTf2 (10:20) PhCF3 25 (25) 
2 2a (ArO)3PAuCl[c]/AgNTf2 (10:20) PhCF3 40 (trace) 
3 2b (ArO)3PAuCl[c]/AgNTf2 (10:20) PhCF3 70 
4 2b (Ar’O)3PAuCl[d]/AgNTf2 (10:20) PhCF3 58 
5 2b IPrAuCl/AgNTf2 (10:20) PhCF3 45 
6 2b PPh3AuCl/AgNTf2 (10:20) PhCF3 54 
7 2b tBuXPhosAuCl/AgNTf2 (10:20) PhCF3 50 
8 2b (ArO)3PAuCl[c]/AgNTf2 (10:20) 1,2-DCE 50 
9 2b (ArO)3PAuCl[c]/AgNTf2 (10:20) PhCF3/H2O (10:1) 44 
10[e] 2b (ArO)3PAuCl[c]/AgNTf2 (10:20) PhCF3 17 
11[f] 2b (ArO)3PAuCl[c]/AgNTf2 (10:20) PhCF3 63 
12 2b (ArO)3PAuCl[c]/AgNTf2 (10:10) PhCF3 40 
13 2b AgNTf2 (20) PhCF3 trace 
14 2b PtCl2, or Cu(OTf)2 (20) PhCF3 - 
[a] Reaction conditions: 1a (0.1 mmol), 2 (0.2 mmol) were reacted in 0.5 mL PhCF3 at 
80 oC for 12 h. [b] Isolated yield of 3; yield of product 4aa given in parentheses. [c] Ar 
= 2,4-di-tert-butylphenyl. [d] Ar’ = 2-(tert-butyl)-4-(trifluoromethyl)phenyl. [e] 10 
mol% MsOH was added. [f] 10 mg of 4Å MS was added. 
 
3.2.2 Scope and Limitation with regard to the Substrate 
Under the optimized conditions, first a diverse set of o-ethynylbiaryls were tested by 
varying the aromatic rings A and B (Table 2). The unsubstituted precursor gave the 
corresponding N-doped PAH 3ab in 70% yield.[10] A scale-up (1 mmol) conversion 
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gave a 60% yield. o-Ethynylbiaryls with either electron-donating (3bb–3gb) or 
electron-withdrawing (3hb) substituents attached to the para position of the phenyl 
ring A proceeded smoothly to provide the desired products in moderate to good yield 
(33–68%). Fluorine and trifluoromethoxy groups were also compatible.[11] A vinyl 
group (3fb) remained intact. A trimethylsilyl(TMS)-prefunctionalized N-doped PAH 
3gb, a common precursor for Hiyama cross-coupling reaction,[12] was prepared in a 
good yield of 68%. If a methoxy group was tethered at the meta position of the A ring, 
a pair of inseparable regioisomers 3ib and 3ib’ was isolated in a 3:2 ratio. 1j failed to 
undergo the desired π-extension reaction. A 3,5-disubstituted o-ethynylbiphenyl still 
gave the target product 3kb in moderate yield. Besides substituted phenyl moieties, 
naphthyl (3lb, 3mb), heterocyclic rings such as 2- (3ob) or 3-thienyl (3nb/3nb’, ratio 
3:2) and 2-benzothienyl (3pb) could also be introduced, affording the desired product 
in moderate to good yields. The effect of the substitution pattern on the B ring of 
substrate 1 was also examined. The corresponding N-doped PAHs 3qb–3sb with 
fluorine groups emerging at position 5, 6, or 7 were obtained in good yields. The 
electronic nature of the substituent played no detrimental influence on the efficiency 
of the conversion (3sb versus 3tb). In addition, the phenyl ring B could also be 
replaced by a naphthyl (3ub) moiety. 
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Table 2: Scope with regard to o-ethynylbiaryls.[a] 
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Next, the substrate scope of the reaction with respect to the anthranil was investigated 
(Table 3). The conversion of differently substituted anthranils 2 with 
o-ethynylbiphenyl (1a) proceeded regioselectively to afford diverse N-doped PAHs in 
moderate to good yields. A variety of functional groups, including fluoride (3af), 
chloride (3ac, 3ag, 3am), bromide (3ah, 3aj), methoxy (3ad), ester (3ai, 3an) and 
trifluoromethyl (3ae) were well tolerated, allowing further derivatization at the 
relevant positions. Substituents could be attached to each position of the anthranil, 
showcasing the great flexibility and generality of this synthetic strategy. π-Extended 
system 3ak could also be readily constructed by virtue of this strategy. Even the 
sterically bulky N-doped PAHs 3al and 3am were obtained in 50% and 30% yields, 
respectively. 
 
Table 3: Substrate scope with respect to anthranils.[a] 
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3.2.3 Alternative Synthesis and Applications 
Intriguingly, treatment of TMS-protected o-ethynylbiphenyl (TMS-1a) with anthranil 
2b also provided N-doped PAH 3ab in comparable yield (65%), which further 
improved the step economy as no additional deprotection step is necessary (Scheme 
2). After construction of these N-doped PAHs, we then moved to investigate the 
optical properties of representative analogues 3ab, 3lb, 3ob, 3ub, and 3ak in dilute 
CH2Cl2 solution (Figure 2). UV-Vis spectroscopy indicated that the λmax of tested 
N-doped PAHs appeared in the range of 278–302 nm. In addition, they emitted 
violet-blue fluorescence (e.g., 3ak: ΦF = 0.45) with large Stokes shift (107–138 nm). 
 
Scheme 2. In situ TMS removal on the way to N-doped PAH. 
 
 




In conclusion, a rapid, concise, and facile route to N-doped PAHs enabled by the 
gold-catalyzed ring-expansion π-extension reaction of anthranils using 
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o-ethynylbiaryls as a π-extending agent has been developed. A ligand-controlled 
pseudo-intramolecular regioselective C–H annulation allows this π-extension 
technology. Unlike previous synthetic methods, our complementary strategy features 
a one-step operation, high atom economy, as well as a broad substrate scope. 
Preliminary photochemical studies suggest these compounds emit violet-blue 
fluorescence, and the investigation on application in material science is ongoing. 
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3.5 Experimental Section 
General Remarks: Chemicals were purchased from commercial suppliers and used 
without further purification. Reagents 1[1] and 2[2] were easily prepared according to 
our previous literatures. Dry solvents were dispensed from the solvent purification 
system MB SPS-800. Deuterated solvents were bought from Euriso-Top. Unless 
otherwise stated, NMR spectra were recorded at room temperature on the following 
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spectrometers: Bruker Avance 300, 400, 500 or 600. Chemical shifts were referenced 
to residual solvent protons and reported in ppm and coupling constants in Hz. The 
following abbreviations were used for 1H NMR spectra to indicate the signal 
multiplicity: s (singlet), d (doublet), t (triplet), q (quartet), and m (multiplet). All 13C 
NMR spectra were measured with 1H-decoupling. The multiplicities mentioned in 
these spectra [s (singlet, quaternary carbon), d (doublet, CH-group), t (triplet, 
CH2-group), q (quartet, CH3-group)] were determined by DEPT135. HRMS were 
determined at the chemistry department of the University of Heidelberg. EI+-spectra 
were measured on a JOEL JMS-700 spectrometer. For DART-spectra a Bruker ICR 
Apex-Qe spectrometer was applied. IR spectra were recorded on a Bruker Vector 22, 
and the absorption maxima were given in wavelength in cm-1 units. X-ray crystal 
structure analyses were measured at the chemistry department of the University of 
Heidelberg under the direction of Dr. F. Rominger on a Bruker Smart CCD or Bruker 
APEX-II CCD instrument using Mo-Kα-radiation. The structures were solved and 
refined by Dr. F. Rominger using the SHELXTL software package. Thin-layer 
chromatography (TLC) was performed on precoated polyester sheets (POLYGRAM 
SIL G/UV254), and components were visualized by observation under UV light. 
Melting points were uncorrected. 
 
[1] a) H. Jin, L. Huang, J. Xie, M. Rudolph, F. Rominger, A. S. K.Hashmi, Angew. 
Chem. Int. Ed. 2016, 55, 794–797; Angew. Chem. 2016, 128, 804–808; b) H. Jin, B. 
Tian, X. Song, J. Xie, M. Rudolph, F. Rominger, A. S. K, Hashmi, Angew. Chem. Int. 
Ed. 2016, 55, 12688–12692; Angew. Chem. 2016, 128, 12880–12884. 
[2] a) A. Fürstner, V. Mamane, J. Org. Chem. 2002, 67, 6264–6267; b) J. Carreras, G. 
Gopakumar, L. Gu, A. Gimeno, P. Linowski, J. Petuškova, W. Thiel, M. Alcarazo, J. 
Am. Chem. Soc. 2013, 135, 18815–18823; c) D. Lu, Y. Wan, L. Kong, G. Zhu, Chem. 
Commun. 2016, 52, 13971–13974. 
 
Detailed Optimization of Reaction Condition 
Table S1: Detailed Optimization 
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entry 2 catalyst (mol%) additive, solvent yield [%][b] 
1 2a IPrAuCl/AgNTf2 (10:20) --, PhCF3 25 (25) 
2 2a (ArO)3PAuCl[c]/AgNTf2 (10:20) --, PhCF3 40 (trace) 
3 2b (ArO)3PAuCl[c]/AgNTf2 (10:20) --, PhCF3 70 
4 2b (Ar’O)3PAuCl[d]/AgNTf2 (10:20) --, PhCF3 58 
5 2b IPrAuCl/AgNTf2 (10:20) --, PhCF3 45 
6 2b PPh3AuCl/AgNTf2 (10:20) --, PhCF3 54 
7 2b tBuXPhosAuCl/AgNTf2 (10:20) --, PhCF3 50 
8 2b PicAuCl2 (10) --, PhCF3 trace 
9 2b (ArO)3PAuCl[c]/AgNTf2 (10:20) 10 mol% MsOH, PhCF3 17 
10 2b (ArO)3PAuCl[c]/AgNTf2 (10:20) 10mol% In(OTf)3, PhCF3 39 
11 2b (ArO)3PAuCl[c]/AgNTf2 (10:20) 10 mg of 4Å MS, PhCF3 63 
12 2b (ArO)3PAuCl[c]/AgNTf2 (10:20) 10 mol% (ArO)3P, PhCF3 63 
13 2b (ArO)3PAuCl[c]/AgNTf2 (10:20) --, 1,2-DCE 50 
14 2b (ArO)3PAuCl[c]/AgNTf2 (10:20) --, PhCF3/TFE (1:1) 24 
15 2b (ArO)3PAuCl[c]/AgNTf2 (10:20) --, PhCF3/H2O (10:1) 44 
16[e] 2b (ArO)3PAuCl[c]/AgNTf2 (10:20) --, PhCF3 62 
17[f] 2b (ArO)3PAuCl[c]/AgNTf2 (10:20) --, PhCF3 44 
18 2b (ArO)3PAuNTf2[c]/AgNTf2 (10:10) --, PhCF3 51 
19 2b (ArO)3PAuCl[c]/AgNTf2 (10:10) --, PhCF3 40 
20 2b AgNTf2, PtCl2, or M(OTf)2[g] (20) --, PhCF3 < 5 
[a] Reaction conditions: 1a (0.1 mmol), 2 (0.2 mmol) were reacted in 0.5 mL solvent at 80 oC 
for 12 h. [b] Isolated yield of 3; yield of product 4aa given in parentheses. [c] Ar = 
2,4-di-tert-butylphenyl. [d] Ar’ = 2-(tert-butyl)-4-(trifluoromethyl)phenyl. [e] 3 equiv. of 2b 
was used. [f] Run at 100 oC. [g] M = Cu, Zn. 
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Experiment Procedure: Gold-catalyzed ring-expansion π-extension to access 
N-doped PAHs 
A round bottom flask equipped with a magnetic stirrer bar was charged with 
(ArO)3PAuCl (10 mol%, 17.6 mg), AgNTf2 (20 mol%, 15.5 mg), and PhCF3 (0.5 mL). 
The mixture was stirred for 5 minutes at room temperature. Biarylacetylenes 1 or 
TMS-1a (0.2 mmol) and anthranils 2 (0.4 mmol) were added followed by 0.5 mL 
PhCF3. The reaction mixture was then stirred at 80 
oC and the progress of the reaction 
was monitored by TLC. Upon completion, the mixture was concentrated and the 
residue was purified by chromatography on silica gel (eluent: PE/EA) to afford the 
desired product 3. 
 
Scale-up reaction: A round bottom flask equipped with a magnetic stirrer bar was 
charged with (ArO)3PAuCl (10 mol%, 70.4 mg), AgNTf2 (20 mol%, 62.1 mg), and 
PhCF3 (2.5 mL). The mixture was stirred for 5 minutes at room temperature. 
Biphenylacetylene 1a (1.0 mmol) and anthranil 2b (2.0 mmol) were added followed 
by 2.5 mL PhCF3. The reaction mixture was then stirred at 80 
oC for 14 h. Upon 
completion, the mixture was concentrated and the residue was purified by 
chromatography on silica gel (eluent: PE/EA) to afford the desired product 3ab in 
60% yield (176.0 mg). 
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Optical and Photophysical Properties 
All properties were examined in CH2CH2 solution (0.27–0.32 mg/L) and in quartz 
cuvettes providing a layer thickness of 1 cm. UV-vis absorption spectra were recorded 
on a Jasco V-670 device. Fluorescence spectra were measured on a Jasco FP6500 
device. Photographs were taken under UV light irradiation (λ = 365 nm) using a 
Canon EOS 7D digital camera (objective: EF-S60mm f/2.8 Macro USM). 
 
Table S2: Photophysical data of representative N-doped PAHs. 
 λabs [nm] (log ε) λem[a] [nm] (ΦF[b]) Stokes shift (nm) 
3ab 288 (4.84) 395 (0.11) 107 
3lb 293 (4.94) 433 (0.20) 140 
3ob 278 (4.71) 416 (0.40) 138 
3ub 294 (4.91) 432 (0.22) 138 
3ak 302 (4.71) 411 (0.45) 109 





light yellow solid, m.p.: 145–146 oC; 1H NMR (500 MHz, CDCl3) δ 
9.97 (s, 1H), 9.62 (s, 1H), 7.82 (d, J = 7.8 Hz, 1H), 7.76–7.74 (m, 1H), 
7.54 (dd, J = 7.3, 0.8 Hz, 1H), 7.49–7.42 (m, 3H), 7.37–7.35 (m, 3H), 7.33–7.31 (m, 
2H), 7.20 (t, J = 7.6 Hz, 1H), 6.54 (d, J = 2.3 Hz, 1H) ppm; 13C NMR (125 MHz, 
CDCl3) δ 193.0 (d), 141.0 (s), 140.4 (s), 139.7 (s), 134.0 (s), 131.1 (d), 130.5 (s), 
129.61 (d), 129.60 (s), 129.2 (d, 2C), 128.6 (d, 2C), 128.30 (d), 128.27 (d), 127.8 (d), 
127.5 (d, 2C), 120.0 (s), 119.4 (d), 102.0 (d) ppm; IR (reflection): ṽ 3442, 3058, 2819, 
2742, 1663, 1604, 1590, 1568, 1548, 1496, 1465, 1452, 1435, 1381, 1352, 1336, 1296, 
1251, 1231, 1211, 1170, 1113, 1065, 1047, 1008, 961, 948, 936, 915, 879, 811, 786, 
776, 761, 745, 717, 700, 683, 666, 615 cm-1; HRMS (EI) calcd for [C21H15NO]
+ (M)+: 
297.1148; found: 297.1154. 
 
3ab: 10-methyldibenzo[a,c]acridine 
41.1 mg (70% yield), yellow solid, m.p.: 184–185 oC; 1H NMR (500 
MHz, CDCl3) δ 9.56–9.54 (m, 1H), 9.16 (s, 1H), 8.64–8.62 (m, 1H), 
8.57–8.55 (m, 1H), 8.52–8.51 (m, 1H), 7.86 (d, J = 8.2 Hz, 1H), 7.75–7.71 (m, 2H), 
7.67–7.63 (m, 3H), 7.48 (t, J = 7.5 Hz, 1H), 3.03 (s, 3H) ppm; 13C NMR (125 MHz, 
CDCl3) δ 146.6 (s), 146.3 (s), 137.4 (s), 131.9 (s), 131.6 (s), 130.2 (d), 129.8 (s), 
129.5 (d), 129.3 (d), 129.2 (s), 128.0 (d), 127.6 (d), 127.5 (d), 127.0 (s), 126.3 (d), 
126.02 (d), 126.00 (d), 123.6 (d), 123.5 (d), 123.0 (s), 122.6 (d), 18.1 (q) ppm; IR 
(reflection): ṽ 3071, 3040, 2955, 2919, 2850, 1919, 1728, 1615, 1599, 1574, 1553, 
1505, 1493, 1461, 1446, 1402, 1383, 1372, 1351, 1295, 1250, 1176, 1155, 1131, 1081, 
1050, 1033, 972, 961, 944, 910, 890, 857, 805, 788, 762, 721, 701, 679, 617 cm-1; 
HRMS (EI) calcd for [C22H15N]
+ (M)+: 293.1199; found: 293.1210. 
 
3bb: 2,10-dimethyldibenzo[a,c]acridine 
Note: The numbers in the structure are gave in random, thus not consistent with those 
in chemical nomenclature. 
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33.2 mg (54% yield), light yellow solid, m.p.: 158–159 oC; 1H 
NMR (400 MHz, CDCl3) δ 9.55–9.51 (m, C21-H), 9.14 (s, C8-H), 
8.49–8.45 (m, C18-H), 8.42 (d, J = 8.3 Hz, C15-H), 8.39 (s, C11-H), 
7.86 (d, J = 8.2 Hz, C5-H), 7.74–7.67 (m, C19-H and C20-H), 7.63 
(d, J = 6.8 Hz, C3-H), 7.46 (ddd, J = 8.2, 7.1, 4.1 Hz, C4-H and C14-H), 3.04 (s, 
C1-H3), 2.61 (s, C13-H3) ppm; 13C NMR (100 MHz, CDCl3) δ 146.6 (s), 146.5 (s), 
137.4 (s), 137.2 (s), 132.1 (s), 131.3 (s), 130.1 (d, C8), 129.4 (d, C3), 129.30 (d, C19), 
129.27 (d, C14), 129.2 (s), 127.5 (s), 127.1 (d, C20), 127.0 (s), 126.2 (d, C21), 126.0 
(d, C5), 125.9 (d, C4), 123.7 (d, C11), 123.4 (d, C15), 123.0 (s), 122.4 (d, C18), 21.7 
(q, C13), 18.1 (q, C1) ppm; IR (reflection): ṽ 3030, 2968, 2952, 2916, 2855, 1737, 
1614, 1600, 1575, 1548, 1514, 1486, 1466, 1447, 1427, 1397, 1376, 1352, 1304, 1233, 
1192, 1158, 1113, 1080, 1055, 1039, 964, 952, 907, 889, 859, 812, 803, 782, 756, 720, 
712, 703, 666, 616 cm-1; HRMS (DART) calcd for [C23H18N]




21.3 mg (33% yield), light red solid, m.p.: 176–177 oC; 1H NMR 
(500 MHz, CDCl3) δ 9.53 (dd, J = 7.9, 1.4 Hz, 1H), 9.13 (s, 1H), 8.49 
(d, J = 9.0 Hz, 1H), 8.43 (d, J = 7.9 Hz, 1H), 8.06 (d, J = 2.6 Hz, 1H), 
7.89 (d, J = 8.2 Hz, 1H), 7.73–7.64 (m, 3H), 7.49 (dd, J = 8.1, 7.0 Hz, 1H), 7.28–7.25 
(m, 2H), 4.06 (s, 3H), 3.05 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 159.2 (s), 
146.72 (s), 146.67 (s), 137.4 (s), 132.1 (s), 130.73 (s), 130.65 (s), 130.3 (d), 129.6 (d), 
129.4 (d), 126.9 (s), 126.7 (d), 126.3 (d), 126.02 (d), 125.97 (d), 125.1 (d), 123.7 (s), 
122.8 (s), 122.1 (d), 116.0 (d), 106.7 (d), 55.6 (q), 18.1 (q) ppm; IR (reflection): ṽ 
2998, 2958, 2916, 2832, 1608, 1548, 1512, 1487, 1465, 1455, 1428, 1398, 1137, 1359, 
1326, 1292, 1249, 1238, 1222, 1208, 1183, 1156, 1130, 1114, 1078, 1043, 999, 981, 
959, 901, 881, 849, 840, 826, 782, 767, 758, 717, 709, 662 cm-1; HRMS (DART) 
calcd for [C23H18NO]




32.4 mg (42% yield), light yellow solid, m.p.: 191–192 oC; 1H 
NMR (400 MHz, CDCl3) δ 9.54–9.51 (m, 1H), 8.98 (s, 1H), 8.51 (d, 
J = 9.0 Hz, 1H), 8.44–8.41 (m, 1H), 8.24 (d, J = 2.5 Hz, 1H), 7.81 
(d, J = 8.2 Hz, 1H), 7.74–7.67 (m, 2H), 7.63 (d, J = 6.8 Hz, 1H), 
7.48–7.41 (m, 3H), 7.33 (dd, J = 8.9, 2.5 Hz, 1H), 7.22–7.16 (m, 3H), 3.03 (s, 3H) 
ppm; 13C NMR (100 MHz, CDCl3) δ 157.3 (s), 156.7 (s), 146.8 (s), 146.4 (s), 137.4 
(s), 131.7 (s), 131.1 (s, 2C), 130.5 (d), 130.0 (d, 2C), 129.7 (d), 129.4 (d), 127.2 (d), 
126.9 (s), 126.3 (d), 126.1 (d), 126.0 (d), 125.7 (s), 125.3 (d), 123.6 (d), 122.5 (s), 
122.4 (d), 119.5 (d), 119.0 (d, 2C), 112.9 (d), 18.1 (q) ppm; IR (reflection): ṽ 3050, 
2919, 1741, 1613, 1587, 1552, 1484, 1444, 1397, 1372, 1357, 1323, 1292, 1261, 1224, 
1181, 1161, 1132, 1071, 1036, 1021, 986, 964, 906, 883, 852, 840, 820, 800, 758, 745, 
719, 695, 666 cm-1; HRMS (EI) calcd for [C28H19NO]




40.0 mg (53% yield), light yellow solid, m.p.: 204–205 oC; 1H NMR 
(600 MHz, CDCl3, 50 
oC) δ 9.49 (dd, J = 6.4, 3.0 Hz, 1H), 9.01 (s, 
1H), 8.52 (d, J = 8.9 Hz, 1H), 8.41–8.39 (m, 1H), 8.37 (s, 1H), 7.85 
(d, J = 8.2 Hz, 1H), 7.73–7.70 (m, 2H), 7.65 (d, J = 6.8 Hz, 1H), 7.50–7.48 (m, 2H), 
3.01 (s, 3H) ppm; 13C NMR (150 MHz, CDCl3, 50 
oC) δ 148.98 (s), 148.97 (s), 147.3 
(s), 146.5 (s), 137.8 (s), 131.9 (s), 131.2 (s, d: JC-F = 7.1 Hz), 130.7 (d), 130.2 (d), 
129.7 (d), 128.7 (s), 128.2 (d), 127.2 (s), 126.7 (d), 126.6 (d), 126.2 (d), 125.6 (d), 
122.8 (d), 122.2 (s), 121.0 (s, q: JC-F = 257.5 Hz), 120.7 (d), 115.6 (d), 18.1 (q) ppm; 
19F NMR (282 MHz, CDCl3) δ -57.42 ppm; IR (reflection): ṽ 3073, 2951, 2916, 1600, 
1553, 1511, 1490, 1463, 1448, 1378, 1352, 1260, 1203, 1184, 1150, 1078, 1039, 1002, 
969, 909, 890, 858, 843, 827, 785, 762, 720, 709, 671, 632 cm-1; HRMS (EI) calcd 
for [C23H14NOF3]
+ (M)+: 377.1022; found: 377.1017. 
 
3fb: 10-methyl-2-vinyldibenzo[a,c]acridine 
30.0 mg (47% yield), light yellow solid, m.p.: 185–186 oC; 1H NMR (500 MHz, 
68 
CDCl3) δ 9.52 (s, 1H), 9.17 (dd, J = 7.7, 5.3 Hz, 1H), 8.52 (dd, J = 
35.7, 6.8 Hz, 3H), 7.89 (d, J = 5.4 Hz, 1H), 7.75–7.71 (m, 3H), 7.64 
(d, J = 6.5 Hz, 1H), 7.49 (t, J = 7.4 Hz, 1H), 6.98 (dd, J = 17.4, 11.0 
Hz, 1H), 6.01 (d, J = 17.5 Hz, 1H), 5.45 (d, J = 10.8 Hz, 1H), 3.03 (s, 
3H) ppm; 13C NMR (125 MHz, CDCl3) δ 146.6 (s), 146.4 (s), 137.4 (s), 136.7 (d), 
136.6 (s), 131.8 (s), 131.6 (s), 130.2 (d), 129.5 (d), 129.39 (s), 129.35 (d), 129.3 (s), 
127.6 (d), 127.0 (s), 126.3 (d), 126.1 (d), 126.0 (d), 125.3 (d), 123.8 (d), 122.9 (s), 
122.6 (d), 121.8 (d), 114.8 (t), 18.1 (q) ppm; IR (reflection): ṽ 3042, 2914, 1599, 1543, 
1512, 1485, 1450, 1373, 1234, 1196, 1157, 1115, 1080, 1032, 987, 960, 903, 882, 858, 
835, 803, 786, 760, 726, 711, 682, 666 cm-1; HRMS (EI) calcd for [C24H17N]
+ (M)+: 
319.1356; found: 319.1365. 
 
3gb: 10-methyl-2-(trimethylsilyl)dibenzo[a,c]acridine 
41.7 mg (68% yield), yellow solid, m.p.: 214–215 oC; 1H NMR (500 
MHz, CDCl3) δ 9.57 (dd, J = 6.2, 3.2 Hz, 1H), 9.26 (s, 1H), 8.83 (s, 
1H), 8.57–8.54 (m, 2H), 7.94 (d, J = 8.2 Hz, 1H), 7.82 (dd, J = 8.0, 
0.8 Hz, 1H), 7.76–7.72 (m, 2H), 7.65 (d, J = 6.8 Hz, 1H), 7.51 (dd, J = 8.0, 7.1 Hz, 
1H), 3.05 (s, 3H), 0.47 (s, 9H) ppm; 13C NMR (125 MHz, CDCl3) δ 147.5 (s), 147.3 
(s), 140.5 (s), 138.3 (s), 133.7 (d), 132.9 (s), 132.7 (s), 131.1 (s), 130.9 (d), 130.4 (d), 
130.3 (d), 129.5 (d), 129.2 (s), 128.6 (d), 128.0 (s), 127.2 (d), 127.0 (d), 126.9 (d), 
124.0 (s), 123.6 (d), 123.5 (d), 19.0 (q), 0.0 (q, 3C) ppm; IR (reflection): ṽ 3061, 3038, 
2953, 2914, 1600, 1567, 1509, 1482, 1462, 1420, 1364, 1259, 1246, 1214, 1157, 1124, 
1080, 1054, 1036, 978, 945, 903, 884, 836, 806, 787, 771, 756, 723, 705, 649, 622 
cm-1; HRMS (EI) calcd for [C25H23NSi]
+ (M)+: 365.1594; found: 365.1583. 
 
3hb: 2-fluoro-10-methyldibenzo[a,c]acridine 
36.7 mg (59% yield), light yellow solid, m.p.: 213–214 oC; 1H NMR 
(500 MHz, CDCl3) δ 9.56 (d, J = 6.9 Hz, 1H), 9.11 (s, 1H), 8.58–8.55 
(m, 1H), 8.46 (d, J = 7.3 Hz, 1H), 8.29 (d, J = 10.0 Hz, 1H), 7.90 (d, J 
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= 8.3 Hz, 1H), 7.76–7.67 (m, 3H), 7.51 (t, J = 7.3 Hz, 1H), 7.39 (t, J = 7.3 Hz, 1H), 
3.05 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 163.9 (s, d: JC-F = 247.5 Hz, s), 
146.7 (s), 145.7 (s, d: JC-F = 0.9 Hz), 137.3 (s), 134.0 (s, d: JC-F = 8.4 Hz), 130.4 (d), 
129.71 (s), 129.67 (d), 128.98 (s, d: JC-F = 0.4 Hz), 128.96 (d), 128.9 (d), 128.10 (d), 
128.08 (s), 128.05 (d), 126.9 (s), 126.04 (d), 126.02 (d), 123.7 (d, d: JC-F = 6.6 Hz), 
122.5 (s), 115.6 (d, d: JC-F = 22.5 Hz), 108.4 (d, d: JC-F = 23.0 Hz), 18.1 (q) ppm; 19F 
NMR (282 MHz, CDCl3) δ -111.39 ppm; IR (reflection): ṽ 3068, 3051, 3036, 2957, 
2922, 1930, 1730, 1614, 1597, 1554, 1510, 1488, 1465, 1448, 1396, 1377, 1352, 1289, 
1260, 1214, 1192, 1160, 1114, 1076, 1035, 1003, 984, 964, 945, 912, 892, 855, 822, 
803, 782, 762, 720, 707 cm-1; HRMS (DART) calcd for [C22H15FN]
+ (M+H)+: 
312.1183; found: 312.1180. 
 
3ib + 3ib’: 3-methoxy and 1-methoxy-10-methyldibenzo[a,c]acridine 
Inseparable regioisomers, 25.9 mg (40% 
combined yield), yellow solid; 1H NMR (500 
MHz, CDCl3) δ 10.28 (s, 1H), 9.62–9.60 (m, 
1H), 9.57–9.55 (m, 0.7H), 9.05 (s, 0.7H), 8.53–8.51 (m, 1.7H), 8.45–8.44 (m, 0.7H), 
8.27 (d, J = 8.1 Hz, 1H), 7.97 (s, 0.7H), 7.89 (d, J = 8.1 Hz, 1H), 7.84 (d, J = 8.1 Hz, 
0.7H), 7.73 (dd, J = 8.5, 4.5 Hz, 3.4H), 7.65–7.62 (m, 1.7H), 7.61–7.58 (m, 1H), 
7.49–7.44 (m, 1.7H), 7.22 (t, J = 9.6 Hz, 1.7H), 4.17 (s, 3H), 4.02 (s, 2.1H), 3.05 (s, 
3H), 3.04 (s, 2.1H) ppm; 13C NMR (125 MHz, CDCl3) δ 159.57 (s), 159.55 (s), 
146.48 (s), 146.12 (s), 145.75 (s), 145.41 (s), 137.38 (s), 136.93 (s), 136.80 (d), 
132.24 (s), 132.17 (s), 131.97 (s), 131.68 (s), 131.32 (s), 129.40 (s), 129.38 (d), 
129.24 (d), 129.21 (d), 129.06 (d), 127.90 (d), 127.73 (d), 127.18 (s), 127.01 (s), 
126.80 (d), 126.42 (d), 126.35 (d), 125.98 (d), 125.83 (d), 125.54 (d), 125.20 (d), 
123.27 (d), 123.15 (s), 122.84 (s), 122.82 (s), 122.63 (d), 119.19 (d), 117.80 (s), 
116.17 (s), 115.57 (d), 110.00 (d), 109.99 (s), 106.54 (d), 55.86 (q), 55.53 (q), 18.12 
(q), 17.90 (q) ppm; IR (reflection): ṽ 2915, 2833, 1726, 1614, 1575, 1556, 1505, 1463, 
1435, 1402, 1381, 1359, 1322, 1253, 1238, 1213, 1181, 1159, 1133, 1093, 1069, 1055, 
1021, 960, 920, 885, 866, 843, 819, 799, 760, 722, 702, 686, 656, 618 cm-1; HRMS 
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(DART) calcd for [C23H18NO]
+ (M+H)+: 324.1383; found: 324.1380. 
 
3kb: 1,3,10-trimethyldibenzo[a,c]acridine 
25.7 mg (40% yield), light yellow solid, m.p.: 147–148 oC; 1H 
NMR (500 MHz, CDCl3) δ 9.56–9.54 (m, 1H), 9.27 (s, 1H), 8.52 
(d, J = 8.4 Hz, 1H), 8.32 (s, 1H), 7.86 (d, J = 8.2 Hz, 1H), 7.72–7.68 (m, 2H), 7.64 (d, 
J = 6.7 Hz, 1H), 7.48 (t, J = 7.5 Hz, 1H), 7.36 (s, 1H), 3.09 (s, 3H), 3.05 (s, 3H), 2.58 
(s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 147.3 (s), 145.3 (s), 137.0 (s), 136.8 (s), 
136.3 (s), 134.9 (d), 133.4 (d), 132.5 (s), 131.9 (s), 131.4 (s), 129.37 (d), 129.36 (d), 
127.5 d), 126.8 (s), 126.3 (d), 126.1 (d), 126.0 (s), 125.8 (d), 124.3 (s), 123.0 (d), 
122.0 (d), 26.6 (q), 21.5 (q), 17.9 (q) ppm; IR (reflection): ṽ 2911, 1736, 1615, 1498, 
1459, 1403, 1382, 1307, 1178, 1154, 1079, 1030, 902, 884, 850, 805, 787, 766, 754, 
731, 701, 639 cm-1; HRMS (EI) calcd for [C24H19N]




28.2 mg (41% yield), yellow solid, m.p.: 169–170 oC; 1H NMR 
(500 MHz, CDCl3) δ 9.64 (d, J = 7.7 Hz, 1H), 9.23 (s, 1H), 8.97 
(d, J = 8.3 Hz, 1H), 8.81 (d, J = 7.8 Hz, 1H), 8.62 (d, J = 8.6 Hz, 1H), 8.01 (d, J = 8.2 
Hz, 2H), 7.91 (d, J = 8.1 Hz, 1H), 7.79–7.73 (m, 2H), 7.67–7.59 (m, 3H), 7.50 (t, J = 
7.5 Hz, 1H), 3.08 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 146.7 (s), 146.3 (s), 
137.4 (s), 134.0 (s), 132.6 (s), 131.7 (s), 130.8 (d), 130.4 (s), 129.6 (d), 128.8 (d), 
128.4 (d), 128.19 (d), 128.16 (d), 128.1 (d), 127.5 (s), 127.4 (s), 127.2 (s), 127.1 (d), 
126.33 (d), 126.30 (d), 126.1 (d, 2C), 126.0 (d), 123.1 (s), 120.6 (d), 18.2 (q) ppm; IR 
(reflection): ṽ 3067, 3046, 2972, 2944, 2911, 1925, 1755, 1589, 1545, 1483, 1458, 
1431, 1406, 1375, 1361, 1331, 1270, 1246, 1211, 1159, 1124, 1087, 1049, 979, 946, 
900, 875, 861, 837, 816, 797, 789, 774, 761, 741, 706, 685, 666, 629, 611 cm-1; 
HRMS (DART) calcd for [C26H18N]




33.0 mg (48% yield), yellow solid, m.p.: 187–188 oC; 1H NMR 
(400 MHz, CDCl3) δ 9.65–9.54 (m, 1H), 9.54 (s, 1H), 8.92 (d, J = 
8.4 Hz, 1H), 8.61–8.57 (m, 2H), 8.04 (d, J = 8.5 Hz, 2H), 7.91 (d, J 
= 8.2 Hz, 1H), 7.83–7.76 (m, 2H), 7.71–7.67 (m, 2H), 7.65–7.61 (m, 
1H), 7.52 (dd, J = 8.0, 7.1 Hz, 1H), 3.10 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ 
147.0 (s), 146.0 (s), 137.3 (s), 136.2 (d), 133.7 (s), 131.9 (s), 131.8 (s), 130.6 (d), 
129.6 (s), 129.5 (d), 128.5 (d), 128.4 (d, 2C), 127.63 (d), 127.59 (d), 126.8 (d), 126.5 
(s), 126.2 (s), 126.1 (d), 126.04 (d), 126.00 (d), 125.9 (d), 123.2 (d), 122.5 (s), 120.9 
(d), 18.0 (q) ppm; IR (reflection): ṽ 3072, 3057, 2977, 2953, 2916, 2851, 1921, 1779, 
1600, 1568, 1545, 1489, 1464, 1426, 1407, 1374, 1347, 1329, 1220, 1165, 1127, 1075, 
1041, 1011, 953, 921, 893, 858, 816, 790, 750, 715, 706, 665, 630 cm-1; HRMS (EI) 
calcd for [C26H17N]
+ (M)+: 343.1356; found: 343.1357. 
 
3nb + 3nb’: 9-methylbenzo[c]thieno[2,3-a]acridine and 
9-methylbenzo[c]thieno[3,4-a]acridine 
Inseparable regioisomers, 19.8 mg (33% combined 
yield), yellow solid; 1H NMR (500 MHz, CDCl3) δ 
9.55–9.53 (m, 1H), 9.31–9.29 (m, 0.7H), 8.75 (s, 
0.7H), 8.74 (s, 1H), 8.20 (d, J = 7.4 Hz, 1H), 8.12–8.10 (m, 1.4H), 8.01 (d, J = 2.9 Hz, 
0.7H), 7.92 (d, J = 5.3 Hz, 1H), 7.85 (d, J = 8.2 Hz, 1H), 7.78–7.70 (m, 2.8H), 
7.64–7.58 (m, 4H), 7.50–7.43 (m, 1.7H), 3.05 (s, 3H), 2.99 (s, 2.1H) ppm; 13C NMR 
(125 MHz, CDCl3) δ 146.99 (s), 146.33 (s), 146.32 (s), 145.40 (s), 137.71 (s), 137.62 
(s), 135.24 (s), 134.91 (s), 134.76 (s), 134.10 (s), 130.89 (s), 130.73 (s), 130.63 (s), 
130.24 (d), 130.22 (s), 129.93 (d), 129.55 (d), 129.28 (d), 129.23 (d), 129.17 (d), 
127.38 (d), 127.17 (s), 126.84 (s), 126.61 (d), 126.55 (d), 126.40 (d), 126.26 (d), 
126.21 (d), 125.67 (d), 125.52 (d), 125.49 (d), 123.63 (d), 123.56 (d), 123.42 (d), 
121.72 (s), 121.70 (s), 118.46 (d), 117.71 (d), 18.22 (q), 18.07 (q) ppm; IR 
(reflection): ṽ 3102, 3041, 2912, 1603, 1561, 1527, 1498, 1475, 1457, 1405, 1373, 
1349, 1301, 1250, 1214, 1193, 1156, 1134, 1109, 1093, 1079, 1038, 989, 960, 906, 
889, 865, 813, 780, 762, 715, 659, 630 cm-1; HRMS (DART) calcd for [C20H14NS]
+ 
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(M+H)+: 300.0841; found: 300.0838. 
 
3ob: 9-methylbenzo[c]thieno[3,2-a]acridine 
36.5 mg (61% yield), light yellow solid, m.p.: 150–151 oC; 1H NMR 
(500 MHz, CDCl3) δ 9.56–9.52 (m, 1H), 8.90 (s, 1H), 8.07–8.05 (m, 
1H), 8.00 (d, J = 5.3 Hz, 1H), 7.88 (d, J = 8.2 Hz, 1H), 7.73–7.69 (m, 2H), 7.65 (d, J 
= 6.8 Hz, 1H), 7.58 (d, J = 5.3 Hz, 1H), 7.50 (dd, J = 8.1, 7.0 Hz, 1H), 3.06 (s, 3H) 
ppm; 13C NMR (125 MHz, CDCl3) δ 146.1 (s), 146.0 (s), 137.7 (s), 136.6 (s), 133.8 
(s), 130.4 (d), 130.3 (s), 130.2 (s), 129.4 (d), 129.1 (d), 126.9 (s), 126.8 (d), 126.4 (d), 
126.1 (d), 125.7 (d), 125.3 (d), 123.6 (d), 123.4 (d), 122.0 (s), 18.2 (q) ppm; IR 
(reflection): ṽ 3026, 2957, 2916, 1908, 1738, 1602, 1561, 1529, 1496, 1462, 1432, 
1413, 1374, 1333, 1298, 1283, 1264, 1238, 1217, 1191, 1160, 1095, 1056, 1034, 994, 
974, 956, 904, 879, 854, 807, 784, 753, 728, 706, 681, 647 cm-1; HRMS (EI) calcd 
for [C20H13NS]
 + (M)+: 299.0763; found: 299.0768. 
 
3pb: 11-methylbenzo[c]benzo[4,5]thieno[3,2-a]acridine 
14.0 mg (20% yield), light yellow solid, m.p.: 230–231 oC; 1H NMR 
(500 MHz, CDCl3) δ 9.63–9.60 (m, 2H), 8.80 (d, J = 8.3 Hz, 1H), 
8.06 (d, J = 7.9 Hz, 1H), 7.99 (d, J = 7.9 Hz, 1H), 7.93 (d, J = 8.2 Hz, 
1H), 7.80–7.76 (m, 2H), 7.70–7.64 (m, 2H), 7.47 (dt, J = 14.7, 7.4 Hz, 2H), 3.09 (s, 
3H) ppm; 13C NMR (125 MHz, CDCl3) δ 146.2 (s), 145.4 (s), 139.3 (s), 138.7 (s), 
137.8 (s), 137.5 (s), 131.2 (s), 130.2 (d), 129.9 (s), 129.5 (d), 129.3 (d), 127.8 (d), 
126.7 (s), 126.49 (s), 126.46 (d), 126.3 (d), 126.0 (d), 125.3 (d), 125.2 (d), 124.4 (d), 
124.1 (d), 123.5 (d), 123.1 (s), 18.03 (q) ppm; IR (reflection): ṽ 3053, 2920, 2852, 
1926, 1721, 1608, 1563, 1521, 1493, 1459, 1406, 1393, 1378, 1322, 1252, 1227, 1200, 
1162, 1062, 1040, 1010, 983, 894, 872, 858, 833, 820, 761, 745, 718, 653, 631 cm-1; 
HRMS (EI) calcd for [C24H15NS]
+ (M)+: 349.0920; found: 349.0933. 
 
3qb: 5-fluoro-10-methyldibenzo[a,c]acridine 
35.5 mg (57% yield), yellow solid, m.p.: 177–178 oC; 1H NMR (500 MHz, CDCl3) δ 
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9.45 (d, J = 7.9 Hz, 1H), 9.19 (s, 1H), 9.06–9.04 (m, 1H), 
8.68–8.67 (m, 1H), 7.88 (d, J = 8.1 Hz, 1H), 7.69–7.64 (m, 4H), 
7.51–7.43 (m, 2H), 3.02 (s, 3H) ppm; 13C NMR (125 MHz, 
CDCl3) δ 161.3 (s, d: JC-F = 251.7 Hz), 146.7 (s), 145.5 (s, d: JC-F = 3.7 Hz), 137.4 (s), 
134.4 (s), 134.3 (s), 130.3 (d), 129.7 (d), 129.5 (s), 128.7 (d, d: JC-F = 27.4 Hz), 128.3 
(d, d: JC-F = 2.6 Hz), 127.71 (d, d: JC-F = 7.6 Hz), 127.66 (d), 127.3 (s), 126.4 (d), 
126.0 (d), 123.3 (d), 123.1 (s), 122.2 (d, d: JC-F = 3.4 Hz), 120.9 (s, d: JC-F = 7.9 Hz), 
116.8 (d, d: JC-F = 25.7 Hz), 18.1 (q) ppm; 19F NMR (282 MHz, CDCl3) δ -109.97 
ppm; IR (reflection): ṽ 3053, 3028, 2971, 2951, 2916, 1943, 1684, 1612, 1575, 1552, 
1505, 1485, 1462, 1445, 1405, 1387, 1377, 1352, 1310, 1286, 1234, 1217, 1156, 1125, 
1076, 1042, 983, 958, 908, 891, 859, 835, 816, 793, 770, 718, 704, 683, 664 cm-1; 
HRMS (EI) calcd for [C22H14NF]
+ (M)+: 311.1105; found: 311.1110. 
 
3rb: 6-fluoro-10-methyldibenzo[a,c]acridine 
33.0 mg (53% yield), light yellow solid, m.p.: 190–191 oC; 1H 
NMR (500 MHz, CDCl3) δ 9.20 (s, 1H), 9.16 (dd, J = 10.5, 1.8 Hz, 
1H), 8.65 (d, J = 7.1 Hz, 1H), 8.51–8.49 (m, 2H), 7.89 (d, J = 8.2 Hz, 1H), 7.68–7.65 
(m, 3H), 7.52–7.49 (m, 1H), 7.44 (td, J = 8.5, 2.8 Hz, 1H), 3.03 (s, 3H) ppm; 13C 
NMR (125 MHz, CDCl3) δ 162.5 (s, d: JC-F = 246.2 Hz), 146.6 (s), 145.4 (s, d: JC-F = 
3.4 Hz), 137.5 (s), 133.9 (s, d: JC-F = 8.3 Hz), 130.4 (d), 129.7 (d), 129.3 (s), 128.7 (s, 
d: JC-F = 0.9 Hz), 128.4 (s, d: JC-F = 2.3 Hz), 128.2 (d), 127.4 (d), 127.3 (s), 126.4 (d), 
126.0 (d), 125.0 (d, d: JC-F = 8.3 Hz), 123.6 (d), 123.4 (d), 123.2 (s), 117.4 (d, d: JC-F 
= 23.4 Hz), 111.6 (d, d: JC-F = 22.9 Hz), 18.1 (q) ppm; 19F NMR (282 MHz, CDCl3) δ 
-113.59 ppm; IR (reflection): ṽ 3038, 2917, 2388, 2285, 1609, 1578, 1555, 1508, 
1489, 1449, 1398, 1376, 1338, 1280, 1241, 1179, 1157, 1081, 1038, 944, 890, 861, 
842, 825, 801, 783, 764, 745, 728, 717, 701 cm-1; HRMS (EI) calcd for [C22H14NF]
+ 
(M)+: 311.1105; found: 311.1107. 
 
3sb: 7-fluoro-10-methyldibenzo[a,c]acridine 
29.3 mg (47% yield), light yellow solid, m.p.: 200–201 oC; 1H NMR (500 MHz, 
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CDCl3) δ 9.49–9.46 (m, 1H), 9.10 (s, 1H), 8.59–8.58 (m, 1H), 
8.39–8.37 (m, 1H), 8.07 (dd, J = 11.0, 2.3 Hz, 1H), 7.84 (d, J = 8.2 
Hz, 1H), 7.68–7.62 (m, 3H), 7.49–7.46 (m, 1H), 7.39 (td, J = 8.8, 
2.4 Hz, 1H), 2.98 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 
163.9 (s, d: JC-F = 247.5 Hz, s), 146.7 (s), 145.7 (s, d: JC-F = 0.9 Hz), 137.3 (s), 134.0 
(s, d: JC-F = 8.4 Hz), 130.4 (d), 129.71 (s), 129.67 (d), 128.98 (s, d: JC-F = 0.4 Hz), 
128.96 (d), 128.9 (d), 128.10 (d), 128.08 (s), 128.05 (d), 126.9 (s), 126.04 (d), 126.02 
(d), 123.7 (d, d: JC-F = 6.6 Hz), 122.5 (s), 115.6 (d, d: JC-F = 22.5 Hz), 108.4 (d, d: JC-F 
= 23.0 Hz), 18.1 (q) ppm; 19F NMR (282 MHz, CDCl3) δ -111.39 ppm; IR 
(reflection): ṽ 3038, 2392, 1920, 1617, 1600, 1576, 1542, 1498, 1453, 1421, 1402, 
1382, 1348, 1315, 1263, 1231, 1216, 1185, 1171, 1156, 1127, 1107, 1081, 1030, 977, 
961, 948, 910, 898, 890, 868, 834, 798, 782, 766, 734, 698, 650, 634, 607 cm-1; 
HRMS (EI) calcd for [C22H14NF]
+ (M)+: 311.1105; found: 311.1115. 
 
3tb: 7,10-dimethyldibenzo[a,c]acridine 
Note: The numbers in the structure are gave in random, thus not 
consistent with those in chemical nomenclature. 
30.7 mg (50% yield), light yellow solid, m.p.: 188–189 oC; 1H 
NMR (400 MHz, CDCl3) δ 9.27 (s, C21-H), 9.10 (s, C8-H), 8.57 (dd, J = 6.8, 2.5 Hz, 
C11-H), 8.49 (dd, J = 6.9, 2.5 Hz, C14-H), 8.36 (d, J = 8.3 Hz, C17-H), 7.82 (d, J = 
8.2 Hz, C5-H), 7.64–7.57 (m, C3-H, C13-H and C12-H), 7.52 (dd, J = 8.3, 1.7 Hz, 
C18-H), 7.46 (dd, J = 8.1, 7.0 Hz, C4-H), 3.04 (s, C1-H3), 2.65 (s, C20-H3) ppm; 13C 
NMR (100 MHz, CDCl3) δ 146.5 (s), 146.3 (s), 137.4 (s, 2C), 131.5 (s), 130.7 (d, 
C18), 130.1 (d, C8), 130.0 (s), 129.6 (s), 129.4 (d, C13), 128.8 (s), 127.9 (d, C3), 
126.99 (d, C12), 126.95 (s), 126.1 (d, C21), 126.0 (d, C5), 125.9 (d, C4), 123.5 (d, 
C11), 123.2 (d, C14), 123.1 (s), 122.6 (d, C17), 21.8 (q, C20), 18.1 (q, C1) ppm; IR 
(reflection): ṽ 3038, 2915, 1613, 1599, 1572, 1551, 1510, 1491, 1422, 1400, 1377, 
1352, 1263, 1236, 1187, 1154, 1081, 1039, 900, 885, 858, 817, 803, 757, 727, 702, 
663 cm-1; HRMS (EI) calcd for [C23H17N]




28.2 mg (41% yield), yellow solid, m.p.: 168–169 oC; 1H NMR 
(500 MHz, CDCl3) δ 9.59 (d, J = 8.6 Hz, 1H), 9.29 (s, 1H), 8.97 
(d, J = 7.5 Hz, 1H), 8.88 (d, J = 7.8 Hz, 1H), 8.76 (d, J = 7.4 Hz, 1H), 8.09–8.05 (m, 
2H), 7.93 (d, J = 8.1 Hz, 1H), 7.72–7.61 (m, 5H), 7.51 (t, J = 7.5 Hz, 1H), 3.08 (s, 3H) 
ppm; 13C NMR (125 MHz, CDCl3) δ 147.0 (s), 146.2 (s), 137.5 (s), 135.1 (s), 130.4 
(s), 130.3 (s), 129.97 (d), 129.95 (s), 129.9 (s), 129.7 (s), 129.6 (d), 129.5 (d), 128.6 
(d), 128.1 (d), 128.0 (d), 127.0 (d, 2C), 126.9 (d), 126.4 (d), 126.1 (d), 126.02 (d), 
125.98 (d), 123.9 (d), 123.2 (s), 123.0 (d), 18.2 (q) ppm; IR (reflection): ṽ 3072, 3044, 
2953, 2918, 1916, 1765, 1618, 1595, 1546, 1495, 1478, 1440, 1401, 1382, 1299, 1275, 
1247, 1214, 1192, 1155, 1144, 1126, 1113, 1079, 1053, 1031, 937, 899, 883, 858, 826, 
794, 769, 746, 714, 659, 632, 608 cm-1; HRMS (EI) calcd for [C26H17N]
+ (M)+: 
343.1356; found: 343.1345. 
 
3aa: dibenzo[a,c]acridine 
22.3 mg (40% yield), yellow solid, m.p.: 194–195 oC; 1H NMR (300 
MHz, CDCl3) δ 9.68 (s, 1H), 9.25 (s, 1H), 8.92–8.31 (m, 4H), 7.98 (d, 
J = 7.5 Hz, 1H), 7.91–7.46 (m, 6H) ppm; 13C NMR (75 MHz, Cl2CDCDCl2, 80 oC) δ 
145.8 (s), 144.3 (s), 133.7 (d), 133.7 (d), 133.0 (d), 132.9 (s), 132.0 (s), 131.4 (d), 
129.8 (s), 129.1 (d), 128.3 (d), 128.2 (d), 127.9 (s), 127.7 (d), 127.4 (d), 127.0 (s), 
126.9 (d), 123.9 (s), 123.8 (d), 123.7 (d), 123.1 (d) ppm; IR (reflection): ṽ 3067, 3030, 
2801, 1634, 1611, 1526, 1501, 1475, 1458, 1444, 1380, 1344, 1265, 1252, 1227, 1183, 
1159, 1094, 1036, 966, 925, 893, 877, 802, 754, 715, 699, 681, 617 cm-1; HRMS 
(DART) calcd for [C21H14N]
+ (M+H)+: 280.1121; found: 280.1118. 
 
3ac: 10-chlorodibenzo[a,c]acridine 
15.6 mg (20% yield), light yellow solid, m.p.: 216–217 oC; 1H NMR 
(500 MHz, CDCl3) δ 9.65–9.63 (m, 1H), 9.28 (s, 1H), 8.67 (d, J = 7.4 
Hz, 1H), 8.61 (d, J = 7.4 Hz, 1H), 8.56–8.54 (m, 1H), 7.98 (d, J = 8.1 Hz, 1H), 7.93 (d, 
J = 7.2 Hz, 1H), 7.80–7.75 (m, 2H), 7.73–7.67 (m, 2H), 7.51 (t, J = 7.8 Hz, 1H) ppm; 
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13C NMR (125 MHz, CDCl3) δ 148.0 (s), 143.5 (s), 133.8 (s), 132.2 (s), 131.1 (s), 
130.6 (d), 130.2 (s), 130.0 (d), 129.6 (d), 128.7 (s), 128.6 (d), 128.2 (s), 128.0 (d), 
127.7 (d), 127.1 (d), 126.9 (d), 125.9 (d), 124.1 (s), 123.8 (d), 123.7 (d), 122.6 (d) 
ppm; IR (reflection): ṽ 3073, 2923, 2854, 1738, 1611, 1599, 1541, 1492, 1450, 1406, 
1378, 1346, 1263, 1228, 1205, 1192, 1161, 1128, 1049, 1036, 989, 970, 962, 942, 913, 
891, 853, 805, 790, 759, 722, 700, 689, 669, 617 cm-1; HRMS (DART) calcd for 
[C21H13ClN]
+ (M+H)+: 314.0731; found: 314.0729. 
 
3ad: 10-methoxydibenzo[a,c]acridine 
26.6 mg (43% yield), yellow solid, m.p.: 220–221 oC; 1H NMR (500 
MHz, CDCl3) δ 9.58 (dd, J = 6.1, 3.2 Hz, 1H), 9.29 (s, 1H), 
8.71–8.69 (m, 1H), 8.63–8.61 (m, 1H), 8.57–8.55 (m, 1H), 7.77–7.75 (m, 2H), 
7.72–7.65 (m, 3H), 7.53 (t, J = 7.9 Hz, 1H), 7.13 (d, J = 7.5 Hz, 1H), 4.21 (s, 3H) 
ppm; 13C NMR (125 MHz, CDCl3) δ 155.4 (s), 146.6 (s), 139.9 (s), 131.9 (s), 131.2 
(s), 130.3 (d), 130.1 (s), 129.6 (d), 129.0 (s, 2C), 128.3 (d), 127.8 (d), 127.6 (d), 126.7 
(d), 126.4 (d), 123.8 (s), 123.7 (d), 123.6 (d), 122.6 (d), 120.0 (d), 107.6 (d), 56.4 (q) 
ppm; IR (reflection): ṽ 2917, 2849, 1737, 1619, 1550, 1493, 1462, 1409, 1387, 1356, 
1265, 1255, 1239, 1135, 1111, 1000, 957, 908, 862, 794, 762, 724 cm-1; HRMS (EI) 
calcd for [C22H15NO]
+ (M)+: 309.1148; found: 309.1140. 
 
3ae: 11-(trifluoromethyl)dibenzo[a,c]acridine 
25.7 mg (37% yield), light yellow solid, m.p.: 165–166 oC; 1H 
NMR (400 MHz, CDCl3) δ 9.48 (dd, J = 7.7, 1.6 Hz, 1H), 9.25 (s, 
1H), 8.65–8.52 (m, 4H), 8.13 (d, J = 8.6 Hz, 1H), 7.80–7.66 (m, 5H) ppm; 13C NMR 
(100 MHz, CDCl3) δ 148.8 (s), 146.2 (s), 132.2 (s), 131.3 (s, q: JC-F = 32.5 Hz), 130.7 
(s), 130.23 (s), 130.16 (d), 129.9 (d), 129.2 (d), 128.8 (d), 128.6 (s), 128.1 (s), 127.9 
(d), 127.8 (d), 127.4 (d, q: JC-F = 4.5 Hz), 126.4 (d), 124.9 (s), 124.15 (s, q: JC-F = 
272.5 Hz), 123.9 (d), 123.7 (d), 122.7 (d), 121.5 (d, q: JC-F = 3.0 Hz) ppm; 19F NMR 
(282 MHz, CDCl3) δ -62.64 ppm; IR (reflection): ṽ 3071, 3032, 2923, 1738, 1637, 
1598, 1494, 1479, 1454, 1435, 1421, 1386, 1333, 1301, 1283, 1256, 1212, 1195, 1168, 
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1143, 1101, 1054, 1036, 965, 927, 901, 891, 825, 798, 777, 752, 718, 700, 656, 617 
cm-1; HRMS (EI) calcd for [C22H12NF3]
+ (M)+: 347.0916; found: 347.0910. 
 
3af: 12-fluorodibenzo[a,c]acridine 
20.8 mg (35% yield), light yellow solid, m.p.: 191–192 oC; 1H 
NMR (500 MHz, CDCl3) δ 9.46 (dd, J = 7.6, 1.7 Hz, 1H), 9.16 (s, 
1H), 8.63–8.52 (m, 3H), 8.30 (dd, J = 9.2, 5.4 Hz, 1H), 7.77–7.56 (m, 6H) ppm; 13C 
NMR (125 MHz, CDCl3) δ 160.3 (s, d: JC-F = 248.5 Hz), 147.1 (s, d: JC-F = 2.6 Hz), 
144.7 (s), 132.1 (d), 132.0 (d), 131.9 (s), 131.0 (s), 130.1 (s), 129.7 (d), 129.4 (d, d: 
JC-F = 6.2 Hz), 128.7 (s), 128.5 (d), 127.8 (d), 127.7 (d), 127.4 (s, d: JC-F = 10.2 Hz), 
126.1 (d), 123.9 (s), 123.7 (d, d: JC-F = 16.2 Hz), 122.7 (d), 120.6 (d, d: JC-F = 26.6 
Hz), 110.3 (d, d: JC-F = 21.6 Hz) ppm; 19F NMR (282 MHz, CDCl3) δ -113.44 ppm; 
IR (reflection): ṽ 3071, 2923, 1911, 1703, 1630, 1605, 1548, 1504, 1493, 1474, 1437, 
1380, 1346, 1302, 1263, 1230, 1205, 1173, 1150, 1119, 1051, 1037, 973, 950, 897, 
852, 825, 775, 747, 717, 700, 679, 624 cm-1; HRMS (EI) calcd for [C21H12NF]
+ (M)+: 
297.0948; found: 297.0956. 
 
3ag: 12-chlorodibenzo[a,c]acridine 
16.9 mg (27% yield), light yellow solid, m.p.: 228–229 oC; 1H 
NMR (500 MHz, CDCl3) δ 9.49–9.47 (m, 1H), 9.17 (s, 1H), 8.60 
(ddd, J = 31.3, 16.5, 7.5 Hz, 3H), 8.26 (d, J = 9.0 Hz, 1H), 8.02 (d, J = 2.1 Hz, 1H), 
7.79–7.66 (m, 5H) ppm; 13C NMR (125 MHz, CDCl3) δ 147.8 (s), 145.8 (s), 132.1 (s), 
131.9 (s), 131.1 (d), 130.8 (d), 130.1 (s), 129.9 (d), 129.2 (d), 128.7 (s), 128.6 (d), 
127.9 (d), 127.8 (d), 127.5 (s, 2C), 126.4 (d), 126.3 (d), 124.1 (s), 123.7 (d), 123.6 (d), 
122.8 (d) ppm; IR (reflection): ṽ 1702, 1598, 1576, 1542, 1499, 1489, 1463, 1427, 
1378, 1342, 1302, 1259, 1231, 1189, 1128, 1068, 1049, 1035, 960, 917, 906, 875, 861, 
822, 797, 781, 761, 721, 698, 653, 619 cm-1; HRMS (EI) calcd for [C21H12NCl]
+ (M)+: 




26.5 mg (37% yield), light yellow solid, m.p.: 237–238 oC; 1H 
NMR (500 MHz, CD2Cl2) δ 9.45 (d, J = 7.9 Hz, 1H), 9.21 (s, 1H), 
8.67 (dd, J = 6.4, 2.8 Hz, 1H), 8.62–8.60 (m, 1H), 8.57 (d, J = 7.9 Hz, 1H), 8.25 (d, J 
= 1.9 Hz, 1H), 8.16 (d, J = 9.0 Hz, 1H), 7.86 (dd, J = 9.0, 2.1 Hz, 1H), 7.80–7.68 (m, 
4H) ppm; 13C NMR (125 MHz, CD2Cl2) δ 147.9 (s), 146.0 (s), 133.2 (d), 132.2 (s), 
131.1 (d), 130.9 (s), 123.0 (s), 129.91 (d), 129.90 (d), 129.2 (d), 128.8 (s), 128.6 (d), 
128.1 (s), 127.83 (d), 127.81 (d), 126.1 (d), 124.0 (s), 123.8 (d), 123.6 (d), 122.8 (d), 
119.9 (s) ppm; IR (reflection): ṽ 1707, 1597, 1575, 1489, 1458, 1421, 1378, 1342, 
1302, 1259, 1231, 1189, 1167, 1129, 1055, 1034, 983, 960, 907, 878, 863, 826, 798, 
781, 762, 722, 697, 639, 617 cm-1; HRMS (EI) calcd for [C21H12NBr]
+ (M)+: 
357.0148; found: 357.0145. 
 
3ai: dibenzo[a,c]acridin-12-yl acetate 
30.4 mg (45% yield), light yellow solid, m.p.: 213–214 oC; 1H 
NMR (500 MHz, CD2Cl2) δ 9.45 (dd, J = 7.8, 1.3 Hz, 1H), 9.24 
(s, 1H), 8.66–8.64 (m, 1H), 8.60–8.58 (m, 1H), 8.55 (d, J = 7.8 Hz, 1H), 8.28 (d, J = 
9.1 Hz, 1H), 7.79–7.66 (m, 5H), 7.55 (dd, J = 9.1, 2.5 Hz, 1H), 2.38 (s, 3H) ppm; 13C 
NMR (125 MHz, CD2Cl2) δ 169.5 (s), 148.5 (s), 147.4 (s), 145.5 (s), 132.0 (s), 131.0 
(s), 130.8 (d), 129.90 (s), 129.85 (d), 129.7 (d), 128.9 (s), 128.4 (d), 127.74 (d), 
127.72 (d), 127.2 (s), 126.0 (d), 125.6 (d), 123.73 (d), 123.70 (s), 123.5 (d), 122.7 (d), 
118.2 (d), 21.0 (q) ppm; IR (reflection): ṽ 3070, 2924, 1920, 1742, 1632, 1601, 1548, 
1504, 1493, 1474, 1437, 1384, 1370, 1343, 1295, 1261, 1217, 1150, 1133, 1036, 1015, 
969, 959, 947, 915, 902, 865, 847, 831, 784, 744, 716, 701, 655, 627 cm-1; HRMS (EI) 
calcd for [C23H15NO2]
+ (M)+: 337.1097; found: 337.1102. 
 
3aj: 13-bromodibenzo[a,c]acridine 
17.1 mg (24% yield), light yellow solid, m.p.: 264–265 oC; 1H NMR 
(500 MHz, CDCl3) δ 9.68 (s, 1H), 9.52 (d, J = 7.9 Hz, 1H), 
8.80–8.78 (m, 1H), 8.63–8.61 (m, 1H), 8.58 (d, J = 7.9 Hz, 1H), 8.32 (d, J = 8.3 Hz, 
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1H), 7.90 (d, J = 7.2 Hz, 1H), 7.81–7.72 (m, 4H), 7.66 (t, J = 7.9 Hz, 1H) ppm; 13C 
NMR (125 MHz, CDCl3) δ 148.2 (s), 147.9 (s), 132.4 (s), 130.5 (s), 130.1 (s), 130.11 
(d), 130.05 (s), 130.0 (d), 129.8 (d), 129.4 (d), 128.9 (d), 128.7 (d), 127.88 (d), 127.87 
(d), 126.6 (d), 126.5 (s), 124.4 (s), 124.1 (d), 123.6 (d), 122.8 (d), 122.1 (s) ppm; IR 
(reflection): ṽ 3068, 2922, 2852, 1738, 1602, 1563, 1536, 1490, 1456, 1393, 1371, 
1330, 1295, 1261, 1231, 1207, 1177, 1129, 1032, 969, 897, 861, 837, 809, 794, 778, 
758, 718, 698, 684, 658, 611 cm-1; HRMS (EI) calcd for [C21H12NBr]
+ (M)+: 
357.0148; found: 357.0155. 
 
3ak: tribenzo[a,c,h]acridine 
22.4 mg (34% yield), light yellow solid, m.p.: 205–206 oC; 1H 
NMR (500 MHz, CDCl3) δ 9.73 (d, J = 7.0 Hz, 1H), 9.65 (d, J = 
7.8 Hz, 1H), 9.19 (s, 1H), 8.62 (dd, J = 34.1, 15.7 Hz, 3H), 7.93 (d, J = 7.6 Hz, 1H), 
7.85–7.69 (m, 8H) ppm; 13C NMR (125 MHz, CDCl3) δ 145.72 (s), 145.70 (s), 133.9 
(s), 131.8 (s), 131.7 (s), 131.5 (s), 129.9 (s), 129.8 (d), 129.2 (d), 129.1 (s), 128.5 (d), 
127.93 (d), 127.89 (d), 127.7 (d), 127.6 (d), 127.5 (d), 127.1 (d), 126.2 (d), 125.7 (d), 
125.4 (s, 2C), 125.0 (d), 123.53 (d), 123.52 (d), 122.7 (d) ppm; IR (reflection): ṽ 3067, 
3033, 1594, 1571, 1550, 1502, 1485, 1465, 1442, 1404, 1391, 1315, 1237, 1198, 1170, 
1151, 1127, 1110, 1066, 1047, 1029, 1016, 955, 904, 876, 859, 817, 803, 760, 747, 
722, 700, 672, 625, 617 cm-1; HRMS (DART) calcd for [C25H16N]
+ (M+H)+: 
330.1277; found: 330.1274. 
 
3al: 14-phenyldibenzo[a,c]acridine 
35.5 mg (50% yield), yellow solid, m.p.: 245–246 oC; 1H NMR (500 
MHz, CDCl3) δ 9.53–9.51 (m, 1H), 8.51 (t, J = 7.0 Hz, 2H), 8.32 (d, J 
= 8.4 Hz, 1H), 7.80–7.71 (m, 3H), 7.67–7.55 (m, 5H), 7.48–7.41 (m, 
4H), 7.04 (t, J = 7.7 Hz, 1H) ppm; 13C NMR (125 MHz, CD2Cl2) δ 148.1 (s), 146.7 
(s), 145.5 (s), 139.9 (s), 132.2 (s), 131.5 (s), 131.3 (s), 129.98 (d), 129.97 (d, 2C), 
129.8 (s), 129.7 (d), 129.5 (d, 2C), 129.4 (d), 129.3 (d), 128.2 (d), 127.7 (d), 127.4 (d), 
127.1 (s), 126.64 (d), 126.57 (d), 126.0 (d), 125.9 (d), 123.4 (d), 122.5 (d), 121.5 (s) 
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ppm; IR (reflection): ṽ 3062, 2923, 1953, 1739, 1606, 1587, 1565, 1539, 1502, 1489, 
1471, 1454, 1442, 1397, 1369, 1354, 1255, 1237, 1176, 1126, 1107, 1073, 1044, 1027, 
976, 960, 865, 850, 812, 782, 758, 723, 703, 685, 642, 613 cm-1; HRMS (DART) 
calcd for [C27H18N]
+ (M+H)+: 356.1434; found: 356.1430. 
 
3am: 12-chloro-14-phenyldibenzo[a,c]acridine 
23.4 mg (57% yield), light yellow solid, m.p.: 222–223 oC; 1H 
NMR (600 MHz, CD2Cl2) δ 9.48 (dd, J = 7.9, 1.4 Hz, 1H), 8.51 (t, 
J = 8.2 Hz, 2H), 8.27 (d, J = 8.9 Hz, 1H), 7.76–7.70 (m, 3H), 
7.65–7.60 (m, 4H), 7.52 (d, J = 8.4 Hz, 1H), 7.49–7.46 (m, 1H), 7.40–7.39 (m, 2H), 
7.05–7.02 (m, 1H) ppm; 13C NMR (150 MHz, CD2Cl2) δ 148.7 (s), 145.3 (s), 145.0 
(s), 139.6 (s), 132.6 (s), 132.0 (s), 131.8 (s), 131.6 (s), 131.4 (d), 130.6 (d), 130.4 (d), 
130.2 (d), 130.1 (d, 2C), 130.0 (d, 2C), 129.7 (s), 128.8 (d), 128.12 (d), 128.06 (s), 
128.0 (d), 126.8 (d), 126.3 (d), 125.5 (d), 123.7 (d), 122.8 (d), 122.5 (s) ppm; IR 
(reflection): ṽ 3062, 2924, 2853, 1734, 1606, 1566, 1538, 1497, 1465, 1442, 1419, 
1398, 1353, 1339, 1262, 1230, 1197, 1182, 1125, 1106, 1078, 1041, 1028, 978, 957, 
923, 874, 828, 805, 781, 763, 742, 723, 705, 681, 657, 626, 615 cm-1; HRMS (EI) 
calcd for [C27H16NCl]
+ (M)+: 389.0966; found: 389.0962. 
 
3an: methyl dibenzo[a,c]acridine-11-carboxylate 
25.6 mg (38% yield), light yellow solid, m.p.: 230–231 oC; 1H 
NMR (500 MHz, Cl2CDCDCl2) δ 9.42 (d, J = 7.0 Hz, 1H), 
9.17 (s, 1H), 8.93 (s, 1H), 8.59–8.48 (m, 3H), 8.07 (dd, J = 38.5, 7.7 Hz, 2H), 
7.77–7.65 (m, 4H), 4.02 (s, 3H) ppm; 13C NMR (125 MHz, Cl2CDCDCl2) δ 167.1 (s), 
148.4 (s), 146.4 (s), 132.2 (d), 132.1 (s), 131.0 (s), 130.6 (s), 130.3 (d), 130.1 (s), 
130.0 (d), 129.2 (s), 129.0 (d), 128.6 (s), 128.5 (d), 128.1 (d), 128.0 (d), 126.4 (d), 
125.4 (d), 124.8 (s), 124.1 (d), 123.7 (d), 122.9 (d), 52.8 (q) ppm; IR (reflection): ṽ 
3072, 3028, 2952, 2841, 1712, 1601, 1567, 1491, 1477, 1453, 1435, 1387, 1316, 1297, 
1270, 1250, 1210, 1191, 1139, 1094, 1078, 1036, 978, 960, 903, 806, 756, 721, 707, 
618 cm-1; HRMS (EI) calcd for [C23H15NO2]
+ (M)+: 337.1097; found: 337.1082. 
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Chapter 4: Gold(III)-Catalyzed Site-Selective and Divergent 
Synthesis of 2-Aminopyrroles and Quinoline-Embedded 
Polyazaheterocycles 
4.1 Introduction 
The efficient and rapid synthesis of azaheterocycles is of significance for synthetic 
and medicinal chemistry.[1] 2-Aminopyrroles[2] as well as quinoline-fused 
polyazaheterocycles, such as pyrrolo[2,3-b]quinoline[3] and 
dihydrodibenzo[b,f][1,8]naphthyridine derivatives,[4,5f] are fundamental motifs in 
numerous pharmaceuticals, natural products, and organic functional materials. Several 
synthetic routes towards these quinoline-fused polyazaheterocycles have been 
developed.[5] However, most methods involve multiple-step synthesis from the 
relevant quinoline precursors, and suffer from low functional group tolerance.[5] More 
importantly, the installation of a propenal side chain to the parent pyrrole ring is also a 
challenge, making it difficult to construct the pyrrolo[2,3-b]quinolines with such a 
valuable grip.[5a-d] To this end, the development of a novel, general, and 
environmentally benign method towards these polyazaheterocycles in a selective and 
divergent fashion from easily accessible starting materials is still highly desired. 
Recent rapid advances in gold carbene-promoted reactions have provided efficient 
and powerful strategies to access complex and diverse carbon- and azaheterocycles.[6] 
In this context, gold-catalyzed intra-/intermolecular nitrene transfers of azide moieties 
onto carbon-carbon triple bonds were used to prepare different azaheterocycles, 
including pyrroles,[7a-c] indoles,[7d-h] imidazoles,[7i] (iso)quinolines,[7j-m] and others.[7n-o] 
The azide moieties were generally introduced from sodium azide, a toxic and 
potentially explosive reagent. Intermolecular protocols to access α-imino gold carbene 
intermediates from non-toxic, safe and easily available nitrenoid precursors, are more 
practical and flexible. In line with this principle, various nitrenoid equivalents have 
been realized for intermolecular nitrene-transfer processes to ynamides, generating 
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highly electrophilic gold carbene intermediates A.[8] Typically, a nucleophilic 
functionality tethered on the nitrene-transfer reagent traps the gold carbene, leading to 
formal [3+2] cycloadducts (Scheme 1, upper);[8] or a new C–C double bond is formed 
via a 1,2-hydride shift if the α-hydrogens exist (middle).[8a,8o] The site-selective 
trapping by the R1 substituent at the ynamide is more challenging, as the competing 
nucleophilic site Z can induce undesired side reactions. Recently, we disclosed a 
gold(I)-catalyzed synthesis of 7-acylindoles via the C–Ha annulation between alkynes 
and anthranils by exploiting the potential binucleophilicity of anthranils (Scheme 2, 
path a).[8n] We envisioned that the in-situ generated α-imino gold carbene species A1 
could be quenched by the C–Hb bond of N-benzyl ynamides as alternative to the C–Ha 
insertion known from the indole synthesis.[8n] Finally, the desired quinoline-embedded 
polyazaheterocycles would be formed via a Friedel-Crafts-type cyclization of 
intermediate B1. 
 





Scheme 2. Site-selective C–H functionalization of gold carbene intermediates. path a: 
our previous work; path b: present new initial design. 
 
4.2 Results and Discussion 
4.2.1 Optimization of Reaction Condition 
To evaluate the feasibility, N-benzyl ynamide 1a and anthranil 2a were initially 
chosen as the model reaction (Table 1). After various screenings, a “standard 
condition” (5 mol% KAuBr4 in 1,2-DCE at –20 oC for 2 h; then heating to 40 oC for 
10 h) was obtained, which delivered product 3a in 50% isolated yield accompanied by 
a small amount of the undesired indole product 4a (Table 1, entry 1). Other tested 
gold(III) catalysts gave a similar proportion between 3a and 4a (entries 2–5). 
Switching to the cationic gold(I) complex favored the formation of indole product 
while the unactivated catalyst delivered messy conversion (entries 6–7). Unexpectedly, 
neutral ligand-free AuCl also worked in a selective manner, affording 3a in 43% yield 
(about 5:1 3a:4a; entry 8). PhCF3 as reaction medium did not improve the efficiency 
(entry 9). The control experiment in the absence of catalyst showed no conversion 
(entry 10). 
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Table 1: Representative examples from the optimization of the reaction conditions.[a] 
 
entry deviation from “standard” conditions yield of 3a[b] yield of 4a[b] 
1 none 54% (50%) 9 
2 NaAuBr4 as catalyst 50 14 
3 HAuBr4 as catalyst 49 15 
4 AuBr3 as catalyst 45 17 
5 PicAuCl2 as catalyst 47 14 
6 IPrAuCl/AgNTf2 as catalyst 27 37 
7 IPrAuCl as catalyst trace trace 
8 10 mol % AuCl as catalyst 43 8 
9 PhCF3 instead of 1,2-DCE 48 12 
10 no KAuBr4 - - 
[a] “Standard” conditions: a solution of 1a (0.1 mmol) in 1,2-DCE (0.5 mL) was 
added over 5 mins to a mixture of 2a (0.15 mmol), KAuBr4 (5 mol%) in 
1,2-DCE (0.5 mL) at –20 oC and after 2 h the reaction mixture was heated to 40 
oC for 10 h. [b] Measured by 1H NMR with 1,3,5-trimethoxybenzene as the 
internal standard. Yield of isolated product given in parentheses. 
 
4.2.2 Scope with regard to the Substrate 
Under the optimized conditions, a diverse set of N-benzyl ynamides with different 
anthranils were first tested (Table 2). Ynamides bearing different protecting groups 
(Ms, Ts, Bs, Ns, SO2Ph) on nitrogen reacted quite well with anthranil 2a, giving 3a–e 
in satisfying yields. A scale-up (1 mmol) synthesis of 3e provided a slightly lower 
yield. A tolyl group in 3f delivered 58% yield. Various substituted anthranils were 
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then examined. Besides the phenyl group (3g), methyl or hydrogen at the R2 position 
afforded the desired products 3h or 3i in 48% and 62% yields, respectively. A 
less-polar carbon-carbon triple bond, that was also reactive in our previous work, 
remained intact.[8n] The obtained product 3j emitted violet-blue fluorescence (ΦF = 
0.21), somewhat showcasing the importance of the compatibility with such a triple 
bond.[9] Besides, some other functional groups including chloride (3k), bromide (3l), 
ester (3m) and acetal (3n) were well tolerant, thus allowing for further derivatization. 
If an aryl group was introduced at the C6 position of anthranils, 3o was obtained in 
60% yield. For the structural assignments of these products, single-crystal X-ray 
structure analyses of 3b and 3e were conducted.[9] 
 
Ynamides with an electron-rich heteroaromatic system which has the potential to 
serve as an alternative nucleophilic site to trap the gold carbene intermediate were 
also tested. Under the above optimum condition, it was found that the treatment of 
N-furanylmethyl ynamide 5a and anthranil 2a proceeded well. However, the above 
expected tetracyclic N-heterocycles derived by C3–H insertion into the gold carbene 
were not obtained; instead pyrrole (E)-6a was isolated in 69% yield. Despite being 
thermodynamically less stable than its E isomer, the isolation of (Z)-6a was also 
viable by just omitting the subsequent warming, which suggests the latter was likely 
to be generated first via a ring opening of furan by the regioselective attack of the 
C2-position to the gold carbene (Scheme 3). The primary product can be further 
transformed to the thermodynamically stable (E)-isomer 6a or to tricyclic 
azaheterocycles (E)-7a via a Friedel-Crafts-type cyclization driven by heating or/and 
Lewis acid. 
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Scheme 3. Proposed mechanism towards 2-aminopyrroles and related derivatives 
 
This synthetic strategy features the ability to deliver 2-aminopyrroles 6 with a 
propenal side chain at C4 position. The location of such a versatile handle at this 
position is not so easy to be introduced, thus distinguishing this method for pyrrole 
synthesis.[10] Besides, a myriad of potential derivatization for the enal moiety could be 
anticipated, such as cycloaddition and some textbook transformations (oxidation, 
reduction and Michael addition).[11] With this in mind, various 2-aminopyrroles 6 
were first investigated from anthranils and N-furanylmethyl ynamide 5a under the 
adjusted reaction temperature. Aromatic (6b), aliphatic (6c and 6d) and 
electron-neutral (6f–i) substituents could be attached to the R2 position, providing the 
desired products in moderate to good yield. Again, a carbon-carbon triple bond was 
possible to be pre-installed on the anthranil substrate (6e). Other functional groups 
such as chloride (6a), methoxy (6d and 6f), ester (6g), acetal (6h) were well tolerated. 
While internal N-benzyl ynamides were unsuccessful for the synthesis of 3, the 
corresponding internal N-furanylmethyl derivative was converted into trisubstituted 
pyrrole 6j. At a relatively higher reaction temperature, some pyrrole-fused compounds 
7 were also accessible in 35–59% yields via a one-pot process. A 45% yield of 7a was 
acquired on a 1 mmol scale and its constitutional isomerism was further verified by 
X-ray diffraction.[9] 
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In conclusion, an atom-economical, site-selective, divergent assembly of valuable and 
versatile 2-aminopyrroles and quinoline-fused polyazaheterocycles has been achieved. 
This protocol was enabled by a simple gold(III) catalyst leading to a preferable 
quenching of gold carbene intermediate by a nucleophilic functionality on the 
ynamides, complementary to the C–H annulation known from the indole synthesis. 
This will also open up a new window for the challenging intramolecular site-selective 
C–H functionalization. Unlike previous synthetic methods, our strategy features a 
one-step operation, easily accessible starting materials, good functional-group 
tolerance, and scale-up potential accompanied by a broad substrate scope. Further 
application of anthranils for the synthesis of (π-extended) N-doped polycyclic 
aromatics is ongoing in our lab. 
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4.5 Experimental Section 
General Remarks: Chemicals were purchased from commercial suppliers and used 
without further purification. Ynamide substrates 1 and 5 were easily prepared 
according to the previous literatures.[1] Dry solvents were dispensed from the solvent 
purification system MB SPS-800. Deuterated solvents were bought from Euriso-Top. 
Unless otherwise stated, NMR spectra were recorded at room temperature on the 
following spectrometers: Bruker Avance 400, 500 or 600. Chemical shifts were 
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referenced to residual solvent protons and reported in ppm and coupling constants in 
Hz. The following abbreviations were used for 1H NMR spectra to indicate the signal 
multiplicity: s (singlet), d (doublet), t (triplet), q (quartet), and m (multiplet). All 13C 
NMR spectra were measured with 1H-decoupling. The multiplicities mentioned in 
these spectra [s (singlet, quaternary carbon), d (doublet, CH-group), t (triplet, 
CH2-group), q (quartet, CH3-group)] were determined by DEPT135. HRMS were 
determined at the chemistry department of the University of Heidelberg. EI+-spectra 
were measured on a JOEL JMS-700 spectrometer. For DART-spectra a Bruker ICR 
Apex-Qe spectrometer was applied. IR spectra were recorded on a Bruker Vector 22, 
and the absorption maxima were given in wavelength in cm-1 units. X-ray crystal 
structure analyses were measured at the chemistry department of the University of 
Heidelberg under the direction of Dr. F. Rominger on a Bruker Smart CCD or Bruker 
APEX-II CCD instrument using Mo-Kα-radiation. The structures were solved and 
refined by Dr. F. Rominger using the SHELXTL software package. Thin-layer 
chromatography (TLC) was performed on precoated polyester sheets (POLYGRAM 
SIL G/UV254), and components were visualized by observation under UV light. 
Melting points were uncorrected. 
 
Experiment Procedures 
General Procedure 1: Synthesis of substituted anthranils 2[2] 
 
A round bottom flask equipped with a magnetic stirrer bar was charged with the 
corresponding substituted 2-nitroacylbenzene (3.0 mmol) in EtOAc–MeOH (1:1, v/v; 
20 mL). SnCl2.2H2O (9.0 mmol) was added and the reaction was stirred at room 
temperature for 24 h. The reaction was quenched by saturated NaHCO3 (20 mL), and 
filtered. The aqueous phase was extracted with EtOAc (3 × 10 mL) and the organic 
portions combined, washed with H2O (20 mL), saturated aqueous NaCl (20 mL), 
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dried over NaSO4, filtered and reduced in vacuo. The residue was purified by column 
chromatography to provide the title compound. 
 
General Procedure 2: Gold(III)-catalyzed site-selective reaction of ynamides and 
anthranils 
A round bottom flask equipped with a magnetic stirrer bar was charged with KAuBr4 
(5 mol%, 3.3 mg) and anthranils 2 (1.8 equiv.) in 1,2-DCE (1.2 mL). The reaction was 
cooled to –20 oC and ynamides 1 or 5 (0.12 mmol, 1.0 equiv.) dissolved in 1,2-DCE 
(1.2 mL) was added dropwise over 6 minutes and maintained at –20 oC for 1h. Then 
the reaction mixture was heating at the relevant temperature and the progress of the 
reaction was monitored by TLC. Upon completion, the mixture was concentrated and 
the residue was purified by chromatography on silica gel (eluent: PE/EtOAc) to afford 
the desired products 3, 6, and 7. 
 
Scale-up reaction: A round bottom flask equipped with a magnetic stirrer bar was 
charged with KAuBr4 (5 mol%, 27.8 mg) and anthranil 2a (1.5 mmol, 345.0 mg) in 
1,2-DCE (10.0 mL). The reaction was cooled to –20 oC and ynamides 1 or 5 (1.0 
mmol) dissolved in 1,2-DCE (10.0 mL) was added dropwise over 6 minutes and 
maintained at –20 oC for 1 h. Then the reaction mixture was heating at the relevant 
temperature and the progress of the reaction was monitored by TLC. Upon 
completion, the mixture was concentrated and the residue was purified by 
chromatography on silica gel (eluent: PE/EtOAc) to afford the desired products 3e 
and 7a. 
 
[1] a) L. Zhu, Y. Yu, Z. Mao, X. Huang, Org. Lett. 2015, 17, 30–33; b) Z. Zeng, H. 
Jin, J. Xie, B. Tian, M. Rudolph, F. Rominger, A. S. K. Hashmi, Org. Lett. 2017, 19, 
1020–1023. 
[2] a) H. Jin, L. Huang, J. Xie, M. Rudolph, F. Rominger, A. S. K. Hashmi, Angew. 
Chem. Int. Ed. 2016, 55, 794–797; b) H. Jin, B. Tian, X. Song, J. Xie, M. Rudolph, F. 
Rominger, A. S. K, Hashmi, Angew. Chem. Int. Ed. 2016, 55, 12688–12692. 
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X-Ray Single Crystal Structure Analyses 
The crystallographic data of compounds 3b, 3e, and 7a can be obtained free of charge 











All properties were examined in CH2CH2 solution (9.6 mg/L) and in quartz cuvettes 
providing a layer thickness of 1 cm. UV-vis absorption spectra were recorded on a 
Jasco V-670 device. Fluorescence spectra were measured on a Jasco FP6500 device. 
Photographs were taken under UV light irradiation (λ = 365 nm) using a Canon EOS 
7D digital camera (objective: EF-S60mm f/2.8 Macro USM). 
 
Table S1. Photophysical data of compound 3j. 
 λabs [nm] (log ε) λem[a] [nm] (ΦF[b]) Stokes shift (nm) 
3j 280 (4.52) 542 (21.3%) 162 
[a] Excited at λabs. [b] Fluorescence quantum yields (ΦF) in CH2Cl2 
at 298 K. 
 
 
Figure S1. UV/Vis absorption (black lines), emission spectra (blue) and picture in 




60% yield, light yellow solid, m.p.: 56–57 oC; 1H NMR (500 MHz, 
CDCl3) δ 7.65–7.63 (m, 4H), 7.47–7.41 (m, 3H), 7.35–7.32 (m, 1H), 
7.11–7.08 (m, 1H) ppm; 13C NMR (125 MHz, CDCl3) δ 157.2 (s), 
149.3 (s), 131.9 (d, 2C), 131.1 (d), 130.1 (d), 128.7 (d, 2C), 125.2 (d), 121.0 (s), 120.3 
(s), 119.8 (d), 115.7 (d), 103.5 (s), 75.8 (s) ppm; IR (reflection): ṽ 3058, 2207, 1638, 
1634, 1557, 1552, 1493, 1447, 1304, 1232, 1148, 1132, 1066, 924, 903, 847, 859, 694, 
658, 640 cm-1; HRMS (EI) calcd for [C15H9NO]
+ (M)+: 219.0679; found: 219.0682. 
 
4a: N-(7-benzoyl-5-chloro-1H-indol-2-yl)-N-benzyl-4-methylbenzenesulfonamide 
yellow solid, m.p.: 67–68 oC; 1H NMR (500 MHz, CDCl3) δ 
10.66 (s, 1H), 7.77–7.75 (m, 2H), 7.63–7.60 (m, 4H), 
7.55–7.51 (m, 2H), 7.49 (d, J = 1.9 Hz,1H), 7.35 (d, J = 7.1 
Hz, 2H), 7.31–7.27 (m, 4H), 7.24–7.21 (m, 1H), 5.91 (d, J = 2.3 Hz, 1H), 4.77 (s, 2H), 
2.43 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 196.3 (s), 144.5 (s), 138.1 (s), 
137.0 (s), 135.2 (s), 134.2 (s), 132.0 (d), 131.9 (s), 129.9 (d, 2C), 129.5 (s), 129.4 (d, 
2C), 128.7 (d, 2C), 128.5 (d, 2C), 128.0 (d), 127.9 (d, 2C), 127.6 (d, 2C), 126.9 (d), 
125.3 (d), 124.5 (s), 119.7 (s), 94.2 (d), 54.0 (t), 21.7 (q) ppm; IR (reflection): ṽ 3420, 
2962, 2924, 1738, 1638, 1598, 1581, 1537, 1496, 1459, 1406, 1357, 1331, 1253, 1211, 
1160, 1089, 1055, 1025, 963, 916, 856, 807, 774, 744, 715, 697, 664 cm-1; HRMS (EI) 
calcd for [C29H23N2O3SCl]
+ (M)+: 514.1112; found: 514.1096. 
 
3a:  10-chloro-12-phenyl-6-tosyl-5,6-dihydrodibenzo[b,f][1,8]naphthyridine 
34.0 mg (57% yield), white solid, m.p.: 264–265 oC; 1H NMR (500 
MHz, CDCl3) δ 8.15 (d, J = 7.8 Hz, 2H), 7.87 (d, J = 8.7 Hz, 1H), 
7.57–7.47 (m, 5H), 7.32 (d, J = 6.8 Hz, 3H), 7.26 (s, 2H), 7.18 (t, J = 
7.3 Hz, 1H), 6.88 (t, J = 7.6 Hz, 1H), 6.68 (d, J = 8.0 Hz, 1H), 4.99 (s, 
2H), 2.41 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 150.4 (s), 145.2 (s), 144.0 (s), 
143.8 (s), 137.4 (s), 136.7 (s), 135.4 (s), 131.3 (s), 130.5 (d), 130.2 (d, 2C), 130.1 (s), 
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129.5 (d), 129.4 (d, 2C), 129.2 (d), 129.1 (d, 2C), 129.0 (d, 2C), 128.8 (d), 128.1 (d), 
127.3 (d), 126.8 (s), 126.1 (d), 125.4 (d), 120.3 (s), 49.0 (t), 21.6 (q) ppm; IR 
(reflection): ṽ 1395, 1380, 1353, 1323, 1275, 1168, 1134, 1099, 1083, 1027, 936, 918, 
906, 814, 784, 762, 734, 705, 661, 634 cm-1; HRMS (DART) calcd for 
[C29H22N2O2SCl]




28.3 mg (56% yield), white solid, m.p.: 250–251 oC; 1H NMR (500 
MHz, CDCl3) δ 7.94 (d, J = 8.9 Hz, 1H), 7.60 (dd, J = 8.9, 2.3 Hz, 
1H), 7.55–7.53 (m, 4H), 7.34–7.32 (m, 2H), 7.29 (d, J = 7.5 Hz, 1H), 7.19 (t, J = 7.4 
Hz, 1H), 6.90 (t, J = 7.7 Hz, 1H), 6.74 (d, J = 8.1 Hz, 1H), 4.92 (s, 2H), 3.68 (s, 3H) 
ppm; 13C NMR (125 MHz, CDCl3) δ151.1 (s), 145.6 (s), 144.0 (s), 136.7 (s), 135.5 
(s), 131.5 (s), 130.7 (d), 130.1 (d, 2C), 130.0 (s), 129.7 (d), 129.4 (d, 2C), 129.2 (d), 
128.9 (d), 128.2 (d), 127.3 (d), 126.9 (s), 126.0 (d), 125.4 (d), 120.5 (s), 48.2 (t), 42.7 
(q) ppm; IR (reflection): ṽ 2259, 1601, 1566, 1480, 1442, 1420, 1396, 1331, 1285, 
1255, 1226, 1161, 1138, 1117, 1102, 1083, 1053, 1031, 992, 971, 963, 937, 913, 877, 
831, 797, 763, 728, 703, 660, 648, 630 cm-1; HRMS (EI) calcd for [C23H17N2O2SCl]
+ 




33.7 mg (50% yield), white solid, m.p.: 288–289 oC; 1H NMR (500 
MHz, CDCl3) δ 8.13 (d, J = 8.6 Hz, 2H), 7.84 (d, J = 8.9 Hz, 1H), 7.66 
(d, J = 8.6 Hz, 2H), 7.58 (dd, J = 8.9, 2.2 Hz, 1H), 7.52–7.49 (m, 4H), 7.32 (d, J = 7.4 
Hz, 1H), 7.28–7.26 (m, 2H), 7.20 (t, J = 7.4 Hz, 1H), 6.90 (t, J = 7.6 Hz, 1H), 6.69 (d, 
J = 8.0 Hz, 1H), 5.14 (d, J = 156.5 Hz, 2H) ppm; 13C NMR (125 MHz, CDCl3) δ 
150.1 (s), 145.5 (s), 143.9 (s), 139.4 (s), 136.6 (s), 135.1 (s), 131.7 (d, 2C), 131.5 (s), 
130.7 (d), 130.4 (d, 2C), 130.1 (d, 2C), 130.0 (s), 129.4 (d, 3C), 129.2 (d), 128.9 (d), 
128.2 (d), 128.1 (s), 127.4 (d), 126.9 (s), 126.1 (d), 125.4 (d), 120.3 (s), 49.0 (t) ppm; 
99 
IR (reflection): ṽ 1572, 1472, 1394, 1350, 1329, 1278, 1164, 1137, 1120, 1100, 1085, 
1070, 1049, 1031, 1008, 949, 937, 904, 867, 830, 820, 790, 761, 743, 728, 700, 660, 
641 cm-1; HRMS (EI) calcd for [C28H18N2O2SClBr]





45.6 mg (72% yield), light yellow solid, m.p.: 255–256 oC; 1H NMR 
(500 MHz, CDCl3) δ 8.41  (dd, J = 35.9, 8.5 Hz, 4H), 7.80 (d, J = 8.8 
Hz, 1H), 7.59 (dd, J = 8.6, 1.4 Hz, 1H), 7.51 (dd, J = 11.3, 2.9 Hz, 4H), 7.34 (d, J = 
7.3 Hz, 1H), 7.27–7.26 (m, 2H), 7.22 (t, J = 7.3 Hz, 1H), 6.91 (t, J = 7.6 Hz, 1H), 6.69 
(d, J = 8.0 Hz, 1H), 5.03 (s, 2H) ppm; 13C NMR (125 MHz, CDCl3) δ 150.1 (s), 149.7 
(s), 146.4 (s), 145.8 (s), 143.8 (s), 136.4 (s), 134.8 (s), 131.9 (s), 131.0 (d), 130.04 (d, 
2C), 129.99 (d, 2C), 129.9 (s), 129.5 (d, 2C), 129.3 (d, 2C), 129.0 (d), 128.3 (d), 
127.6 (d), 127.1 (s), 126.2 (d), 125.5 (d), 123.7 (d, 2C), 120.4 (s), 49.3 (t) ppm; IR 
(reflection): ṽ 3115, 3069, 2926, 2858, 1603, 1567, 1528, 1477, 1444, 1351, 1327, 
1288, 1209, 1170, 1136, 1117, 1100, 1081, 1050, 1030, 954, 936, 918, 854, 828, 811, 
789, 768, 736, 715, 700, 681, 660, 640 cm-1; HRMS (EI) calcd for [C28H18N3O4SCl]
+ 




30.1 mg (52% yield), white solid, m.p.: 273–274 oC; 1H NMR (500 
MHz, CDCl3) δ 8.25 (d, J = 7.5 Hz, 2H), 7.85 (d, J = 8.9 Hz, 1H), 
7.58–7.47 (m, 8H), 7.33 (d, J = 7.5 Hz, 1H), 7.27–7.25 (m, 2H), 7.19 (t, J = 7.4 Hz, 
1H), 6.89 (t, J = 7.7 Hz, 1H), 6.68 (d, J = 8.1 Hz, 1H), 5.02 (s, 2H) ppm; 13C NMR 
(125 MHz, CDCl3) δ 150.3 (s), 145.3 (s), 144.0 (s), 140.5 (s), 136.7 (s), 135.3 (s), 
132.9 (d), 131.4 (s), 130.6 (d), 130.1 (d, 2C), 130.0 (s), 129.5 (d), 129.4 (d, 2C), 129.2 
(d), 128.8 (d), 128.7 (d, 2C), 128.4 (d, 2C), 128.1 (d), 127.3 (d), 126.9 (s), 126.1 (d), 
125.4 (d), 120.3 (s), 49.0 (t) ppm; IR (reflection): ṽ 3066, 2853, 1568, 1480, 1446, 
100 
1396, 1380, 1350, 1325, 1275, 1210, 1171, 1159, 1130, 1084, 1026, 936, 910, 882, 
850, 829, 790, 772, 759, 736, 720, 705, 689, 636, 605 cm-1; HRMS (EI) calcd for 
[C28H19N2O2SCl]
+ (M)+: 482.0850; found: 482.0857. 
 
3f: 10-chloro-2-methyl-12-phenyl-6-tosyl-5,6-dihydrodibenzo[b,f][1,8]naphthyridine 
35.6 mg (58% yield), light yellow solid, m.p.: 246–247 oC; 1H 
NMR (400 MHz, CDCl3) δ 8.15 (d, J = 8.2 Hz, 2H), 7.87 (d, J = 
8.8 Hz, 1H), 7.56 (dd, J = 8.9, 2.2 Hz, 1H), 7.52–7.49 (m, 4H), 
7.31 (d, J = 8.1 Hz, 2H), 7.27–7.25 (m, 2H), 7.19 (d, J = 7.6 Hz, 
1H), 6.99 (d, J = 7.3 Hz, 1H), 6.42 (s, 1H), 4.96 (s, 2H), 2.41 (s, 3H), 1.93 (s, 3H) 
ppm; 13C NMR (100 MHz, CDCl3) δ 150.5 (s), 145.0 (s), 143.9 (s), 143.7 (s), 137.5 
(s), 136.9 (s), 136.7 (s), 132.5 (s), 131.2 (s), 130.4 (d), 130.2 (d, 2C), 130.0 (d), 129.8 
(s), 129.5 (d), 129.2 (d, 2C), 129.0 (d, 2C), 128.9 (d, 2C), 128.7 (d), 128.6 (d), 126.8 
(s), 125.8 (d), 125.3 (d), 120.4 (s), 48.7 (t), 21.6 (q), 21.1 (q) ppm; IR (reflection): ṽ 
2922, 1738, 1605, 1561, 1478, 1443, 1421, 1389, 1353, 1323, 1281, 1227, 1209, 1165, 
1083, 1051, 1001, 950, 923, 892, 877, 829, 812, 794, 759, 736, 700, 662, 633 cm-1; 
HRMS (EI) calcd for [C30H23N2O2SCl]
+ (M)+: 510.1163; found: 510.1165. 
 
3g: 12-phenyl-6-tosyl-5,6-dihydrodibenzo[b,f][1,8]naphthyridine 
30.0 mg (54% yield), light yellow solid, m.p.: 266–267 oC; 1H NMR 
(500 MHz, CD2Cl2) δ 8.12 (d, J = 8.2 Hz, 2H), 7.89 (d, J = 8.3 Hz, 
1H), 7.63 (t, J = 7.5 Hz, 1H), 7.51–7.47 (m, 4H), 7.32–7.31 (m, 4H), 7.27 (dd, J = 6.2, 
2.8 Hz, 2H), 7.16 (t, J = 7.4 Hz, 1H), 6.87 (t, J = 7.7 Hz, 1H), 6.72 (d, J = 8.0 Hz, 1H), 
4.95 (s, 2H), 2.38 (s, 3H) ppm; 13C NMR (125 MHz, CD2Cl2) δ 150.3 (s), 146.2 (s), 
145.4 (s), 144.0 (s), 137.5 (s), 137.3 (s), 135.6 (s), 130.5 (s), 130.2 (d, 2C), 129.8 (d), 
129.1 (d), 129.03 (d, 2C), 129.01 (d, 2C), 128.8 (d, 2C), 128.5 (d), 127.7 (d), 127.6 
(d), 127.1 (d), 126.7 (d), 126.0 (s), 125.9 (d), 125.5 (d), 119.5 (s), 49.1 (t), 21.3 (q) 
ppm; IR (reflection): ṽ 2840, 1738, 1582, 1566, 1483, 1445, 1396, 1352, 1335, 1290, 
1276, 1255, 1235, 1207, 1185, 1164, 1132, 1112, 1088, 1048, 1033, 1018, 949, 926, 
896, 864, 816, 785, 757, 735, 715, 701, 672, 655, 635 cm-1; HRMS (EI) calcd for 
101 
[C29H22N2O2S]
+ (M)+: 462.1397; found: 462.1382. 
 
3h: 12-methyl-6-tosyl-5,6-dihydrodibenzo[b,f][1,8]naphthyridine 
23.0 mg (48% yield), white solid, m.p.: 243–244 oC; 1H NMR (500 
MHz, CDCl3) δ 8.06 (d, J = 8.1 Hz, 2H), 7.98 (d, J = 8.3 Hz, 1H), 7.94 
(d, J = 8.3 Hz, 1H), 7.65 (t, J = 7.4 Hz, 1H), 7.58 (d, J = 7.3 Hz, 1H), 7.48 (t, J = 7.4 
Hz, 1H), 7.44–7.35 (m, 3H), 7.23 (d, J = 8.0 Hz, 2H), 4.92 (s, 2H), 2.92 (s, 3H), 2.36 
(s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 150.2 (s), 145.1 (s), 143.5 (s), 141.5 (s), 
137.4 (s), 135.8 (s), 131.0 (s), 129.5 (d), 129.3 (d), 128.9 (d, 2C), 128.8 (d, 2C), 128.7 
(d), 128.0 (d), 127.6 (d), 126.9 (s), 126.2 (d), 125.5 (d), 124.3 (d), 121.1 (s), 49.3 (t), 
21.6 (q), 17.7 (q) ppm; IR (reflection): ṽ 3079, 3028, 1738, 1587, 1489, 1440, 1398, 
1353, 1343, 1290, 1252, 1206, 1187, 1163, 1118, 1088, 1070, 1040, 994, 969, 865, 
808, 762, 745, 716, 704, 672, 651, 618 cm-1; HRMS (EI) calcd for [C24H20N2O2S]
+ 
(M)+: 400.1240; found: 400.1239. 
 
3i: 6-tosyl-5,6-dihydrodibenzo[b,f][1,8]naphthyridine 
28.8 mg (62% yield), white solid, m.p.: 214–215 oC; 1H NMR (500 
MHz, CDCl3) δ 8.37 (s, 1H), 8.16 (d, J = 8.2 Hz, 2H), 7.90 (d, J = 8.4 
Hz, 1H), 7.83 (d, J = 7.5 Hz, 1H), 7.76 (d, J = 8.0 Hz, 1H), 7.63 (t, J = 7.6 Hz, 1H), 
7.44–7.32 (m, 4H), 7.29 (d, J = 8.1 Hz, 2H), 5.12 (s, 2H), 2.39 (s, 3H) ppm; 13C 
NMR (125 MHz, CDCl3) δ 149.2 (s), 146.0 (s), 143.8 (s), 137.3 (s), 132.8 (s), 131.0 
(d), 130.1 (s), 129.9 (d), 129.02 (d, 2C), 128.98 (d, 2C), 128.8 (d), 128.6 (d), 127.9 (d), 
127.7 (d), 126.4 (d), 126.1 (s), 125.7 (d), 123.7 (d), 121.3 (s), 48.6 (t), 21.6 (q) ppm; 
IR (reflection): ṽ 2926, 2838, 2738, 1668, 1626, 1585, 1506, 1466, 1368, 1339, 1262, 
1190, 1157, 1121, 1087, 1062, 1038, 1008, 980, 939, 908, 810, 784, 750, 722, 702, 
670, 644, 622, 612 cm-1; HRMS (EI) calcd for [C23H18N2O2S]
+ (M)+: 386.1084; found: 
386.1085. 
 
3j:  12-(phenylethynyl)-6-tosyl-5,6-dihydrodibenzo[b,f][1,8]naphthyridine 
14.0 mg (24% yield), light yellow solid, m.p.: 218–219 oC; 1H NMR (600 MHz, 
102 
CDCl3) δ 9.10 (d, J = 7.5 Hz, 1H), 8.71 (d, J = 8.1 Hz, 1H), 8.41 
(d, J = 7.8 Hz, 2H), 8.25 (d, J = 8.0 Hz, 1H), 8.00 (t, J = 7.3 Hz, 
1H), 7.95 (d, J = 4.5 Hz, 2H), 7.86 (t, J = 7.3 Hz, 1H), 7.77–7.73 
(m, 5H), 7.59–7.57 (m, 3H), 5.32 (s, 2H), 2.70 (s, 3H) ppm; 13C 
NMR (150 MHz, CDCl3) δ 150.2 (s), 145.5 (s), 144.0 (s), 137.5 (s), 135.5 (s), 132.2 
(d, 2C), 130.6 (s), 130.4 (d), 129.9 (d), 129.4 (d), 129.3 (d, 2C), 129.2 (d, 2C), 129.0 
(d, 2C), 128.6 (d), 128.3 (d), 127.9 (d), 126.72 (s), 126.69 (d), 126.6 (d), 126.4 (d), 
125.8 (s), 122.8 (s), 122.6 (s), 102.7 (s), 86.1 (s), 49.2 (t), 21.9 (q) ppm; IR 
(reflection): ṽ 3068, 2204, 1738, 1599, 1561, 1492, 1444, 1396, 1355, 1338, 1307, 
1290, 1259, 1243, 1202, 1186, 1168, 1116, 1089, 1039, 969, 899, 884, 866, 841, 813, 
758, 733, 715, 674, 657, 628 cm-1; HRMS (DART) calcd for [C31H23N2O2S]
+ (M + 
H)+: 487.1475; found: 487.1464. 
 
3k: 10-chloro-6-tosyl-5,6-dihydrodibenzo[b,f][1,8]naphthyridine 
23.7 mg (47% yield), white solid, m.p.: 242–243 oC; 1H NMR (500 
MHz, CDCl3) δ 8.26 (s, 1H), 8.13 (d, J = 8.3 Hz, 2H), 7.81 (d, J = 8.6 
Hz, 2H), 7.73 (d, J = 1.9 Hz, 1H), 7.54 (dd, J = 8.9, 2.1 Hz, 1H), 
7.44–7.34 (m, 3H), 7.30 (d, J = 8.2 Hz, 2H), 5.12 (s, 2H), 2.40 (s, 3H) ppm; 13C 
NMR (125 MHz, CDCl3) δ 149.4 (s), 144.3 (s), 144.0 (s), 137.1 (s), 132.8 (s), 131.2 
(s), 130.6 (d), 129.8 (d), 129.6 (s), 129.4 (d), 129.2 (d), 129.04 (d, 2C), 128.96 (d, 2C), 
128.7 (d), 126.7 (s), 126.5 (d), 126.3 (d), 123.8 (d), 122.1 (s), 48.5 (t), 21.6 (q) ppm; 
IR (reflection): ṽ 2923, 1738, 1604, 1486, 1452, 1431, 1408, 1352, 1293, 1274, 1203, 
1161, 1135, 1087, 1075, 1019, 982, 949, 916, 906, 865, 813, 778, 758, 729, 702, 662, 
634, 615 cm-1; HRMS (EI) calcd for [C23H17N2O2SCl]




25.7 mg (46% yield), white solid, m.p.: 196–197 oC; 1H NMR (500 
MHz, CDCl3) δ 8.24 (s, 1H), 8.14 (d, J = 8.2 Hz, 2H), 7.89 (d, J = 1.9 
103 
Hz, 1H), 7.79 (d, J = 7.5 Hz, 1H), 7.73 (d, J = 8.9 Hz, 1H), 7.66 (dd, J = 8.9, 2.0 Hz, 
1H), 7.43–7.29 (m, 5H), 5.12 (s, 2H), 2.40 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) 
δ 149.4 (s), 144.5 (s), 144.0 (s), 137.1 (s), 133.1 (d), 132.8 (s), 129.7 (d), 129.6 (d), 
129.51 (s), 129.46 (d), 129.3 (d), 129.1 (d, 2C), 129.0 (d, 2C), 128.7 (d), 127.2 (s), 
126.5 (d), 123.8 (d), 122.0 (s), 119.1 (s), 48.5 (t), 21.6 (q) ppm; IR (reflection): ṽ 
1738, 1716, 1600, 1483, 1429, 1406, 1352, 1294, 1273, 1186, 1162, 1087, 1061, 1008, 
914, 816, 778, 757, 727, 702, 688, 658, 631, 615 cm-1; HRMS (EI) calcd for 
[C23H17N2O2SBr]
+ (M)+: 464.0189; found: 464.0179. 
 
3m: 6-tosyl-5,6-dihydrodibenzo[b,f][1,8]naphthyridin-10-yl acetate 
38.4 mg (72% yield), light yellow solid, m.p.: 232–233 oC; 1H NMR 
(500 MHz, CDCl3) δ 8.31 (s, 1H), 8.11 (d, J = 8.1 Hz, 2H), 7.89 (d, J = 
8.9 Hz, 1H), 7.79 (d, J = 6.9 Hz, 1H), 7.50 (s, 1H), 7.43–7.34 (m, 4H), 
7.28–7.26 (m, 2H), 5.13 (s, 2H), 2.39 (s, 3H), 2.36 (s, 3H) ppm; 13C NMR (125 MHz, 
CDCl3) δ 169.5 (s), 149.1 (s), 147.9 (s), 143.93 (s), 143.90 (s), 137.1 (s), 132.8 (s), 
130.6 (d), 129.7 (s), 129.3 (d), 129.1 (d), 129.0 (d, 2C), 128.9 (d, 2C), 128.6 (d), 
126.5 (d), 126.2 (s), 124.9 (d), 123.8 (d), 121.8 (s), 118.5 (d), 48.5 (t), 21.6 (q), 21.3 
(q) ppm; IR (reflection): ṽ 1759, 1611, 1496, 1443, 1410, 1358, 1297, 1275, 1201, 
1163, 1088, 1044, 1012, 962, 912, 826, 780, 756, 728, 705, 681, 662, 640, 621 cm-1; 
HRMS (EI) calcd for [C25H20N2O4S]
+ (M)+: 444.1138; found: 444.1148. 
 
3n: 6-tosyl-5,6-dihydro-[1,3]dioxolo[4',5':4,5]benzo[1,2-b]benzo[f][1,8]naphthyridine 
25.3 mg (49% yield), light yellow solid, m.p.: 250–251 oC; 1H NMR 
(500 MHz, CDCl3) δ 8.17 (s, 1H), 8.03 (d, J = 7.8 Hz, 2H), 7.72 (d, 
J = 6.4 Hz, 1H), 7.39–7.30 (m, 3H), 7.26–7.20 (m, 3H), 7.01 (s, 1H), 
6.08 (s, 2H), 5.07 (s, 2H), 2.38 (s, 3H) ppm; 13C NMR (125 MHz, 
CDCl3) 151.1 (s), 147.7 (s), 147.3 (s), 144.3 (s), 143.6 (s), 137.4 (s), 132.4 (s), 130.3 
(s), 130.1 (d), 129.0 (d, 2C), 128.7 (d, 2C), 128.42 (d), 128.41 (d), 126.3 (d), 123.3 (d), 
122.9 (s), 119.5 (s), 105.0 (d), 103.0 (d), 101.8 (t), 48.8 (t), 21.6 (q) ppm; IR 
(reflection): ṽ 2897, 2779, 1620, 1493, 1451, 1399, 1375, 1322, 1281, 1265, 1241, 
104 
1186, 1156, 1121, 1093, 1083, 1035, 1020, 1011, 983, 949, 907, 858, 847, 815, 775, 
755, 716, 700, 681, 657, 638, 623, 615 cm-1; HRMS (EI) calcd for [C24H18N2O4S]
+ 
(M)+: 430.0982; found: 430.0996. 
 
3o: 9-(4-(tert-butyl)phenyl)-6-tosyl-5,6-dihydrodibenzo[b,f][1,8]naphthyridine 
37.3 mg (60% yield), light yellow solid, m.p.: 243–244 oC; 1H 
NMR (500 MHz, CDCl3) δ 8.39 (d, J = 0.7 Hz, 1H), 8.17 (d, J 
= 7.8 Hz, 2H), 8.10 (s, 1H), 7.83 (s, 2H), 7.71 (d, J = 7.8 Hz, 
3H), 7.57 (d, J = 7.7 Hz, 2H), 7.43–7.34 (m, 3H), 7.29 (d, J = 
7.8 Hz, 2H), 5.13 (s, 2H), 2.38 (s, 3H), 1.41 (s, 9H) ppm; 13C NMR (125 MHz, 
CDCl3) δ 151.1 (s), 149.6 (s), 146.4 (s), 143.8 (s), 142.5 (s), 137.5 (s), 137.1 (s), 132.7 
(s), 130.9 (d), 130.2 (s), 129.1 (d, 2C), 129.0 (d, 2C), 128.8 (d), 128.6 (d), 128.2 (d), 
127.2 (d, 2C), 126.4 (d), 126.0 (d, 2C), 125.5 (d), 125.3 (d), 125.1 (s), 123.7 (d), 
121.0 (s), 48.6 (t), 34.7 (s), 31.4 (q, 3C), 21.6 (q) ppm; IR (reflection): ṽ 2959, 2867, 
2260, 1736, 1610, 1500, 1485, 1449, 1403, 1360, 1336, 1272, 1194, 1168, 1090, 1010, 
982, 933, 904, 834, 809, 779, 761, 728, 704, 688, 659, 619 cm-1; HRMS (EI) calcd 
for [C33H30N2O2S]




45.4 mg (Z/E = 17:1, 75% combined yield,), light yellow solid; 
1H NMR (500 MHz, CD2Cl2) δ 10.16 (d, J = 7.9 Hz, 1H), 9.77 (s, 1H), 7.73 (d, J = 
7.2 Hz, 2H), 7.67 (d, J = 8.3 Hz, 2H), 7.63 (t, J = 7.4 Hz, 1H), 7.55–7.47 (m, 3H), 
7.47 (d, J = 2.4 Hz, 1H), 7.14 (dd, J = 17.6, 9.9 Hz, 3H), 7.06 (dd, J = 9.0, 2.4 Hz, 
1H), 6.59 (d, J = 9.0 Hz, 1H), 6.30 (s, 1H), 5.98 (dd, J = 11.7, 7.9 Hz, 1H), 2.31 (s, 
3H) ppm; 13C NMR (125 MHz, CD2Cl2) δ 197.8 (s), 190.8 (d), 146.2 (s), 146.1 (s), 
139.1 (d), 138.6 (s), 134.1 (s), 133.9 (d), 133.0 (d), 132.2 (d), 131.4 (s), 129.9 (d, 2C), 
129.5 (d, 2C), 128.4 (d, 2C), 127.8 (d, 3C), 122.1 (s), 121.8 (d), 120.7 (s), 120.4 (s), 
115.9 (d), 107.5 (d), 21.3 (q) ppm; IR (reflection): ṽ 1672, 1629, 1595, 1572, 1493, 
1447, 1402, 1370, 1288, 1238, 1190, 1174, 1119, 1088, 1061, 949, 810, 701, 666, 647 
105 
cm-1; HRMS (DART) calcd for [C27H22N2O4SCl]





41.8 mg (69% yield), yellow solid, m.p.: 84–85 oC; 1H NMR 
(500 MHz, CDCl3) δ 9.80 (s, 1H), 9.62 (d, J = 7.8 Hz, 1H), 7.76–7.71 (m, 4H), 
7.64–7.61 (m, 1H), 7.55–7.52 (m, 3H), 7.48 (d, J = 2.5 Hz, 1H), 7.32 (d, J = 15.7 Hz, 
1H), 7.13 (d, J = 8.2 Hz, 2H), 7.10 (dd, J = 9.0, 2.5 Hz, 1H), 6.66 (d, J = 9.0 Hz, 1H), 
6.37 (dd, J = 15.7, 7.8 Hz, 1H), 6.26 (s, 1H), 2.33 (s, 3H) ppm; 13C NMR (125 MHz, 
CDCl3) δ 197.8 (s), 193.3 (d), 146.0 (s), 145.9 (s), 144.4 (d), 138.4 (s), 134.3 (s), 
133.9 (d), 133.0 (d), 132.4 (d), 132.1 (s), 130.0 (d, 2C), 129.7 (d, 2C), 128.5 (d, 2C), 
128.0 (d), 127.9 (d, 2C), 122.5 (s), 121.6 (s), 121.3 (d), 120.9 (s), 116.1 (d), 103.2 (d), 
21.6 (q) ppm; IR (reflection): ṽ 1736, 1671, 1630, 1595, 1572, 1492, 1371, 1288, 
1239, 1190, 1174, 1156, 1119, 1087, 1061, 949, 809, 701, 666, 647 cm-1; HRMS 
(DART) calcd for [C27H22N2O4SCl]
+ (M + H)+: 505.0983; found: 505.0974. 
 
6b: (E)-3-(5-((2-benzoylphenyl)amino)-1-tosyl-1H-pyrrol-3-yl)acrylaldehyde 
28.8 mg (51% yield), yellow oil, m.p.: 42–43 oC; 1H NMR 
(500 MHz, CDCl3) δ 10.00 (s, 1H), 9.62 (d, J = 7.8 Hz, 1H), 
7.75 (d, J = 7.1 Hz, 4H), 7.61–7.49 (m, 5H), 7.32 (d, J = 15.7 
Hz, 1H), 7.19 (t, J = 7.7 Hz, 1H), 7.12 (d, J = 8.1 Hz, 2H), 6.80–6.73 (m, 2H), 6.36 
(dd, J = 15.7, 7.8 Hz, 1H), 6.26 (s, 1H), 2.31 (s, 3H) ppm; 13C NMR (125 MHz, 
CDCl3) δ 198.9 (s), 193.4 (d), 147.2 (s), 145.7 (s), 144.6 (d), 139.2 (s), 134.4 (s), 
134.3 (d), 134.1 (d), 132.9 (s), 131.9 (d), 123.0 (d, 2C), 129.7 (d, 2C), 128.2 (d, 2C), 
127.90 (d), 127.87 (d, 2C), 121.7 (s), 121.0 (d), 120.1 (s), 117.8 (d), 114.6 (d), 102.2 
(d), 21.6 (q) ppm; IR (reflection): ṽ 1674, 1630, 1579, 1513, 1451, 1372, 1308, 1262, 
1217, 1192, 1177, 1123, 1092, 1063, 969, 940, 752, 735, 703, 674 cm-1; HRMS 
(DART) calcd for [C27H23N2O4S]




31.4 mg (64% yield), light yellow solid, m.p.: 155–156 oC; 
1H NMR (500 MHz, CDCl3) δ 10.54 (s, 1H), 9.61 (d, J = 7.8 
Hz, 1H), 7.80 (d, J = 8.0 Hz, 1H), 7.66 (d, J = 8.3 Hz, 2H), 
7.51 (d, J = 1.5 Hz, 1H), 7.31 (d, J = 15.7 Hz, 1H), 7.17–7.11 (m, 3H), 6.77 (t, J = 7.5 
Hz, 1H), 6.67 (d, J = 8.4 Hz, 1H), 6.35 (dd, J = 15.7, 7.8 Hz, 1H), 6.24 (s, 1H), 2.68 (s, 
3H), 2.32 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 201.5 (s), 193.4 (d), 147.3 (s), 
145.6 (s), 144.6 (d), 134.6 (d), 134.4 (s), 132.4 (s), 132.0 (d), 129.9 (d, 2C), 127.9 (d), 
127.8 (d, 2C), 121.6 (s), 121.3 (d), 119.4 (s), 117.9 (d), 114.3 (d), 103.4 (d), 28.1 (q), 
21.6 (q) ppm; IR (reflection): ṽ 1681, 1643, 1628, 1588, 1569, 1503, 1452, 1360, 
1244, 1218, 1187, 1161, 1114, 1085, 1053, 964, 804, 755, 667, 639 cm-1; HRMS 
(DART) calcd for [C22H21N2O4S]




28.1 mg (50% yield), yellow solid, m.p.: 75–76 oC; 1H NMR 
(500 MHz, CDCl3) δ 10.73 (s, 1H), 9.61 (d, J = 7.8 Hz, 1H), 7.68 (d, J = 8.3 Hz, 2H), 
7.52 (d, J = 1.7 Hz, 1H), 7.31 (d, J = 15.7 Hz, 1H), 7.18 (s, 1H), 7.15 (d, J = 8.2 Hz, 
2H), 6.34 (dd, J = 15.7, 7.8 Hz, 1H), 6.22 (s, 1H), 6.09 (s, 1H), 3.87 (s, 3H), 3.61 (s, 
3H), 2.62 (s, 3H), 2.34 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 199.1 (s), 193.3 
(d), 155.2 (s), 145.7 (s), 144.6 (d), 144.4 (s), 141.2 (s), 134.4 (s), 132.9 (s), 129.9 (d, 
2C), 127.9 (d, 2C), 127.8 (d), 121.6 (s), 121.3 (d), 114.0 (d), 111.8 (s), 102.9 (d), 96.9 
(d), 56.7 (q), 55.7 (q), 27.9 (q), 21.6 (q) ppm; IR (reflection): ṽ 1671, 1627, 1577, 
1511, 1451, 1407, 1366, 1342, 1257, 1205, 1190, 1166, 1120, 1088, 1058, 999, 957, 
812, 729, 671 cm-1; HRMS (DART) calcd for [C22H21N2O4S]






40.9 mg (69% yield), yellow solid, m.p.: 78–79 oC; 1H NMR (500 MHz, CDCl3) δ 
10.31 (s, 1H), 9.62 (d, J = 7.8 Hz, 1H), 8.28 (dd, J = 8.0, 1.4 Hz, 1H), 7.72–7.67 (m, 
4H), 7.56 (d, J = 1.8 Hz, 1H), 7.52–7.49 (m, 1H), 7.45 (t, J = 7.4 Hz, 2H), 7.33 (d, J = 
15.7 Hz, 1H), 7.23–7.19 (m, 1H), 7.15 (d, J = 8.2 Hz, 2H), 6.84 (t, J = 7.5 Hz, 1H), 
6.64 (d, J = 8.4 Hz, 1H), 6.38 (dd, J = 15.7, 7.8 Hz, 1H), 6.31 (s, 1H), 2.32 (s, 3H) 
ppm; 13C NMR (125 MHz, CDCl3) δ 193.3 (d), 180.0 (s), 148.5 (s), 145.7 (s), 144.5 
(d), 135.5 (d), 134.6 (d), 134.3 (s), 133.0 (d, 2C), 131.4 (s), 130.8 (d), 130.0 (d, 2C), 
128.8 (d, 2C), 128.0 (d), 127.9 (d, 2C), 121.7 (d), 121.6 (s), 120.2 (s), 119.9 (s), 118.2 
(d), 113.9 (d), 104.9 (d), 93.8 (s), 87.0 (s), 21.6 (q) ppm; IR (reflection): ṽ 2198, 1672, 
1614, 1593, 1573, 1510, 1450, 1370, 1270, 1207, 1191, 1174, 1158, 1119, 1088, 1060, 
1009, 995, 750, 669 cm-1; HRMS (DART) calcd for [C29H23N2O4S]
+ (M + H)+: 




21.9 mg (43% yield), light yellow solid, m.p.: 70–71 oC; 1H 
NMR (500 MHz, CDCl3) δ 9.92 (s, 1H), 9.66 (s, 1H), 9.61 (d, J = 7.8 Hz, 1H), 7.66 
(d, J = 8.3 Hz, 2H), 7.50 (d, J = 1.7 Hz, 1H), 7.31 (d, J = 15.7 Hz, 1H), 7.15 (d, J = 
8.2 Hz, 2H), 7.07 (d, J = 2.9 Hz, 1H), 6.88 (dd, J = 9.1, 2.9 Hz, 1H), 6.67 (d, J = 9.1 
Hz, 1H), 6.35 (dd, J = 15.7, 7.8 Hz, 1H), 6.23 (s, 1H), 3.81 (s, 3H), 2.34 (s, 3H) ppm; 
13C NMR (125 MHz, CDCl3) δ 193.9 (d), 193.3 (d), 152.3 (s), 145.7 (s), 144.5 (d), 
141.3 (s), 134.4 (s), 132.5 (s), 130.0 (d, 2C), 128.0 (d), 127.8 (d, 2C), 123.8 (d), 121.7 
(s), 121.2 (d), 119.8 (s), 117.7 (d), 115.3 (d), 102.9 (d), 55.9 (q), 21.6 (q) ppm; IR 
(reflection): ṽ 3131, 2927, 2838, 2740, 1667, 1626, 1584, 1505, 1464, 1366, 1340, 
1272, 1225, 1190, 1157, 1120, 1088, 1061, 1038, 968, 933, 811, 777, 730, 702, 667 
cm-1; HRMS (EI) calcd for [C22H20N2O5S]





11.9 mg (22% yield), light yellow solid, m.p.: 71–72 oC; 1H NMR (500 MHz, CDCl3) 
δ 9.90 (s, 1H), 9.82 (s, 1H), 9.62 (d, J = 7.8 Hz, 1H), 7.63 (d, J = 8.2 Hz, 2H), 7.54 (d, 
J = 1.3 Hz, 1H), 7.33–7.30 (m, 2H), 7.15 (d, J = 8.1 Hz, 2H), 6.93 (dd, J = 9.0, 2.4 Hz, 
1H), 6.61 (d, J = 9.1 Hz, 1H), 6.37 (dd, J = 15.7, 7.8 Hz, 1H), 6.30 (s, 1H), 2.34 (s, 
3H), 2.30 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 193.4 (d), 193.3 (d), 169.6 (s), 
146.0 (s), 144.9 (s), 144.2 (d), 142.2 (s), 134.2 (s), 131.2 (s), 130.1 (d, 2C), 129.3 (d), 
128.1 (d), 127.7 (d, 2C), 127.5 (d), 121.58 (d), 121.56 (s), 119.4 (s), 114.3 (d), 104.5 
(d), 21.6 (q), 21.0 (q) ppm; IR (reflection): ṽ 1757, 1667, 1627, 1583, 1510, 1367, 
1299, 1191, 1174, 1148, 1121, 1088, 1061, 1013, 963, 907, 810, 785, 702, 670 cm-1; 
HRMS (DART) calcd for [C23H21N2O6S]




31.6 mg (60% yield), yellow solid, m.p.: 188–189 oC; 1H NMR 
(500 MHz, CDCl3) δ 10.19 (s, 1H), 9.69 (s, 1H), 9.62 (d, J = 7.8 Hz, 1H), 7.66 (d, J = 
8.2 Hz, 2H), 7.55 (d, J = 1.3 Hz, 1H), 7.31 (d, J = 15.7 Hz, 1H), 7.18 (d, J = 8.1 Hz, 
2H), 6.91 (s, 1H), 6.36 (dd, J = 15.7, 7.8 Hz, 1H), 6.27 (s, 1H), 6.08 (s, 1H), 5.92 (s, 
2H), 2.36 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 193.3 (d), 191.4 (d), 154.2 (s), 
146.7 (s), 145.7 (s), 144.3 (d), 140.6 (s), 134.3 (s), 131.3 (s), 130.0 (d, 2C), 128.1 (d), 
127.9 (d, 2C), 121.8 (d), 121.6 (s), 112.9 (s), 112.0 (d), 105.1 (d), 101.9 (t), 94.1 (d), 
21.6 (q) ppm; IR (reflection): ṽ 1671, 1651, 1629, 1592, 1515, 1497, 1480, 1371, 
1266, 1227, 1170, 1122, 1087, 1041, 1011, 978, 938, 815, 802, 671 cm-1; HRMS 
(DART) calcd for [C22H19N2O6S]




36.7 mg (58% yield), light yellow solid, m.p.: 100–101 oC; 1H 
NMR (500 MHz, CDCl3) δ 9.97 (s, 1H), 9.94 (s, 1H), 9.63 (d, 
J = 7.8 Hz, 1H), 7.63 (dd, J = 15.7, 8.1 Hz, 3H), 7.58 (d, J = 
1.7 Hz, 1H), 7.43 (d, J = 8.3 Hz, 2H), 7.31 (dd, J = 20.1, 12.0 Hz, 3H), 7.08 (d, J = 
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8.0 Hz, 3H), 6.70 (s, 1H), 6.38 (dd, J = 15.7, 7.8 Hz, 1H), 6.34 (s, 1H), 2.21 (s, 3H), 
1.34 (s, 9H) ppm; 13C NMR (125 MHz, CDCl3) δ 193.8 (d), 193.4 (d), 152.1 (s), 
148.2 (s), 147.5 (s), 145.7 (s), 144.5 (d), 136.6 (s), 136.4 (d), 134.3 (s), 131.2 (s), 
129.9 (d, 2C), 128.1 (d), 127.8 (d, 2C), 126.8 (d, 2C), 125.9 (d, 2C), 121.7 (d), 121.6 
(s), 118.5 (s), 117.5 (d), 111.2 (d), 105.0 (d), 34.7 (s), 31.3 (q, 3C), 21.6 (q) ppm; IR 
(reflection): ṽ 2968, 2741, 1738, 1663, 1615, 1574, 1556, 1510, 1432, 1371, 1304, 
1271, 1191, 1175, 1119, 1088, 1060, 1016, 967, 928, 839, 808, 728, 702, 669 cm-1; 
HRMS (EI) calcd for [C31H30N2O4S]




44.6 mg (64% yield), light yellow solid, m.p.: 180–181 oC; 1H 
NMR (500 MHz, CDCl3) δ 9.52 (d, J = 7.8 Hz, 1H), 9.38 (s, 1H), 7.81 (s, 1H), 7.69 
(d, J = 8.4 Hz, 2H), 7.65–7.59 (m, 3H), 7.52 (t, J = 7.6 Hz, 2H), 7.32 (d, J = 2.4 Hz, 
1H), 7.28 (d, J = 16.2 Hz, 1H), 7.23 (t, J = 7.6 Hz, 3H), 7.14 (dd, J = 7.8, 1.5 Hz, 2H), 
7.08 (d, J = 8.2 Hz, 2H), 6.82 (dd, J = 9.0, 2.4 Hz, 1H), 6.43 (dd, J = 16.0, 7.8 Hz, 
1H), 6.00 (d, J = 9.0 Hz, 1H), 2.32 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 198.0 
(s), 193.6 (d), 146.9 (s), 146.0 (s), 144.4 (d), 138.6 (s), 134.1 (s), 133.5 (d), 132.6 (d), 
132.2 (d), 130.9 (s), 129.9 (d, 2C), 129.5 (d, 2C), 129.2 (d, 2C), 128.7 (d, 2C), 128.5 
(d, 2C), 128.23 (d), 128.15 (d, 2C), 127.9 (d), 126.6 (s), 124.0 (s), 121.8 (s), 119.9 (s), 
119.84 (d), 119.81 (s), 115.9 (d), 21.6 (q) ppm; IR (reflection): ṽ 1678, 1625, 1596, 
1567, 1514, 1495, 1378, 1237, 1189, 1174, 1154, 1123, 1090, 1067, 1011, 949, 746, 
700, 665, 645 cm-1; HRMS (DART) calcd for [C33H26N2O4SCl]




32.7 mg (56% yield), light yellow solid, m.p.: 230–231 oC; 1H 
NMR (500 MHz, CDCl3) δ 9.05 (d, J = 7.4 Hz, 1H), 8.30–8.27 
(m, 3H), 8.19 (d, J = 9.0 Hz, 1H), 7.66 (dd, J = 9.0, 2.2 Hz, 
1H), 7.64–7.58 (m, 4H), 7.36 (d, J = 7.9 Hz, 4H), 6.45 (d, J = 16.0 Hz, 1H), 6.37 (dd, 
110 
J = 15.9, 7.4 Hz, 1H), 2.40 (s, 4H) ppm; 13C NMR (125 MHz, CDCl3) δ 193.1 (d), 
147.3 (s), 146.1 (s), 143.9 (s), 143.0 (d), 141.2 (s), 134.5 (s), 134.4 (s), 131.3 (s), 
130.7 (d), 130.2 (d), 129.8 (d, 2C), 129.7 (d, 2C), 129.4 (d), 129.1 (d), 129.00 (d, 2C), 
128.98 (d, 2C), 128.3 (d), 125.8 (s), 124.6 (d), 119.7 (s), 115.0 (s), 21.8 (q) ppm; IR 
(reflection): ṽ 3112, 2926, 2854, 1738, 1672, 1611, 1596, 1532, 1488, 1445, 1402, 
1377, 1356, 1310, 1271, 1230, 1212, 1172, 1159, 1122, 1090, 1002, 974, 952, 877, 
835, 821, 813, 766, 731, 710, 664, 628, 605 cm-1; HRMS (DART) calcd for 
[C27H20N2O3SCl]




29.5 mg (52% yield), light yellow solid, m.p.: 214–215 oC; 1H 
NMR (600 MHz, CDCl3) δ 9.05 (d, J = 7.4 Hz, 1H), 8.41 (d, J = 8.1 Hz, 2H), 8.27 (s, 
1H), 8.18 (d, J = 9.0 Hz, 1H), 7.68–7.55 (m, 8H), 7.35 (dd, J = 7.8, 1.3 Hz, 2H), 6.44 
(d, J = 15.9 Hz, 1H), 6.37 (dd, J = 15.9, 7.4 Hz, 1H) ppm; 13C NMR (150 MHz, 
CDCl3) δ 193.4 (d), 147.6 (s), 144.2 (s), 143.2 (d), 141.6 (s), 137.6 (s), 135.0 (d), 
134.7 (s), 131.7 (s), 131.0 (d), 130.6 (d), 130.0 (d, 2C), 129.7 (d), 129.5 (d, 2C), 129.3 
(d, 2C), 129.2 (d, 3C), 128.7 (d), 126.1 (s), 125.0 (d), 120.0 (s), 115.5 (s) ppm; IR 
(reflection): ṽ 3139, 3059, 2926, 1738, 1675, 1610, 1538, 1487, 1448, 1403, 1378, 
1352, 1312, 1272, 1229, 1172, 1158, 1120, 1090, 958, 875, 834, 816, 760, 725, 708, 
683, 666, 630 cm-1; HRMS (EI) calcd for [C26H17N2O3SCl]




32.0 mg (59% yield), light green solid, m.p.: 226–227 oC; 1H 
NMR (500 MHz, CDCl3) δ 9.05 (d, J = 7.2 Hz, 1H), 8.28 (dd, J 
= 29.5, 7.6 Hz, 4H), 7.74 (t, J = 7.5 Hz, 1H), 7.67 (d, J = 8.4 Hz, 
1H), 7.61–7.57 (m, 3H), 7.44 (t, J = 7.5 Hz, 1H), 7.36 (dd, J = 12.8, 7.7 Hz, 4H), 6.48 
(d, J = 15.9 Hz, 1H), 6.37 (dd, J = 15.8, 7.4 Hz, 1H), 2.39 (s, 3H) ppm; 13C NMR 
(125 MHz, CDCl3) δ 193.2 (d), 147.3 (s), 145.9 (s), 145.6 (s), 143.5 (d), 142.0 (s), 
111 
135.2 (s), 134.5 (s), 129.8 (d, 2C), 129.7 (d, 2C), 129.3 (d), 129.2 (d), 129.1 (d), 129.0 
(d, 2C), 128.8 (d, 2C), 128.6 (d), 128.1 (d), 126.1 (d), 125.4 (d), 125.2 (s), 119.1 (s), 
115.1 (s), 21.8 (q) ppm; IR (reflection): ṽ 1673, 1622, 1594, 1537, 1376, 1357, 1333, 
1188, 1172, 1150, 1119, 1089, 955, 814, 760, 735, 703, 681, 663, 650 cm-1; HRMS 
(DART) calcd for [C27H21N2O3S]
+ (M + H)+: 453.1267; found: 453.1258. 
 
7d: (E)-3-(1-tosyl-1H-pyrrolo[2,3-b]quinolin-3-yl)acrylaldehyde 
22.6 mg (50% yield), light yellow solid, m.p.: 216–217 oC; 1H 
NMR (500 MHz, CDCl3) δ 9.71 (d, J = 7.6 Hz, 1H), 8.55 (s, 1H), 
8.26–8.23 (m, 3H), 8.19 (d, J = 8.5 Hz, 1H), 7.93 (d, J = 8.1 Hz, 1H), 7.77–7.74 (m, 
1H), 7.60–7.53 (m, 2H), 7.30 (d, J = 8.2 Hz, 2H), 6.89 (dd, J = 16.1, 7.6 Hz, 1H), 2.35 
(s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 
193.5 (d), 148.0 (s), 146.0 (s), 145.6 (s), 143.2 (d), 134.3 (s), 133.0 (d), 129.7 (d, 3C), 
129.98 (d), 128.95 (d), 128.9 (d, 2C), 128.7 (d), 128.3 (d), 125.8 (s), 125.7 (d), 119.9 
(s), 114.6 (s), 21.7 (q) ppm; IR (reflection): ṽ 1675, 1625, 1596, 1531, 1395, 1366, 
1214, 1191, 1169, 1119, 1089, 1065, 957, 940, 897, 821, 753, 702, 678, 648 cm-1; 
HRMS (DART) calcd for [C21H17N2O3S]
+ (M + H)+: 377.0954; found: 377.0948. 
 
7e: (E)-3-(8-methyl-1-tosyl-1H-pyrrolo[2,3-b]quinolin-3-yl)acrylaldehyde 
16.4 mg (35% yield), white solid, m.p.: 244–245 oC; 1H NMR 
(500 MHz, CD2Cl2) δ 9.69 (d, J = 7.4 Hz, 1H), 8.59 (s, 1H), 
8.27– 8.21 (m, 3H), 7.79 (d, J = 8.2 Hz, 1H), 7.63–7.60 (m, 2H), 
7.43 (t, J = 7.5 Hz, 1H), 7.32 (d, J = 8.0 Hz, 2H), 6.87 (dd, J = 16.1, 7.5 Hz, 1H), 2.88 
(s, 3H), 2.34 (s, 3H) ppm; 13C NMR (125 MHz, CD2Cl2) δ 193.3 (d), 147.2 (s), 146.2 
(s), 144.6 (s), 143.1 (d), 136.4 (s), 134.2 (s), 132.9 (d), 129.7 (d), 129.6 (d, 2C), 129.3 
(d), 128.9 (d, 2C), 128.6 (d), 126.4 (d), 125.7 (s), 125.3 (d), 119.6 (s), 114.5 (s), 21.4 
(q), 18.3 (q) ppm; IR (reflection): ṽ 1677, 1620, 1531, 1395, 1369, 1235, 1218, 1190, 
1163, 1133, 1100, 1036, 972, 922, 815, 799, 765, 706, 672, 651 cm-1; HRMS (DART) 
calcd for [C22H19N2O3S]
+ (M + H)+: 391.1111; found: 391.1102. 
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Chapter 5: Gold-Catalyzed Intermolecular 
Cyclocarboamination of Ynamides with 1,3,5-Triazinanes: 
En Route to Tetrahydropyrimidines 
5.1 Introduction 
Ynamides, a subgroup of nitrogen-substituted alkynes, are versatile synthons. 
They have frequently emerged in contemporary organic synthesis in the past 
decades.[1] Their catalytic annulations with highly ring-strained saturated 
heterocycles were deemed as powerful strategies to construct a wide range of 
heterocyclic scaffolds.[2] For example, in 2012, using epoxides as the 
three-atom building units, Liu’s group disclosed a gold-mediated 
intermolecular [4+3] annulations with ynamides (Scheme 1a).[2a] Later, the 
same group employed the less strained oxetanes and azetidines as four-atom 
building units, and an impressive [4+2] annulation was reported (Scheme 1b).[2b] 
Despite these splendid advances, gold-catalyzed intermolecular annulation 
reaction of ynamides with unstrained saturated heterocycles so far remains a 
challenge. 
 
The 1,3,5-triaryl-1,3,5-triazinanes are attractive building blocks due to their 
stability, structural diversity as well as easy access and handling.[3] The groups 
of Krische[4] and Feng[5] have employed triazinanes as hydroaminomethylation 
reagents in ruthenium-catalyzed transfer hydrogenation and as Mannich 
reagents in asymmetric Mannich-type reactions, respectively. Sun and 
co-workers[6] recently achieved elegant gold-catalyzed [4+1]/[4+3] annulations 
of 1,3,5-triazinanes with diazo esters, where triazinanes reacted directly. 
Inspired by these seminal works and our continual interests in gold-catalyzed 
ynamide transformations,[7] we herein describe a gold-catalyzed regioselective 
cyclocarboamination of ynamides with 1,3,5-triazinanes, which enables the 
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facile and modular access synthesis of 5-aminotetrahydropyrimidine derivatives 
in good to excellent yields (Scheme 1, lower part). Importantly, the resulting 
5-aminotetrahydropyrimidine skeletons possess diverse biological activities 
(Figure 1).[8] This method represents the first direct 
5-aminotetrahydropyrimidine synthesis from ynamides and unstrained saturated 
heterocycles, complementing the current tetrahydropyrimidine synthesis 
strategies,[9] and thus is meaningful for both organic synthesis and medicinal 
chemistry. 
 
Scheme 1. Transition metal-catalyzed intermolecular reactions of ynamides 
with saturated heterocycles 
 
Figure 1. Representative bioactive 5-aminotetrahydropyrimidine frameworks. 
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5.2 Results and Discussion 
5.2.1 Optimization of Reaction Condition 
Initially, ynamide 1a and 1,3,5-triazinane 2a were set as the model substrates to 
optimize the reaction conditions (Table 1). The desired product 3a was obtained 
in 64% yield with 5 mol% of IPrAuCl/AgNTf2 in 1,2-DCE at 80 
oC (entry 3). 
Control experiments with either the silver salt or the gold precatalyst alone 
showed no conversions (entries 1 and 2). The screened gold precatalysts 
bearing phosphane ligands were generally more active than those with NHC or 
phosphate ligands (entries 3–9). With KAuBr4 as the catalyst, product 3a was 
not detected (entry 10). Thus, CyJohnPhosAuCl/AgNTf2 turned out to be the 
optimal catalyst system for this transformation (entry 8). Replacing AgNTf2 
with AgOTf, as the activator of the gold precatalyst, decreased the yield from 
81% to 70% (entries 8 and 11). A further solvent screen revealed that CH2Cl2, 
toluene, and THF could not improve the reaction efficiency (entries 12–14). 
Decreasing the reaction temperature to 60 oC delivered 3a in a lower yield 
(entry 15). Further improvement was achieved by adding the amount of 
1,3,5-triazinane 2a from 1.5 equiv. to 1.8 equiv., and in this case 3a was 
isolated in 90% yield with 5 mol% CyJohnPhosAuCl/AgNTf2 as the catalyst in 
1,2-DCE at 80 oC for 24 h (entry 16).
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Table 1: Optimization of reaction conditions.[a] 
 
entry catalyst solvent yield (%)[b] 
1 AgNTf2 1,2-DCE 0 
2 IPrAuCl 1,2-DCE < 5 
3 IPrAuCl/AgNTf2 1,2-DCE 64 
4 PPh3AuCl/AgNTf2 1,2-DCE 17 
5 (2,4-tBu2PhO)3PAuCl/AgNTf2 1,2-DCE 42 
6 SPhosAuCl/AgNTf2 1,2-DCE 74 
7 JohnPhosAuCl/AgNTf2 1,2-DCE 70 
8 CyJohnPhosAuCl/AgNTf2 1,2-DCE 81 
9 tBuXPhosAuCl/AgNTf2 1,2-DCE 31 
10 KAuBr4 1,2-DCE < 5 
11 CyJohnPhosAuCl/AgOTf 1,2-DCE 70 
12 CyJohnPhosAuCl/AgNTf2 CH2Cl2 71 
13 CyJohnPhosAuCl/AgNTf2 toluene 70 
14 CyJohnPhosAuCl/AgNTf2 THF 70 
15[c] CyJohnPhosAuCl/AgNTf2 1,2-DCE 71 
16[d] CyJohnPhosAuCl/AgNTf2 1,2-DCE 98 (90) 
[a] Reaction conditions: 1a (0.1 mmol) and 2a (0.15 mmol) reacted in 
0.5 mL dry solvent at 80 oC for 24 h. [b] Measured by 1H NMR with 
1,3,5-trimethoxybenzene as the internal standard. Yield of isolated 
product given in parentheses. [c] 60 oC. [c] 1.8 equiv. of 2a. 
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5.2.2 Scope with regard to the Substrate 
After optimization, we began to explore the substrate scope by varying the 
ynamide partner (Table 2). Various protecting groups (PG) such as mesyl (3aa), 
tosyl (3ba), oxazolidinone (3ca), and benzosultam (3da) tethered on the 
ynamide nitrogen were all well compatible, providing good to excellent yields. 
An indole-derived ynamide led to the corresponding tetrahydropyrimidine 3ea 
in 64% yield. A para-methoxylbenzyl group at the sulfonamide moiety turned 
out to be also suitable. Aryl-substituted ynamides, whenever bearing an 
electronically neutral, an electron-donating or an electron-withdrawing 
substituent on the aromatic rings, provided products 3ga–pa in 79–94% yields. 
An array of functional groups, including fluorides (3la), chlorides (3pa), 
bromides (3ma), ethers (3ja, 3ka), esters (3na), and trifluoromethyl (3oa) 
remained intact, giving opportunities for downstream manipulation at such 
positions. The 6-methoxy-2-naphthalenyl substituted ynamide converted into 
the product 3qa in moderate yield. 
 
Next, a series of 1,3,5-triaryl-1,3,5-triazinanes were subjected to the 
gold-catalyzed cyclocarboamination of ynamide 1a under the standard reaction 
conditions (Table 3). In general, both electron-deficient and electron-rich 
groups attached to the ortho-, meta-, or para-positions of the aromatic rings 
were tolerated, affording the target products 3ab–ak in satisfactory yields (up 
to 86%). The reaction of triazinanes with electron-rich substituents usually 
delivered higher yields (3ab–af versus 3ag–ai), which is consistent with a 
step-wise nucleophilic addition mechanism (Scheme 4). A variety of functional 
groups attached to the aromatic ring of such a substrate, namely fluoro (3ag, 
3ak), chloro (3ah, 3al), bromo (3ai), and ether (3ae, 3af) moieties, were also 
compatible. Triazinane substrates bearing disubstituted patterns could furnish 
3al in 81% yield. 
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Table 2: Reaction scope with respect to ynamides.[a,b] 
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Table 3: Reaction scope with respect to 1,3,5-triazinanes.[a,b] 
 
 
To further verify the structural assignment, an X-ray single crystal structure 
analysis of 3da was conducted (Figure 2).[10] The reaction of 1a with 2a could 
be easily run on gram scale with a lower catalyst loading (1 mol%), and 3aa 
was still isolated in a good yield of 80% (Scheme 2). 
 




Scheme 2. Gram-scale synthesis of 3aa. 
 
5.2.3 Mechanistic Study 
With regard to the reaction mechanism, we performed the experiment with the 
deuterium-labelled substrate under the standard condition (Scheme 3a). The 
treatment of 1a with 2a and D6-2a gave a mixture of 3aa, D4-3aa, D2-3aa, 
and/or D2-3aa’, which rules out the direct nucleophilic attacking of triazinanes. 
To further verify a possible step-wise mechanism, a competition experiment 
was conducted (Scheme 3b). The HRMS analysis of the roughly isolated 
products of 1a with 2a and 2b showed the formation of 3aa, 3ab, 4 and/or 4’. 
These two cross-over experiments reveal that the present cyclocarboamination 
is probably caused by a three-component [2+2+2] cycloaddition. 
 
Scheme 3. Mechanistic investigation. 
 
A plausible mechanism is depicted in Scheme 4 according to our observations 
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in combination with previous reports.[4-6] First, formaldimines 2’, in situ 
generated from 1,3,5-triazinanes 2, regiospecifically attack the gold-activated 
ynamides A or A’ to form the iminium intermediates B. It is worth noting that 
in Skrydstrup’s previous report, a preferable intramolecular trapping of the 
iminium species by the aromatic ring (R1 = Ar) affords dihydroisoquinolines.[11] 
However, probably due to the smaller steric hindrance, another formaldimine 
rapidly reacts to give new iminium species C in the present reaction. Then an 
intramolecular cyclization followed by protodeauration takes place to provide 
the final products 3 and regenerates the active gold catalyst. 
 
Scheme 4. Proposed mechanism for the formation of 3. 
 
5.3 Conclusion 
In conclusion, we have demonstrated a facile and modular synthesis of valuable 
5-aminotetrahydropyrimidines through a gold-catalyzed regiocontrolled 
cyclocarboamination of ynamides with 1,3,5-triazinanes. Easy operation, 
readily available starting materials, stable four-atom building units, broad 
functional-group tolerance, and scaling-up potential make this new protocol 
attractive and practical. Mechanistic studies indicate that the present 
intermolecular cyclocarboamination results from a pseudo-three-component 
[2+2+2] cycloaddition.[12] 
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5.5 Experimental Section 
General Remarks: Chemicals were purchased from commercial suppliers and used 
without further purification. Reagents 1 and 2 could be easily prepared according to 
the previous literatures.[1,2] Dry solvents were dispensed from the solvent purification 
system MB SPS-800. Deuterated solvents were bought from Euriso-Top. NMR 
spectra were, if not mentioned otherwise, recorded at room temperature on the 
following spectrometers: Bruker Avance-III-300 and Bruker Avance-III-500. 
Chemical shifts were referenced to residual solvent protons and reported in ppm and 
coupling constants in Hz. The following abbreviations were used for 1H NMR spectra 
to indicate the signal multiplicity: s (singlet), d (doublet), t (triplet), q (quartet), and m 
(multiplet). All 13C NMR spectra were measured with 1H-decoupling. The 
multiplicities mentioned in these spectra [s (singlet, quaternary carbon), d (doublet, 
CH-group), t (triplet, CH2-group), q (quartet, CH3-group)] were determined by 
DEPT135. HRMS were determined at the chemistry department of the University of 
Heidelberg under the direction of Dr. J. Gross. EI+-spectra were measured on a JOEL 
JMS-700 spectrometer. For ESI+-spectra a Bruker ApexQu FT-ICR-MS spectrometer 
was applied. IR spectra were recorded on a Bruker Vector 22, and the absorption 
maxima were given in wavelength in cm-1 units. X-ray crystal structure analyses were 
measured at the chemistry department of the University of Heidelberg under the 
direction of Dr. F. Rominger on a Bruker Smart CCD or Bruker APEX-II CCD 
instrument using Mo-Kα-radiation. The structures were solved and refined by Dr. F. 
Rominger using the SHELXTL software package. Thin-layer chromatography (TLC) 
was performed on precoated polyester sheets (POLYGRAM SIL G/UV254), and 
components were visualized by observation under UV ligh. Melting points were 
uncorrected. 
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Experiment Procedure: Gold-catalyzed intermolecular cyclocarboamination of 
ynamides with 1,3,5-triazinanes 
 
A round bottom flask equipped with a magnetic stirrer bar was charged with 
CyJohnPhosAuCl (5 mol%, 4.4 mg), AgNTf2 (5 mol%, 2.9 mg), and 1,2-DCE (0.40 
mL). The mixture was stirred for 5 minutes at room temperature. Ynamides 1 (0.15 
mmol) and 1,3,5-triazinanes 2 (0.27 mmol) were added followed by 0.35 mL 
1,2-DCE. The reaction mixture was then stirred at 80 oC for 24 h. After cooling to 
room temperature, the mixture was concentrated and the residue was purified by 
chromatography on silica gel (eluent: PE/EA) to afford the desired product 3. 
 
Gram-scale reaction: A round bottom flask equipped with a magnetic stirrer bar was 
charged with CyJohnPhosAuCl (5 mol%, 87.4 mg), AgNTf2 (5 mol%, 58.2 mg), and 
1,2-DCE (8.0 mL). The mixture was stirred for 5 minutes at room temperature. 
Ynamide 1a (3 mmol) and 1,3,5-triazinane 2a (5.4 mmol) were added followed by 7.0 
mL 1,2-DCE. The reaction mixture was then stirred at 80 oC for 24 h. After cooling to 
room temperature, the mixture was concentrated and the residue was purified by 
chromatography on silica gel (eluent: PE/EA) to afford the product 3aa in 80% yield 
(1.01g). 
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X-Ray crystal structure analysis 
The crystallographic data of compound 3da (CCDC 1525557) can be obtained 






A round bottom flask equipped with a magnetic stirrer bar was charged with 
CyJohnPhosAuCl (10 mol%, 5.8 mg), AgNTf2 (10 mol%, 3.9 mg), and 1,2-DCE (0.5 
mL). The mixture was stirred for 5 minutes at room temperature. Ynamide 1a (0.1 
mmol, 2 equiv.), 1,3,5-triazinanes 2a (0.09 mmol, 1.8 equiv.) and D6-2a (0.09 mmol, 
1.8 equiv.) were added followed by 0.5 mL 1,2-DCE. The reaction mixture was then 
stirred at 80 oC for 24 h. After cooling to room temperature, the mixture was 
concentrated and the residue was purified by flash chromatography on silica gel 
(PE/EA = 5:1, v/v) to afford the crude product. Then such a crude product was 
subjected to HRMS analysis. The result showed that the formation of 3aa, D4-3aa, 








A round bottom flask equipped with a magnetic stirrer bar was charged with 
CyJohnPhosAuCl (10 mol%, 5.8 mg), AgNTf2 (10 mol%, 3.9 mg), and 1,2-DCE (0.5 
mL). The mixture was stirred for 5 minutes at room temperature. Ynamide 1a (0.1 
mmol, 2 equiv.), 1,3,5-triazinanes 2a (0.09 mmol, 1.8 equiv.) and 2b (0.09 mmol, 1.8 
equiv.) were added followed by 0.5 mL 1,2-DCE. The reaction mixture was then 
stirred at 80 oC for 24 h. After cooling to room temperature, the mixture was 
concentrated and the residue was purified by flash chromatography on silica gel 
(PE/EA = 5:1, v/v) to afford the crude product. Then such a crude product was 
subjected to HRMS analysis. The result showed that the formation of 3aa, 3ab, 4 










Yield 90%, light yellow solid, m.p.: 59–60 oC; 1H NMR (500 MHz, 
CDCl3) δ 7.57–7.55 (m, 2H), 7.45 (t, J = 7.6 Hz, 2H), 7.37–7.32 (m, 3H), 7.18–7.13 
(m, 5H), 6.77 (t, J = 7.3 Hz, 1H), 6.68 (d, J = 8.6 Hz, 2H), 5.04 (s, 1H), 4.75 (s, 1H), 
4.29 (s, 1H), 4.03 (s, 1H), 2.69 (s, 3H), 2.36 (s, 3H) ppm; 13C NMR (125 MHz, 
CDCl3) δ 147.6 (s), 146.1 (s), 137.2 (s), 137.1 (s), 129.4 (d), 129.2 (d), 128.8 (d), 
128.4 (d), 127.6 (d), 124.7 (d), 124.0 (d), 119.3 (d), 117.7 (s), 115.0 (d), 69.4 (t), 51.0 
(t), 39.9 (q), 37.6 (q) ppm; IR (ATR): ṽ 3057, 3028, 2928, 2853, 1685, 1639, 1595, 
1494, 1451, 1416, 1340, 1220, 1146, 1078, 1041, 1001, 960, 879, 768, 734, 698, 637, 
619 cm-1; HRMS (EI) calcd for [C24H25N3O2S]




Yield 65%, light yellow solid, m.p.: 89–90 oC; 1H NMR (500 MHz, 
CDCl3) δ 7.63 (d, J = 7.5 Hz, 2H), 7.46 (t, J = 7.6 Hz, 2H), 7.36 (t, J = 7.4 Hz, 1H), 
7.25 (d, J = 8.2 Hz, 2H), 7.13 (t, J = 7.9 Hz, 2H), 7.07 (t, J = 7.7 Hz, 2H), 6.95 (t, J = 
8.8 Hz, 3H), 6.75–6.72 (m, 3H), 6.62 (d, J = 8.3 Hz, 2H), 4.80 (s, 2H), 4.14 (s, 2H), 
2.77 (s, 3H), 2.32 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 147.6 (s), 145.9 (s), 
142.5 (s), 137.9 (s), 137.3 (s), 137.2 (s), 129.2 (d), 128.9 (d), 128.7 (d), 128.5 (d), 
128.4 (d), 127.5 (d), 126.7 (d), 123.7 (d), 123.5 (d), 119.0 (d), 118.2 (s), 114.7 (d), 
69.2 (t), 51.0 (t), 38.6 (q), 21.4 (q) ppm; IR (ATR): ṽ 3416, 3058, 3029, 2960, 2926, 
2872, 2852, 1638, 1600, 1494, 1448, 1341, 1287, 1215, 1154, 1088, 1078, 1029, 995, 
961, 931, 863, 813, 761, 696, 668, 646, 607 cm-1; HRMS (EI) calcd for 
[C30H29N3O2S]
+ (M)+: 495.1975; found: 495.1978. 
 
3ca: 3-(1,3,5-triphenyl-1,2,3,6-tetrahydropyrimidin-4-yl)oxazolidin-2-one 
Yield 70%, light yellow solid, m.p.: 82–83 oC; 1H NMR (500 MHz, 
131 
CDCl3) δ 7.42–7.37 (m, 4H), 7.33–7.28 (m, 3H), 7.19–7.11 (m, 5H), 6.79 (t, J = 7.3 
Hz, 1H), 6.73 (d, J = 8.1 Hz, 2H), 4.90 (s, 2H), 4.20 (s, 2H), 4.01 (t, J = 8.0 Hz, 2H), 
3.50 (t, J = 8.0 Hz, 2H) ppm; 13C NMR (125 MHz, CDCl3) δ 154.9 (s), 147.7 (s), 
145.4 (s), 137.6 (s), 132.0 (s), 129.4 (d), 129.2 (d), 128.7 (d), 127.7 (d), 127.3 (d), 
124.8 (d), 123.8 (d), 119.6 (d), 116.3 (s), 115.4 (d), 69.5 (t), 61.9 (t), 50.8 (t), 45.2 (t) 
ppm; IR (ATR): ṽ 3059, 3030, 2918, 2850, 1754, 1681, 1596, 1493, 1447, 1401, 1389, 
1324, 1206, 1120, 1070, 1034, 992, 973, 933, 910, 804, 749, 696, 650 cm-1; HRMS 
(ESI) calcd for [C25H23N3O2Na]




Yield 94%, white solid, m.p.: 168–169 oC; 1H NMR (500 MHz, 
CDCl3) δ 7.71 (s, 1H), 7.56 (d, J = 6.6 Hz, 2H), 7.42 (s, 2H), 7.32–7.12 (m, 10H), 
6.98 (s, 1H), 6.80 (t, J = 6.7 Hz, 1H), 6.70 (d, J = 7.5 Hz, 2H), 4.98 (s, 2H), 4.26 (s, 
2H), 4.20 (s, 2H) ppm; 13C NMR (125 MHz, CDCl3) δ 147.6 (s), 146.7 (s), 136.8 (s), 
134.7 (s), 133.1 (s), 132.9 (s), 132.3 (d), 129.2 (d), 128.9 (d), 128.8 (d), 128.8 (d), 
127.6 (d), 125.0 (d), 124.7 (d), 123.8 (d), 121.4 (d), 119.3 (d), 115.3 (s), 114.9 (d), 
69.7 (t), 50.8 (t), 50.0 (t) ppm; IR (ATR): ṽ 3062, 2865, 2783, 1650, 1597, 1505, 1490, 
1456, 1372, 1304, 1294, 1277, 1267, 1204, 1169, 1131, 1104, 1066, 1056, 1036, 992, 
971, 933, 900, 827, 794, 754, 734, 700, 661, 624, 609 cm-1; HRMS (EI) calcd for 
[C29H25N3O2S]
+ (M)+: 479.1662; found: 479.1668. 
 
3ea: 1-(1-(1,3,5-triphenyl-1,2,3,6-tetrahydropyrimidin-4-yl)-1H-indol-3-yl)ethanone 
Yield 46%, white solid, m.p.: 96–97 oC; 1H NMR (500 MHz, 
CDCl3) δ 8.19–8.17 (m, 1H), 7.56 (s, 1H), 7.53–7.50 (m, 1H), 
7.24–7.21 (m, 2H), 7.17–7.08 (m, 7H), 7.04 (d, J = 7.4 Hz, 2H), 
7.00–6.98 (m, 2H), 6.95 (t, J = 7.2 Hz, 1H), 6.86–6.80 (m, 3H), 5.10 (s, 2H), 4.40 (s, 
2H), 2.28 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 193.4 (s), 147.5 (s), 145.0 (s), 
136.6 (s), 136.3 (s), 135.4 (d), 133.9 (s), 129.4 (d), 129.2 (d), 128.6 (d), 127.2 (d), 
127.2 (d), 1261 (s), 125.0 (d), 123.8 (d), 123.5 (d), 122.9 (d), 122.1 (d), 112.0 (d), 
132 
118.9 (s), 115.6 (d), 114.8 (s), 112.2 (d), 70.0 (t), 50.5 (t), 27.5 (q) ppm; IR (ATR): ṽ 
3056, 3028, 2922, 1738, 1649, 1597, 1530, 1492, 1454, 1376, 1347, 1310, 1271, 1201, 
1154, 1069, 1028, 1016, 996, 973, 932, 909, 748, 695, 637, 615 cm-1; HRMS (EI) 
calcd for [C32H27N3O]




Yield 81%, white solid, m.p.: 73–74 oC; 1H NMR (500 MHz, 
CDCl3) δ 7.41–7.36 (m, 4H), 7.33–7.27 (m, 3H), 7.22 (t, J = 
6.8 Hz, 1H), 7.16–7.12 (m, 4H), 7.08 (d, J = 8.4 Hz, 2H), 6.82 (d, J = 8.5 Hz, 2H), 
6.75 (t, J = 7.3 Hz, 1H), 6.63 (d, J = 8.5 Hz, 2H), 4.93 (d, J = 12.0 Hz, 1H), 4.68 (d, J 
= 12.1 Hz, 1H), 4.16 (d, J = 14.8 Hz, 2H), 4.06–3.96 (m, 2H), 3.81 (s, 3H), 2.04 (s, 
3H) ppm; 13C NMR (125 MHz, CDCl3) δ 159.5 (s), 147.7 (s), 145.8 (s), 137.9 (s), 
135.1 (s), 131.4 (d), 129.42 (d), 129.35 (d), 129.2 (d), 128.3 (d), 127.6 (s), 127.4 (d), 
125.9 (d), 125.7 (d), 119.7 (s), 119.1 (d), 114.8 (d), 113.7 (d), 69.8 (t), 55.3 (q), 51.9 
(t), 51.8 (t), 41.8 (q) ppm; IR (ATR): ṽ 3058, 3037, 2933, 2350, 2248, 1681, 1628, 
1611, 1596, 1512, 1494, 1453, 1338, 1303, 1247, 1216, 1175, 1150, 1073, 1034, 962, 
911, 834, 764, 730, 697, 647, 618 cm-1; HRMS (EI) calcd for [C31H31N3O3S]
+ (M)+: 




Yield 94%, white solid, m.p.: 69–70 oC; 1H NMR (500 MHz, CDCl3) 
δ 7.46 (d, J = 7.9 Hz, 2H), 7.35 (t, J = 7.8 Hz, 2H), 7.27–7.25 (m, 2H), 
7.18–7.12 (m, 5H), 6.77 (t, J = 7.2 Hz, 1H), 6.68 (d, J = 8.5 Hz, 2H), 5.06 (s, 1H), 
4.73 (s, 1H), 4.29 (s, 1H), 4.00 (s, 1H), 2.70 (s, 3H), 2.39 (s, 6H) ppm; 13C NMR (125 
MHz, CDCl3) δ 147.7 (s), 146.2 (s), 137.3 (s), 136.8 (s), 134.1 (s), 129.5 (d), 129.4 
(d), 129.2 (d), 128.2 (d), 124.6 (d), 123.9 (d), 119.2 (d), 117.8 (s), 114.9 (d), 69.4 (t), 
51.1 (t), 40.0 (q), 37.7 (q), 21.3 (q) ppm; IR (ATR): ṽ 3056, 3030, 2923, 2856, 2249, 
1677, 1637, 1597, 1494, 1456, 1336, 1287, 1271, 1220, 1145, 1080, 1039, 996, 961, 
133 
931, 911, 867, 822, 798, 754, 731, 699, 648 cm-1; HRMS (EI) calcd for 
[C24H25N3O2S]




Yield 85%, white solid, m.p.: 176–177 oC; 1H NMR (500 MHz, 
CDCl3) δ 7.48 (q, J = 7.8 Hz, 4H), 7.35 (t, J = 7.6 Hz, 2H), 
7.18–7.12 (m, 5H), 6.77 (t, J = 7.2 Hz, 1H), 6.68 (d, J = 8.0 Hz, 2H), 5.04 (s, 1H), 
4.74 (s, 1H), 4.29 (s, 1H), 4.01 (s, 1H), 2.70 (s, 3H), 2.37 (s, 3H), 1.36 (s, 9H) ppm; 
13C NMR (125 MHz, CDCl3) δ 150.5 (s), 147.7 (s), 146.2 (s), 136.8 (s), 134.1 (s), 
129.4 (d), 129.2 (d), 128.0 (d), 125.6 (d), 124.6 (d), 123.9 (d), 119.2 (d), 117.7 (s), 
117.5 (s), 114.9 (d), 69.4 (t), 51.0 (t), 40.0 (q), 37.7 (q), 34.7 (s), 31.4 (q); IR (ATR): ṽ 
2951, 2866, 1623, 1599, 1505, 1491, 1455, 1395, 1335, 1273, 1209, 1145, 1084, 1060, 
1030, 998, 965, 931, 852, 837, 796, 782, 751, 695, 644 cm-1; HRMS (EI) calcd for 
[C28H33N3O2S]




Yield 79%, white solid, m.p.: 159–160 oC; 1H NMR (500 MHz, 
CDCl3) δ 7.70–7.62 (m, 6H), 7.46 (t, J = 7.7 Hz, 2H), 7.38–7.34 (m, 
3H), 7.18–7.13 (m, 5H), 6.77 (t, J = 7.3 Hz, 1H), 6.69 (d, J = 8.0 Hz, 2H), 5.07 (s, 
1H), 4.74 (s, 1H), 4.35 (s, 1H), 4.04 (s, 1H), 2.74 (s, 3H), 2.40 (s, 3H) ppm; 13C NMR 
(125 MHz, CDCl3) δ 147.6 (s), 146.1 (s), 140.5 (s), 140.1 (s), 137.3 (s), 136.1 (s), 
129.4 (d), 129.2 (d), 128.9 (d), 128.7 (d), 127.4 (d), 127.3 (d), 127.0 (d), 124.7 (d), 
123.9 (d), 119.3 (d), 117.1 (s), 115.0 (d), 69.4 (t), 50.9 (t), 40.0 (q), 37.8 (q) ppm; IR 
(ATR): ṽ 3060, 3029, 2954, 2924, 2852, 1633, 1598, 1502, 1488, 1454, 1339, 1279, 
1212, 1147, 1082, 1032, 1006, 963, 932, 847, 766, 751, 730, 695, 643 cm-1; HRMS 
(EI) calcd for [C24H25N3O2S]





Yield 94%, white solid, m.p.: 145–146 oC; 1H NMR (500 MHz, 
CDCl3) δ 7.50 (d, J = 8.6 Hz, 2H), 7.35 (t, J = 7.8 Hz, 2H), 7.17–7.12 
(m, 5H), 6.99 (d, J = 8.7 Hz, 2H), 6.76 (t, J = 7.3 Hz, 1H), 6.67 (d, J = 8.2 Hz, 2H), 
5.06 (s, 1H), 4.70 (s, 1H), 4.28 (s, 1H), 3.97 (s, 1H), 3.85 (s, 3H), 2.70 (s, 3H), 2.41 (s, 
3H) ppm; 13C NMR (125 MHz, CDCl3) δ 159.0 (s), 147.6 (s), 146.3 (s), 136.7 (s), 
129.5 (d), 129.4 (d), 129.3 (s), 129.2 (d), 124.6 (d), 123.8 (d), 119.2 (d), 117.5 (s), 
114.9 (d), 114.1 (d), 69.4 (t), 55.3 (q), 51.1 (t), 40.1 (q), 37.7 (q) ppm; IR (ATR): ṽ 
3030, 2933, 2838, 2254, 1738, 1641, 1598, 1504, 1494, 1460, 1336, 1278, 1246, 1217, 
1205, 1179, 1145, 1081, 1032, 995, 961, 931, 911, 867, 835, 799, 755, 732, 702, 649, 
615 cm-1; HRMS (EI) calcd for [C25H27N3O3S]




Yield 80%, light yellow solid, m.p.: 60–61 oC; 1H NMR (500 MHz, 
CDCl3) δ 7.55–7.52 (m, 2H), 7.39–7.34 (m, 4H), 7.18–7.13 (m, 6H), 
7.10–7.05 (m, 4H), 6.77 (t, J = 7.3 Hz, 1H), 6.68 (d, J = 7.9 Hz, 2H), 5.06 (s, 1H), 
4.71 (s, 1H), 4.30 (s, 1H), 4.00 (s, 1H), 2.74 (s, 3H), 2.42 (s, 3H) ppm; 13C NMR (125 
MHz, CDCl3) δ 156.9 (s), 156.8 (s), 147.6 (s), 146.2 (s), 137.1 (s), 131.9 (s), 129.9 (d), 
129.7 (d), 129.4 (d), 129.2 (d), 124.7 (d), 123.9 (d), 123.6 (d), 119.3 (d), 119.2 (d), 
118.8 (d), 117.1 (s), 115.0 (d), 69.4 (t), 51.1 (t), 40.1 (q), 37.8 (q) ppm; IR (ATR): ṽ 
3061, 3036, 2929, 2851, 2363, 2252, 1647, 1597, 1489, 1457, 1336, 1273, 1236, 1169, 
1144, 1080, 1033, 995, 961, 932, 910, 868, 800, 750, 732, 694, 650 cm-1; HRMS (EI) 
calcd for [C30H29N3O2S]




Yield 87%, light yellow solid, m.p.: 64–65 oC; 1H NMR (500 MHz, 
135 
CDCl3) δ 7.55–7.52 (m, 2H), 7.37–7.34 (m, 2H), 7.17–7.12 (m, 7H), 6.77 (t, J = 7.3 
Hz, 1H), 6.66 (d, J = 7.9 Hz, 2H), 5.05 (s, 1H), 4.71 (s, 1H), 4.27 (s, 1H), 3.97 (s, 1H), 
2.69 (s, 3H), 2.40 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 162.1 (s, d: JC-F = 
247.1 Hz), 147.5 (s), 146.1 (s), 137.4 (s), 133.0 (s, d: JC-F = 3.4 Hz), 130.1 (d, d: JC-F 
= 8.0 Hz), 129.4 (d), 129.2 (d), 124.8 (d), 123.9 (d), 119.4 (d), 116.8 (s), 115.7 (d, d: 
JC-F = 21.3 Hz), 115.0 (d), 69.5 (t), 51.1 (t), 40.0 (q), 37.8 (q) ppm; 19F NMR (282 
MHz, CDCl3) δ -114.16 ppm; IR (ATR): ṽ 3063, 2929, 1681, 1638, 1595, 1494, 1336, 
1222, 1157, 1146, 1099, 1080, 1040, 961, 912, 840, 799, 761, 729, 696, 648, 613 cm-1; 
HRMS (EI) calcd for [C24H24N3O2S]




Yield 91%, white solid, m.p.: 165–166 oC; 1H NMR (500 MHz, CDCl3) 
δ 7.57 (d, J = 8.4 Hz, 2H), 7.44 (d, J = 8.4 Hz, 2H), 7.36 (t, J = 7.8 Hz, 
2H), 7.18–7.12 (m, 5H), 6.78 (t, J = 7.3 Hz, 1H), 6.67 (d, J = 8.2 Hz, 2H), 5.05 (s, 
1H), 4.70 (s, 1H), 4.29 (s, 1H), 3.98 (s, 1H), 2.70 (s, 3H), 2.39 (s, 3H) ppm; 13C NMR 
(125 MHz, CDCl3) δ 147.5 (s), 146.0 (s), 137.6 (s), 136.1 (s), 131.9 (d), 130.0 (d), 
129.5 (d), 129.3 (d), 124.9 (d), 124.0 (d), 121.5 (s), 119.5 (d), 116.4 (s), 115.0 (d), 
69.4 (t), 50.8 (t), 39.9 (q), 37.8 (q) ppm; IR (ATR): ṽ 3067, 3035, 2862, 1641, 1599, 
1490, 1461, 1424, 1385, 1362, 1329, 1295, 1283, 1199, 1142, 1080, 1041, 1008, 997, 
963, 932, 893, 869, 833, 803, 789, 763, 733, 700, 658 cm-1; HRMS (EI) calcd for 
[C24H24N3O2SBr]
+ (M)+: 497.0767; found: 497.0745. 
 
3na:  methyl  4-(6-(N-methylmethylsulfonamido)-1,3-diphenyl-1,2,3,
4-tetrahydropyrimidin-5-yl)benzoate 
Yield 86%, white solid, m.p.: 81–82 oC; 1H NMR (500 MHz, CDCl3) 
δ 8.11 (d, J = 8.4 Hz, 2H), 7.63 (d, J = 8.4 Hz, 2H), 7.35 (t, J = 7.9 
Hz, 2H), 7.18–7.12 (m, 5H), 6.78 (t, J = 7.3 Hz, 1H), 6.68 (d, J = 7.9 Hz, 2H), 5.05 (s, 
1H), 4.73 (s, 1H), 4.34 (s, 1H), 4.03 (s, 1H), 3.93 (s, 3H), 2.68 (s, 3H), 2.35 (s, 3H) 
ppm; 13C NMR (125 MHz, CDCl3) δ 166.9 (s), 147.5 (s), 145.8 (s), 142.1 (s), 138.2 
136 
(s), 130.0 (d), 129.5 (d), 129.3 (d), 129.0 (s), 128.3 (d), 125.0 (d), 124.1 (d), 119.5 (d), 
116.2 (s), 115.1 (d), 69.3 (t), 52.2 (q), 50.6 (t), 39.8 (q), 37.7 (q) ppm; IR (ATR): ṽ 
2951, 1717, 1685, 1637, 1597, 1494, 1456, 1436, 1337, 1278, 1221, 1182, 1146, 1110, 
1039, 1020, 960, 933, 862, 828, 772, 697, 647 cm-1; HRMS (EI) calcd for 
[C26H27N3O4S]




Yield 80%, light yellow solid, m.p.: 139–140 oC; 1H NMR (500 MHz, 
CDCl3) δ 7.71–7.67 (m, 4H), 7.36 (t, J = 7.9 Hz, 2H), 7.18–7.12 (m, 
5H), 6.79 (t, J = 7.3 Hz, 1H), 6.68 (d, J = 8.0 Hz, 2H), 5.06 (s, 1H), 4.72 (s, 1H), 4.34 
(s, 1H), 4.01 (s, 1H), 2.69 (s, 3H), 2.37 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 
147.5 (s), 145.8 (s), 141.0 (s, d: JC-F = 1.1 Hz), 138.3 (s), 129.5 (d), 129.4 (s, q: JC-F = 
32.5 Hz), 129.3 (d), 128.6 (d), 125.7 (d, q: JC-F = 3.7 Hz), 125.0 (d), 124.15 (s, q: JC-F 
= 270.0 Hz), 124.07 (d), 119.6 (d), 116.0 (s), 115.1 (d), 69.4 (t), 50.7 (t), 39.8 (q), 
37.9 (q) ppm; 19F NMR (470 MHz, CDCl3) δ -62.459, -62.464 ppm; IR (ATR): ṽ 
3029, 2924, 2849, 1599, 1493, 1455, 1411, 1337, 1277, 1213, 1148, 1114, 1066, 1033, 
1016, 996, 963, 935, 862, 850, 794, 769, 754, 694, 609 cm-1; HRMS (EI) calcd for 
[C25H24N3O2SF3]




Yield 82%, light yellow solid, m.p.: 78–79 oC; 1H NMR (500 MHz, 
CDCl3) δ 7.52–7.48 (m, 2H), 7.39–7.29 (m, 4H), 7.18–7.12 (m, 5H), 
6.78 (t, J = 7.3 Hz, 1H), 6.67 (d, J = 7.9 Hz, 2H), 5.03 (s, 1H), 4.71 (s, 1H), 4.27 (s, 
1H), 4.00 (s, 1H), 2.71 (s, 3H), 2.37 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 
147.5 (s), 145.9 (s), 139.1 (s), 137.9 (s), 134.4 (s), 130.1 (d), 129.5 (d), 129.2 (d), 
128.1 (d), 127.6 (d), 126.9 (d), 124.9 (d), 124.1 (d), 119.5 (d), 116.1 (s), 115.1 (d), 
69.4 (t), 50.8 (t), 39.8 (q), 37.7 (q) ppm; IR (ATR): ṽ 3063, 3030, 2929, 2854, 1639, 
1594, 1562, 1493, 1411, 1336, 1285, 1205, 1145, 1080, 1033, 996, 962, 866, 787, 752, 
137 
721, 695, 611 cm-1; HRMS (EI) calcd for [C24H24N3O2SCl]





Yield 40%, white solid, m.p.: 188–189 oC; 1H NMR (500 MHz, 
CDCl3) δ 7.89 (d, J = 1.1 Hz, 1H), 7.80 (t, J = 9.3 Hz, 2H), 7.71 (dd, 
J = 8.4, 1.8 Hz, 1H), 7.37–7.34 (m, 2H), 7.19–7.12 (m, 7H), 6.77 (t, J 
= 7.3 Hz, 1H), 6.70 (d, J = 7.9 Hz, 2H), 5.10 (s, 1H), 4.75 (s, 1H), 4.44 (s, 1H), 4.06 
(s, 1H), 3.94 (s, 3H), 2.67 (s, 3H), 2.39 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 
157.9 (s), 147.7 (s), 146.2 (s), 137.3 (s), 133.8 (s), 132.3 (s), 129.6 (d), 129.4 (d), 
129.2 (d), 128.9 (s), 127.2 (d), 127.1 (d), 126.6 (d), 124.6 (d), 123.8 (d), 119.3 (d), 
119.2 (d), 117.5 (s), 114.9 (d), 105.7 (d), 69.3 (t), 55.4 (q), 51.0 (t), 40.0 (q), 37.8 (q) 
ppm; IR (ATR): ṽ 2932, 2236, 1627, 1599, 1485, 1392, 1340, 1268, 1214, 1156, 1026, 
955, 914, 756, 696 cm-1; HRMS (EI) calcd for [C29H29N3O2S]





Yield 86%, white solid, m.p.: 79–80 oC; 1H NMR (500 MHz, 
CDCl3) δ 7.56 (d, J = 7.8 Hz, 2H), 7.44 (t, J = 7.6 Hz, 2H), 7.32 (t, J = 7.4 Hz, 1H), 
7.15 (d, J = 8.1 Hz, 2H), 7.05 (d, J = 8.1 Hz, 2H), 6.98 (d, J = 8.4 Hz, 2H), 6.61 (d, J 
= 8.4 Hz, 2H), 4.91 (s, 1H), 4.66 (s, 1H), 4.23 (s, 1H), 3.98 (s, 1H), 2.68 (s, 3H), 2.38 
(s, 3H), 2.33 (s, 3H), 2.22 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 145.5 (s), 
143.7 (s), 137.4 (s), 137.2 (s), 134.4 (s), 129.9 (d), 129.7 (d), 128.72 (s), 128.70 (d), 
128.5 (s), 127.4 (d), 124.1 (d), 117.4 (s), 115.3 (d), 70.2 (t), 51.3 (t), 40.0 (q), 37.6 (q), 
20.9 (q), 20.4 (q) ppm; IR (ATR): ṽ 3032, 3010, 2926, 2864, 2239, 1680, 1635, 1596, 
1513, 1450, 1408, 1381, 1339, 1330, 1273, 1218, 1175, 1040, 961, 914, 876, 819, 769, 
729, 703, 645 cm-1; HRMS (EI) calcd for [C26H29N3O2S]





Yield 73%, light yellow solid, m.p.: 140–141 oC; 1H NMR 
(500 MHz, CDCl3) δ 7.58 (d, J = 7.8 Hz, 2H), 7.45 (t, J = 7.5 Hz, 2H), 7.35–7.32 (m, 
1H), 7.19 (d, J = 8.0 Hz, 2H), 7.06 (t, J = 7.7 Hz, 4H), 6.67 (d, J = 8.1 Hz, 2H), 4.98 
(s, 1H), 4.68 (s, 1H), 4.29 (s, 1H), 3.99 (s, 1H), 2.90 (dt, J = 13.8, 6.9 Hz, 1H), 2.80 
(dt, J = 13.8, 6.9 Hz, 1H), 2.70 (s, 3H), 2.40 (s, 3H), 1.25 (d, J = 6.9 Hz, 6H), 1.19 (d, 
J = 6.9 Hz, 6H) ppm; 13C NMR (125 MHz, CDCl3) δ 145.9 (s), 145.3 (s), 143.9 (s), 
139.9 (s), 137.4 (s), 137.3 (s), 128.7 (d), 128.4 (d), 127.4 (d), 127.2 (d), 127.1 (d), 
124.0 (d), 117.4 (s), 115.3 (d), 70.0 (t), 51.3 (t), 40.0 (q), 37.7 (q), 33.5 (q), 33.2 (q), 
24.2 (q), 24.1 (q) ppm; IR (ATR): ṽ 3402, 3053, 3022, 2833, 1738, 1627, 1598, 1509, 
1472, 1440, 1386, 1361, 1291, 1264, 1220, 1176, 1145, 1125, 1030, 980, 956, 935, 
832, 809, 746, 702, 653, 619 cm-1; HRMS (EI) calcd for [C30H37N3O2S]
+ (M)+: 




Yield 70%, light yellow solid, m.p.: 150–151 oC; 1H NMR 
(500 MHz, CDCl3) δ 7.61–7.57 (m, 6H), 7.49–7.32 (m, 13H), 7.22 (d, J = 8.5 Hz, 2H), 
6.77 (d, J = 8.8 Hz, 2H), 5.12 (s, 1H), 4.80 (s, 1H), 4.35 (s, 1H), 4.10 (s, 1H), 2.72 (s, 
3H), 2.42 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 146.9 (s), 145.3 (s), 140.8 (s), 
140.1 (s), 137.4 (s), 137.1 (s), 137.0 (s), 132.1 (s), 128.9 (d), 128.8 (d), 128.7 (d), 
128.4 (d), 128.0 (d), 127.9 (d), 127.6 (d), 127.3 (d), 126.8 (d), 126.5 (d), 124.0 (d), 
117.9 (s), 115.1 (d), 69.1 (t), 51.0 (t), 40.1 (q), 37.7 (q) ppm; IR (reflection): ṽ 3055, 
3030, 2924, 2852, 1681, 1637, 1609, 1523, 1486, 1449, 1337, 1297, 1263, 1215, 1176, 
1145, 1077, 1041, 1007, 960, 931, 911, 841, 762, 728, 697, 649 cm-1; HRMS (ESI) 
calcd for [C36H33N3O2SNa]





Yield 76%, light yellow solid, m.p.: 158–159 oC; 1H NMR 
(500 MHz, CDCl3) δ 7.54–7.52 (m, 2H), 7.42 (t, J = 7.7 Hz, 2H), 7.31 (t, J = 7.4 Hz, 
1H), 7.13–7.10 (m, 2H), 6.89–6.86 (m, 2H), 6.76–6.73 (m, 2H), 6.69–6.66 (m, 2H), 
4.73 (s, 1H), 4.62 (s, 1H), 4.13 (s, 1H), 3.99 (s, 1H), 3.79 (s, 3H), 3.72 (s, 3H), 2.68 (s, 
3H), 2.33 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 157.0 (s), 153.6 (s), 142.0 (s), 
139.4 (s), 137.6 (s), 137.2 (s), 128.7 (d), 128.6 (d), 127.4 (d), 126.0 (d), 117.6 (d), 
117.1 (s), 114.6 (d), 114.4 (d), 71.9 (t), 55.6 (q), 55.4 (q), 52.1 (t), 39.7 (q), 37.4 (q) 
ppm; IR (ATR): ṽ 3058, 3039, 2988, 2958, 2914, 2837, 2788, 1654, 1608, 1581, 1508, 
1455, 1445, 1479, 1331, 1295, 1240, 1194, 1143, 1107, 1088, 1064, 1032, 963, 933, 
876, 837, 828, 770, 747, 699 cm-1; HRMS (EI) calcd for [C26H29N3O4S]
+ (M)+: 




Yield 90%, white solid, m.p.: 75–76 oC; 1H NMR (500 
MHz, CDCl3) δ 7.53 (d, J = 7.1 Hz, 2H), 7.44 (t, J = 7.7 
Hz, 2H), 7.34–7.28 (m, 5H), 7.13–7.08 (m, 3H), 7.04–6.96 
(m, 5H), 6.91–6.88 (m, 4H), 6.74–6.72 (m, 2H), 4.88 (s, 1H), 4.75 (s, 1H), 4.22 (s, 
1H), 4.07 (s, 1H), 2.69 (s, 3H), 2.36 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 
158.4 (s), 157.2 (s), 154.2 (s), 149.8 (s), 144.3 (s), 141.5 (s), 137.3 (s), 136.9 (s), 
129.8 (d), 129.6 (d), 128.8 (d), 128.5 (d), 127.6 (d), 125.7 (d), 123.4 (d), 122.4 (d), 
120.7 (d), 119.6 (d), 118.7 (d), 117.6 (d), 117.4 (s), 117.2 (d), 70.9 (t), 51.8 (t), 39.8 
(q), 37.4 (q) ppm; IR (ATR): ṽ 3059, 3039, 2931, 1643, 1589, 1504, 1487, 1338, 1291, 
1234, 1198, 1144, 1105, 1076, 1023, 961, 931, 869, 841, 756, 692 cm-1; HRMS (EI) 
calcd for [C36H33N3O4S]





Yield 83%, light yellow solid, m.p.: 154–155 oC; 1H NMR 
(300 MHz, CDCl3) δ 7.50 (d, J = 7.1 Hz, 2H), 7.43 (t, J = 7.5 Hz, 2H), 7.33 (t, J = 7.2 
Hz, 1H), 7.18–7.14 (m, 2H), 7.03 (t, J = 8.5 Hz, 2H), 6.87 (t, J = 8.6 Hz, 2H), 
6.67–6.62 (m, 2H), 4.74 (s, 2H), 4.09 (s, 2H), 2.69 (s, 13H), 2.26 (s, 3H); 13C NMR 
(125 MHz, CDCl3) δ 160.1 (s, d: JC-F = 244.8 Hz), 157.1 (s, d: JC-F = 239.0 Hz), 144.2 
(s, d: JC-F = 2.2 Hz), 142.1 (s, d: JC-F = 2.8 Hz), 137.37 (s), 136.72 (s), 128.78 (d), 
128.65 (d), 127.64 (d), 126.21 (d, d: JC-F = 8.2 Hz), 117.53 (s), 117.19 (d, d: JC-F = 7.6 
Hz), 116.11 (d, d: JC-F = 22.5 Hz), 115.69 (d, d: JC-F = 22.3 Hz), 71.25 (t), 51.88 (t), 
39.58 (q), 37.12 (q); 19F NMR (282 MHz, CD3Cl3) δ -122.45, -129.63 ppm; IR (ATR): 
ṽ 3063, 3032, 3012, 2868, 2799, 1648, 1598, 1506, 1462, 1453, 1441, 1425, 1375, 
1330, 1293, 1275, 1224, 1197, 1171, 1154, 1141, 1098, 1081, 1065, 1025, 997, 962, 
934, 911, 883, 843, 822, 774, 762, 752, 733, 723, 701, 642, 608 cm-1; HRMS (ESI) 
calcd for [C24H23N3O2SF2Na]




Yield 55%, yellow solid, m.p.: 170–171 oC; 1H NMR (500 
MHz, CDCl3) δ 7.50 (d, J = 7.1 Hz, 12H), 7.44 (t, J = 7.7 Hz, 
2H), 7.35–7.30 (m, 3H), 7.11–7.09 (m, 4H), 6.58 (d, J = 8.9 
Hz, 2H), 4.81 (s, 2H), 4.10 (s, 2H), 2.67 (s, 3H), 2.30 (s, 3H) ppm; 13C NMR (125 
MHz, CDCl3) δ 146.1 (s), 144.5 (s), 137.0 (s), 136.5 (s), 130.4 (s), 129.6 (d), 129.1 
(d), 128.8 (d), 128.5 (d), 127.8 (d), 125.4 (d), 124.4 (s), 118.0 (s), 116.3 (d), 69.5 (t), 
51.2 (t), 39.8 (q), 37.2 (q); IR (ATR): ṽ 3092, 3061, 2932, 2851, 1685, 1635, 1595, 
1492, 1451, 1391, 1377, 1358, 1337, 1293, 1273, 1245, 1222, 1205, 1147, 1094, 1077, 
1056, 1016, 1001, 961, 927, 910, 854, 836, 816, 800, 780, 766, 756, 731, 701, 661, 
632, 621 cm-1; HRMS (EI) calcd for [C24H23N3O2SCl2]






Yield 53%, light yellow solid, m.p.: 188–189 oC; 1H NMR 
(500 MHz, CDCl3) δ 7.51–7.42 (m, 6H), 7.34 (t, J = 7.3 Hz, 1H), 7.26–7.23 (m, 2H), 
7.05–7.03 (m, 2H), 6.53 (d, J = 9.0 Hz, 2H), 4.80 (s, 2H), 4.09 (s, 2H), 2.67 (s, 3H), 
2.31 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 146.5 (s), 144.9 (s), 136.9 (s), 
136.5 (s), 132.5 (d), 132.0 (d), 128.8 (d), 128.5 (d), 127.8 (d), 125.6 (d), 118.09 (s), 
118.08 (s), 116.6 (d), 111.6 (s), 69.2 (t), 51.1 (t), 39.9 (q), 37.2 (q) ppm; IR (ATR): ṽ 
3054, 3025, 2924, 2851, 1682, 1637, 1590, 1487, 1336, 1217, 1145, 1074, 1040, 1010, 
961, 911, 872, 830, 768, 731, 701 cm-1; HRMS (ESI) calcd for 
[C24H23N3O2S




Yield 86%, light yellow solid, m.p.: 149–150 oC; 1H NMR 
(500 MHz, CDCl3) δ 7.57 (d, J = 7.9 Hz, 2H), 7.45 (t, J = 7.7 Hz, 2H), 7.33 (t, J = 7.4 
Hz, 1H), 7.26–7.22 (m, 1H), 7.06 (t, J = 7.7 Hz, 1H), 6.96–6.85 (m, 3H), 6.61 (d, J = 
7.4 Hz, 1H), 6.52–6.50 (m, 2H), 5.03 (s, 1H), 4.71 (s, 1H), 4.30 (s, 1H), 4.01 (s, 1H), 
2.69 (s, 3H), 2.38 (s, 3H), 2.35 (s, 3H), 2.24 (s, 3H) ppm; 13C NMR (125 MHz, 
CDCl3) δ 147.8 (s), 146.1 (s), 139.2 (s), 139.0 (s), 137.3 (s), 137.1 (s), 129.1 (d), 
129.0 (d), 128.7 (d), 128.4 (d), 127.5 (d), 125.4 (d), 124.5 (d), 120.9 (d), 120.1 (d), 
117.5 (s), 115.7 (d), 112.2 (d), 69.2 (t), 51.2 (t), 39.9 (q), 37.7 (q), 21.7 (q), 21.5 (q) 
ppm; IR (ATR): ṽ 3055, 3034, 3009, 2918, 1682, 1644, 1604, 1490, 1446, 1371, 1333, 
1276, 1238, 1174, 1144, 1078, 1045, 1006, 962, 945, 894, 870, 858, 787, 766, 742, 
704, 688, 659, 610 cm-1; HRMS (ESI) calcd for [C26H29N3O2SNa]
+ (M+Na)+: 





Yield 80%, white solid, m.p.: 160–161 oC; 1H NMR (500 MHz, CDCl3) δ 7.54 (d, J = 
7.5 Hz, 2H), 7.44 (t, J = 7.7 Hz, 2H), 7.33 (t, J = 7.4 Hz, 1H), 7.10–7.08 (m, 3H), 
7.04–6.98 (m, 3H), 6.89–6.85 (m, 2H), 4.84 (s, 1H), 4.71 (s, 1H), 4.19 (s, 1H), 4.14 (s, 
1H), 2.68 (s, 3H), 2.27 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 157.0 (s, d: JC-F = 
198.9 Hz), 155.1 (s, d: J = 197.5 Hz), 137.4 (s), 136.3 (s, d: JC-F = 8.9 Hz), 136.1 (s), 
132.9 (s, d: JC-F = 9.7 Hz), 128.8 (d), 127.6 (d), 127.2 (d), 126.4 (d, d: JC-F = 7.8 Hz), 
124.4 (d, d: JC-F = 3.6 Hz), 124.0 (d, d: JC-F = 3.8 Hz), 122.7 (d, d: JC-F = 7.8 Hz), 
119.6 (d), 119.6 (d), 117.3 (s), 116.2 (d, d: JC-F = 20.0 Hz), 116.2 (d, d: JC-F = 20.0 
Hz), 72.5–67.8 (t, m), 52.5 (t), 39.5 (q), 37.0 (q) ppm; 19F NMR (282 MHz, CDCl3) δ 
-123.46, -124.26 ppm; IR (ATR): ṽ 3053, 2927, 2187, 1656, 1488, 1416, 1356, 1302, 
1259, 1208, 1192, 1154, 1108, 1043, 1017, 980, 938, 883, 828, 793, 732, 714, 675, 
612 cm-1; HRMS (EI) calcd for [C24H23N3O2SF2]




Yield 81%, light yellow solid, m.p.: 121–122 oC; 1H NMR 
(300 MHz, CDCl3) δ 7.53–7.51 (m, 2H), 7.44 (t, J = 7.5 Hz, 2H), 7.36–7.29 (m, 2H), 
7.09 (d, J = 8.7 Hz, 1H), 7.01 (d, J = 2.4 Hz, 1H), 6.94 (dd, J = 8.4, 2.5 Hz, 1H), 6.54 
(d, J = 2.7 Hz, 1H), 6.45 (dd, J = 8.7, 2.8 Hz, 1H), 4.79 (s, 2H), 4.10 (s, 2H), 2.68 (s, 
3H), 2.36 (s, 3H), 2.31 (s, 3H), 2.25 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 
146.3 (s), 144.4 (s), 137.2 (s), 137.1 (s), 136.5 (s), 130.4 (s), 129.8 (d), 129.4 (d), 
128.8 (d), 128.5 (d), 127.7 (d), 126.4 (d), 124.8 (s), 122.6 (d), 117.8 (s), 117.6 (d), 
114.1 (d), 69.4 (t), 51.4 (t), 39.9 (q), 37.2 (q), 20.4 (q), 20.3 (q) ppm; IR (ATR): ṽ 
2927, 2856, 1640, 1597, 1482, 1446, 1413, 1336, 1230, 1145, 1089, 1046, 962, 862, 
817, 767, 700 cm-1; HRMS (EI) calcd for [C26H27N3O2SCl2]
+ (M)+: 515.1196; found: 
515.1198. 
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